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Abstract
The biological and biochemical properties of teLA32 Src were examined in 
established rat fibroblasts. A cell clone expressing this protein (Rati f32) was found to 
be markedly temperature sensitive for morphological transformation and anchorage- 
independent growth. Rati f32 are rendered quiescent by serum deprivation at restrictive 
temperature; temperature shift in the absence of added serum factors results in cell cycle 
transit. The conditional nature of the biological phenotypes was not reflected in any 
examined biochemical parameter: &LA32 Src elevated cellular phosphotyrosine at both 
restrictive and permissive temperatures, and was non-conditionally autophosphorylated. 
teLA32 Src in vitro kinase activity was not measurable by immune-complex assay under 
conditions where thermolabile and wild-type controls behaved as expected, perhaps 
through lability of the mutant protein. Published data indicate that &LA32 Src remains in 
the particulate fraction of CEF at restrictive temperature. These data suggest that in vivo 
enzyme activity, autophosphorylation and membrane localization are together 
insufficient for transformation of Rati cells. Non-catalytic domains of pp60v"lSrc and 
their possible roles in transformation are discussed.
These properties suggest teLA32 Src would be useful in defining early Src- 
responsive events. Preliminary results indicate that very few proteins become 
differentially labelled with ^S-methionine after temperature shift of quiescent Rati f32. 
Dissociation of transformation parameters would allow dissection of these and other Src- 
responsive events. Dissociation was attempted using a thermolabile kinase defective for 
morphological transformation through point mutation of the N-terminal glycine. This 
non-myristylated protein, teLA29A2 Src, retained thermolabile in vitro kinase properties 
but was somewhat toxic in Rati cells. ttLA29A2 was non-mitogenic, and did not induce 
AP-1 binding activity in temperature-shifted quiescent CEF. Furthermore, taLA29A2 Src 
was non-mitogenic in quiescent CEF under conditions where AP-1 activity was 
artificially elevated. These data suggest a need for membrane association in the induction 
of both AP-1 binding activity and other v-src-induced events required for mitogenesis.
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Chapter I
2I INTRODUCTION
In 1911, Peyton Rous described the propagation of a spindle-celled sarcoma of 
chickens by means of a cell-free filtrate1. This observation provided one of the first clues 
to the viral etiology of certain forms of cancer, and with the advent of modern tissue 
culture, enabled a thorough investigation of the mechanisms of action of these agents. 
The study of transforming retroviruses, of which Rous sarcoma virus (RSV) is just one, 
and subsequent identification of the genes responsible for induction of the neoplastic 
state, has shaped our current understanding of the molecular basis of cancer2. The 
realization that these transforming genes, oncogenes, were originally transduced from the 
host cell genome3 has revealed genes whose products function in the process of normal 
cell growth. Hence, the analysis of transforming retroviruses provides a unique 
opportunity to identify and analyze cellular proteins that play important roles in the 
regulation of normal and malignant cell growth.
Genetic and biochemical studies using RSV have provided a wealth of data on the 
relationship between virus expression and cellular transformation. Genetic evidence that 
a viral gene was required for transformation was provided when several groups in the late 
1960s and early 1970s isolated temperature sensitive transformation mutants of RSV4*5*6. 
Further work by Martin and Duesberg7, and Vogt8 demonstrated that mutant viruses 
lacking a particular segment of the wild-type genome were defective for transformation 
whilst retaining the ability to replicate efficiently. Identification of this sequence, src, as 
the transforming function of RSV, led to the seminal observation that homologous 
sequences were present in the host cell DNA3. To follow shortly was the identification of 
the src gene product, ppbO ^9, and the demonstration that the Src protein was a unique 
protein kinase10*11 with specificity for protein tyrosine residues12. These observations 
opened the door to a great deal of biochemical and genetic experimentation on the role of 
tyrosine kinase oncogenes and proto-oncogenes in normal and malignant cells.
3This introduction will concentrate on the known properties of the Src protein, and 
characteristics of cells expressing this and its mutant derivatives. I will also describe 
attempts to identify substrates and effector molecules for the kinase activity and appraise 
the known candidates. This will lead to a description of my approach to this particular 
problem.
The mechanisms involved in regulating the cell cycle have received much 
attention recently, such that it is now possible to derive a molecular model for some of 
the important control points13*14. This introduction will outline the available data on Src- 
induced mitogenesis and in particular, will describe an attempt to dissociate the 
transforming and mitogenic activities of the Src protein, since these biological endpoints 
presumably reflect activity against specific subsets of proteins.
1.1 Transformed Phenotype
Although isolated by virtue of its tumorigenic nature in chickens, much of what is 
known about RSV and the v-src oncogene is the result of in vitro studies. Firstly, the 
target cell for the virus, namely chicken fibroblasts ,^ are easily cultured in vitro and 
secondly, RSV infected tissue culture cells display a number of phenotypic changes that 
correlate well with in vivo tumorigenicity15. Changes to the cellular phenotype can be 
classified loosely into two categories, namely morphological changes and changes in 
growth control. Collectively, these novel characteristics constitute the tranformed 
phenotype. Cells transformed by v-Src in vitro display a markedly different morphology 
to parental fibroblasts. Typically, the cells are rounded and very refractile, presumably as 
a result of underlying changes in the structure of the cytoskeleton and extracellular 
matrix. These refractile cells have now acquired the ability to overgrow upon reaching 
confluence, unlike parental fibroblasts which become contact-inhibited. Indeed, against a 
background monolayer of parental fibroblasts, v-Src transformed cells are able to form 
clumps of disorganised, refractile cells, called foci. Furthermore, individual transformed
4cells are able to proliferate and form colonies in semi-solid media, confirming their 
capacity for anchorage independent growth. v-Src transformed fibroblasts are also able to 
proliferate under conditions where normal cells become arrested, for instance in the 
presence of low concentrations of serum. This presumably results from changes in 
expression or activity of growth factors and / or receptors, or alternatively reflects the 
ability of the tyrosine kinase to replace these functions.
There are a number of metabolic and molecular changes associated with 
acquisition of the transformed state. For example, glycolysis is stimulated in w-Src 
transformed fibroblasts, leading to rapid acidification of culture medium. At least three 
glycolytic enzymes are phosphorylated on tyrosine under these conditions16*17, although 
these may be adventitious events since these tyrosine-phosphorylated enzymes are 
neither rate-limiting nor more active. Rather, it appears that this enhanced metabolic 
activity is a result of increased uptake of extracellular glucose. w-Src appears to achieve 
this end by two distinct mechanisms depending on the cell type studied. Increased 
transcription of the glucose transporter gene has been reported in transformed rodent 
fibroblasts18, whereas in transformed avian cells, w-Src apparently increases the net 
amount of transporter by reducing the rate at which the protein is degraded19. Adenylate 
cyclase activity is reduced rapidly upon w-Src expression20. The consequent change in 
cAMP levels may play a role in controlling glucose transport and cell shape, since 
addition of cAMP analogues to transformed cultures tend to restore these parameters to a 
more normal condition21.
Additional changes in gene expression following w-Src expression include 
increased synthesis of plasminogen activator22, and increased expression of a gene coding 
for a potential growth regulatory / inflammatory factor23*24, although the functional 
significance of the latter is in some doubt. Other workers have identified in cDNA clones, 
genes whose transcription is increased as temperature-sensitive Src exerts its mitogenic 
and transforming effects in avian fibroblasts25. In similar experiments, Durkin and
5Whitfield detected six new proteins as quiescent toRSV-infected NRK cells entered cell- 
cycle and became transformed following shift to the permissive temperature26*27. These 
may represent polypeptides required for the G1 to S transition. Using a rather different 
approach, other workers have demonstated that the activity of AP-1 responsive promoters 
is enhanced in cells expressing w-Src28 . Work from this laboratory has shown that 
increased transcription of c-fos and c-jun is not an early consequence of inducing cells 
into cycle using a ts w-Src mutant, although there is a concomitant increase in the AP-1 
binding activity of nuclear extracts prepared under these conditions29.
To conclude this section on aspects of cellular transformation, it is important to 
stress that these observations relate primarily to w-Src transformed fibroblasts, and that 
the expression of this oncogene can have very different effects in different cellular 
backgrounds. For instance, expression in the PC12 pheochromocytoma line results in 
differentiation rather than transformation30, whereas differentiation is suppressed by v- 
Src expression in murine glial cells31. It is also noteworthy that a subset of mutant 
proteins transformation defective for fibroblasts are still capable of extending the lifespan 
of neuroretinal cells in culture32-33.
1.2 The Src Protein
The src gene of RSV encodes a 60kDa phosphoprotein, pp60. This protein is 
plasma-membrane associated by way of non-covalent interaction with a specific receptor 
protein34. Additional populations of Src protein are found in the nuclear membrane35, and 
in particular within adhesion plaques36, structures where the cell and substratum are 
closely opposed. Localization of the protein to the particulate fraction of the cell is an 
absolute requirement for transforming activity37. The only characterised enzymatic 
activity of pp60 is that of a protein-tyrosine kinase. This is true of highly purified protein 
from eukaryotic cells38-39, and also of protein purified from recombinant E. coli40, 
suggesting that this activity is intrinsic to the protein. Immunoprecipitation of pp60 from
6RS V-infected cells yields immune complexes which, in the presence of Mg^+ (or Mn^4) 
and ATP catalyze both the phosphorylation of pp60 itself (autophosphorylation)41, and / 
or exogenous substrates42. This forms a convenient assay for the kinase activity, and in 
general this in vitro activity reflects the tyrosine kinase activity of pp60 in vivo. That the 
tyrosine-specific kinase activity of pp60 is necessary for initiation and maintenance of the 
transformed phenotype can be deduced from two experimental observations. Firstly, 
transformation by RSV is accompanied by a dramatic increase in the level of cellular 
phosphotyrosine43, and secondly, mutations in the v-src gene that inactivate the in vivo 
kinase activity are invariably defective for transformation44-45*46. These results provide 
compelling evidence that the tyrosine kinase activity of pp60 is indispensable for 
transformation. However the mechanism by which tyrosine phosphorylation mediates the 
events leading to cellular transformation is unclear.
1.3 Biogenesis and Post-translational Modification of pp60
pp60 is translated from a 21S mRNA on cytosolic polyribosomes before transit to 
the cell periphery47-48. A diagram showing the proposed biosynthetic route of pp60 is 
shown in figure 1.1. The precise temporal sequence of events is not known, and hence 
this model should be viewed as a framework only. Cotranslationally, the initiating 
methionine at position 1 is cleaved and glycine 2 is myristylated. The latter modification 
will be discussed in detail below (see section 1.5). Despite intimate association with the 
plasma membrane, pp60 appears not to transit via the endoplasmic reticulum and Golgi 
apparatus49, suggesting a novel transport mechanism is required to localize the protein 
correctly within the cell. One candidate for this transport function is a tri-molecular 
complex formed between pp60 and two cellular phosphoproteins of 50 and 90kDa shortly 
after pp60 synthesis50. The kinetics of association and dissociation of pp60 with this 
complex are consistent with the kinetics of appearance of the protein at the inner surface 
of the plasma membrane51. However, some mutant pp60
7Figure 1.1
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8proteins are able to localize correctly in the absence of detectable complex formation52, 
while the product of another src family member, v-Fgr, associates with pp50 and pp90 in 
a very stable complex53. In addition, this complex is undetectable in cells overexpressing 
the c-Src protein54 (S. Courtneidge, personal communication). These observations argue 
against this tri-molecular complex being the only transport mechanism for the Src 
protein. Indeed, other lines of evidence suggest that the complex could play an entirely 
different role in removing partially denatured forms of pp60 from the cell. Firstly, the 
90kDa host cell protein is a member of the heat-shock protein family50, and secondly 
some temperature-sensitive mutants of pp60 show an increased level of complex 
formation, particularly at restrictive temperature55. One can also postulate other functions 
for this complex either in protecting the cell ffom cytosolic protein tyrosine kinase 
activity, since complexed pp60 is essentially kinase inactive in vitro56, or in protecting 
the Src protein from proteolysis after synthesis. There is no firm evidence to substantiate 
these hypotheses.
pp60 contains two major sites of phosphorylation : tyrosine 416, a proposed 
autophosphorylation site57 and serine 17, a site of phosphorylation by protein kinase A58. 
The stoichiometry of phosphorylation of these residues is approximately 30 and 60% 
respectively59. pp60 found in the tri-molecular complex described above is 
phosphorylated only on serine 17, full kinase activation and tyrosine 416 
autophosphorylation occurring only after release from this complex56. pp60 can also be 
phosphorylated at serine residues 12 and 48 in CEF in response to pharmacological 
agents that increase the activity of protein kinase C60. These residues are normally 
unphosphorylated, and some work suggests that serine 48 may not be a target for protein 
kinase C in mammalian cells61. The functional significance of the serine phosphorylation 
events is unclear since mutation of these residues fails to compromise the transforming 
activity of the protein, and has only modest effects on kinase activity62*63. However, since 
pp60v-iSrc is typically highly overexpressed, subtle changes in localization or activity
9cannot be ruled out. Indeed, the activity of the cellular homologue, chicken pp60c"5rc 
appears to be stimulated in part by phosphorylation of two N-terminal threonine residues, 
34 and 46, and serine 72s4. Human pp60c-lSTC is also subject to mitosis specific 
phosphorylation65. In both cases, these modifications are present only in mitotic cells, 
disappearing within 15min of release from nocodazole arrest, in parallel with 
cytokinesis66. Interestingly, all three sites are located within the consensus sequence 
charged-polar-Ser\Thr(P)-Pro-X-basic, closely related to the sites in histone HI that are 
phosphorylated by p34c^  during mitosis67. The stringent temporal correlation suggests 
that pp60c_,yrc may play a role in regulating passage through mitosis, although the 
survival of mice68 and cell lines69 lacking endogenous c-src indicate that pp60c_,src is not 
essential for mitosis. N-terminal tyrosine (and possibly serine) phosphorylation of pp60c" 
src also occurs in response to stimulation of fibroblasts with PDGF, resulting in a modest 
increase in the kinase activity of the protein70-7!. Recent results have indicated that PDGF 
stimulates the association of pp60c"lSrc, and other src-family members^with the PDGF 
receptor, and that these associated proteins have an elevated in vitro kinase activity72. 
The role of src-homology (SH) domains in the redistribution of src-family kinases and 
other signalling molecules in response to growth factors and transformation is discussed 
below (section 1.6).
C-terminal tyrosine phosphorylation appears to play an important role in 
conferring oncogenicity in src family members, at least in vitro. All activated src family 
kinases are phosphorylated in vivo at a tyrosine in the catalytic domain. This includes the 
viral transforming proteins, chimaeras with their N-terminal three-quarters coded by v- 
src, c-Src proteins with altered C-termini, c-Src proteins complexed with polyoma 
middle T antigen, and overexpressed p 5 6 ^  from LSTRA cells73. This tyrosine is also 
the primary site of phosphorylation when purified src family kinases are incubated with 
ATP in vitro, suggesting that the reaction is autocatalytic57. This reaction is believed to 
be intermolecular rather than intramolecular74. Direct evidence that tyrosine 416
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phosphorylation augments activity has recently been obtained. Incubation of fibroblasts 
with e>rr/zo-vanadate, a protein-tyrosine phosphatase inhibitor, causes pp60c_5rc to 
become extensively phosphorylated at tyrosine 416, and pp60 purified from these cells 
has an elevated in vitro kinase activity75. In \-Src, though tyrosine 416 may be 
dispensable for cell transformation in vitro63*76 (but see ref. 77), its loss has a clear effect 
in experimental animals. Mouse cells transformed by a substitution mutant containing 
phenylalanine at position 416 are tumorigenic in nude mice but essentially non- 
tumorigenic in immunocompetent syngeneic animals78. The biochemical basis for this 
observation is not understood. It is interesting that the v-Src protein encoded by this 
mutant contains reduced but significant phosphotyrosine, indicating that other sites of 
tyrosine phosphorylation exist in the protein. Some published data support this idea and 
suggest that these sites are tightly regulated in vivo by protein phosphatases79. As with 
the other sites of post-translational phosphorylation, establishing a functional role has 
been difficult. Indeed, one should always bear in mind that these sites may no longer play 
any regulatory role due to the presence of additional mutations within the viral protein.
The c-src product is also tightly regulated by C-terminal tyrosine 
phosphorylation. pp60c"lSrc is phosphorylated to high stoichiometry on tyrosine 527 and 
low stoichiometry on tyrosine 416 in unsynchronised cells, this correlating with a 
relatively low in vitro kinase activity73. Dephosphorylation of tyrosine 52780 or mutation 
of this residue to phenylalanine or serine81*82*83*84 markedly stimulates both kinase activity 
and phosphorylation of tyrosine 416. Tyrosine 527, which has been deleted in v-Src, may 
play the major role in negatively regulating pp60c"5rc in vivo. A kinase capable of 
catalysing the specific phosphorylation of tyrosine 527 has been purified85 and recently 
cloned86 although the phosphatase responsible for reversing this modification is presently 
unknown. As noted, the kinase activity of pp60c' ,src can be increased by prior treatment 
of the cells with vanadate, an inhibitor of protein tyrosine phosphatases75. The increase in 
kinase activity correlates with an increase in tyrosine 416 phosphorylation, the level of
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tyrosine 527 phosphorylation remaining high. Although suggesting that kinase activity 
can be regulated independently through phosphorylation of tyrosine 416 or tyrosine 527 
under conditions where the action of protein tyrosine phosphatases has been reduced, 
there is no direct evidence that this plays a physiological role in regulating pp60c_,src 
kinase activity. Available data tentatively suggest that physiological activation of the c- 
Src protein, for instance at mitosis, is accompanied by a small decrease in the 
stoichiometry of phosphorylation of tyrosine 52787, in addition to the appearance of N- 
terminal serine and threonine phosporylation64-65.
In summary, it appears that the deletion of tyrosine 527 in v-Src is largely 
responsible for the increased enzymatic and transforming activity of this protein. Other 
phosphorylation sites appear to play a relatively minor role in determining v-Src kinase 
and transforming activity. However, v-Src is typically overexpressed, and subtle effects 
of modification to an active population of molecules may go un-noticed.
1.4 Domain Structure of pp60
In vitro mutagenesis techniques have facilitated attempts to define important 
structural and functional motifs within the Src protein. Together with analysis of 
biologically selected and naturally occurring variants, this approach has resulted in a 
division of the protein into a linear series of domains. It is important to stress that this is a 
gross oversimplification, since the protein is probably globular in nature and widely 
separated residues are able to interact to form functional structures. Indeed, single point 
mutations can have pleiotropic effects on pp60 function. The term "domain" is used in its 
most general sense. The domain structure of pp60 will be discussed within this context. 
The model referred to is outlined in figure 1.2, and since extensive reviews55*88 are 
available on this subject, only the major features will be discussed.
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The catalytic activity of pp60 resides in a 30kDa proteolytic fragment from the C- 
terminus. This fragment exhibits protein-tyrosine kinase activity in vitro*9, and also 
shares amino acid sequence homology with other members of the src family, with 
receptor tyrosine kinases90, and, to a limited extent serine / threonine kinases91. Mutations 
within the catalytic domain usually have effects on kinase activity and transforming 
potential.
Myristylation of pp60 and subsequent membrane binding is mediated in part by 
an amino-terminal domain consisting of the first 7-10 amino acids of pp6092. As 
discussed below, this domain contains the site of myristylation and additional residues 
required for recognition by the fatty-acyl transferase. Additional N- and C-terminal 
sequences also play a role in ensuring membrane association without directly influencing 
myristylation52-93-94.
The remaining amino terminal sequences comprise what is termed the 
"modulatory region" of the Src protein. This region of pp60 contains the major site of 
serine phosphorylation of the enzyme (serine 17), as well as sequences that exert positive 
and negative effects on the activity of pp60. The region encompassing residues 18 to 83 
is quite divergent within the src family of tyrosine kinases, and has been termed the 
"unique domain"73. One hypothesis is that this region may dictate functional interactions 
of the cellular src family members with non-tyrosine kinase receptor molecules, 
increasing the kinase activity of pp60c-,yrc. This interaction would be redundant in the 
case of v-Src, a constitutive tyrosine kinase. Indeed, the T cell product of the c-lek gene 
has been shown to associate non-covalently with both CD495-96 and CD895-97, lek residues 
15-23 being essential for these interactions98. These complexes appear to be functional, 
since antibody-mediated cross linking of CD4 leads to rapid kinase activation of 
associated p p 5 6 ^ 99. Association with cell surface recptors \  glycoproteins is not unique 
to pp56^\ Several src-related tyrosine kinases associate with cell surface receptors \  
glycoproteins : pp60^n with the T-cell receptor100, pp56^ , pp56^w and pp6(fon with
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the B-cell receptor101, p p 5 6 a n d  pp62c~yes with the IgE receptor102 and pp60^w, 
pp62c~yes and pp56^w with the platelet glycoprotein CD36103.
From residue 84 and extending to the N-terminal boundary of the catalytic 
domain (residue 280), significant sequence homology is evident among the non-receptor 
tyrosine kinases. This "homology region" was initially designated the SH2 (src homology 
2) region based on sequence comparisons of the w-jps, w-abl and w-src genes104. This 
region also exhibits striking similarity with w-crk105, an oncogene whose product appears 
not to be a tyrosine kinase, phospholipase Cy106, phosphatidylinositol 3 kinase-associated 
protein p85107>108*109 and the Ras GTPase activating protein GAP110. This region has been 
subdivided on the basis of the biological properties of mutations within this region and 
the homologies with w-crk, phospholipase Cy, phosphatidylinositol 3 kinase-associated 
p85 and GAP.
1.5 Mvristvlation Domain
The transforming activity of the w-Src product is absolutely dependent on 
association with the particulate fraction of the cell92-111. Presumably, membrane 
association of the normal cellular product is also essential for proper function112. Unlike 
most membrane proteins pp60 is synthesized on cytosolic polysomes47-48*113 and sequence 
analysis reveals that the protein lacks a conventional hydrophobic signal sequence114. The 
interaction of pp60 with cellular membranes requires covalent modification of an amino 
terminal glycine residue with myristic acid52-115-116-117 The importance of myristylation 
has been clearly demonstrated by mutational analysis of the N-terminal sequences of 
pp6092-118. These studies, together with gene fusion experiments119, have demonstrated 
that the first seven residues of pp60 may contain the minimal recognition sequence for 
the fatty-acyl transferase, and that glycine 2 is the site of acylation111-120 A basic residue 
at position 7 is critical for myristylation of Src : replacement of lysine 7 by aspartate but
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not by arginine, greatly reduced myristylation, membrane association and transforming 
activity of pp60121.
Though essential for membrane localization of the Src protein, recent biochemical 
evidence suggests that myristylation of pp60 is not itself sufficient for proper insertion of 
pp60 in cellular membranes. Using in vitro reconstitution experiments, Resh has shown 
that stable association of pp60 with membrane vesicles requires both myristylation of 
pp60 and also the presence of cellular proteins in the reconstitution mix122. These results 
suggest that cellular proteins are involved in the stable insertion of pp60 in cellular 
membranes. Subsequent work from the same group has implicated a 32kDa host cell 
protein in stimulating association of pp60 with purified plasma membranes123. This 
cellular protein appears to be an integral membrane protein, and available data suggest it 
may be acting as a specific receptor for myristylated Src proteins124.
Analysis of several mutant Src proteins indicates that structural features distant 
from the myristylation domain also play a role in ensuring stable membrane association 
(reviewed in ref. 125). A number of ts mutants, for example the pp60 of &LA29 RSV, 
exhibit a reduction in membrane binding particularly at the non-permissive temperature 
despite full myristylation93. Since the critical mutation in &LA29 Src is at residue 507, it 
has been suggested that membrane association at the non-permissive temperature is 
influenced by a defect in transit to the membrane94.
In summary, both genetic and biochemical experiments support the notion that 
myristylation of the Src protein requires a domain spanning the first seven residues of 
pp60. However, the association of myristylated pp60 with cellular membranes is more 
complex, and requires the interaction of other pp60 sequences and at least one cellular 
membrane protein.
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1.6 Homology Domain
Analysis of mutant Src proteins suggests that the homology domain plays a role in 
modulating the function of both the viral and cellular Src proteins. The properties of 
individual mutants with structural alterations in this region, and the noted homology 
between sequences within this domain and other cellular and viral proteins, suggests that 
the homology domain can be further subdivided into at least two regions, SH2 and 
SH3126.
Immediately N-terminal to the catalytic domain is a sequence of approximately 
100 residues which is present in proteins encoded by v-src, v-fps and v-abl104. The 
overall sequence identity in this SH2 domain is approximately 30%, although the more 
N-terminal 45 residues are especially conserved. Most of the evidence relating to the 
function of this domain in cytoplasmic protein tyrosine kinases has been gleaned using 
oncogenic proteins with cellular transformation as a biological endpoint Since the SH2 
domain can be removed from v-Src, v-Fps or v-Abl proteins without destoying kinase 
activity, it is clearly unnecessary for this catalytic function126. Nonetheless, both 
circumstantial and direct genetic evidence suggest that the SH2 domain is important for 
efficient fibroblast transformation. This domain is retained in all non-receptor tyrosine 
kinase oncoproteins104*127*128 and mutations within this domain of pp60 render the protein 
entirely, conditionally or partially defective for transformation77*104*129*130*131*132*133. 
Mutations within the highly conserved N-terminal sequences of this domain can abolish 
v-Src and v-Fps transforming activity. In v-Fps, these mutations reduce the specific 
kinase activity of the protein, suggesting that the SH2 domain might act in cis with the 
kinase domain to modify catalytic activity104. Similar mutations in v-Src have a less 
pronounced effect on kinase activity, but appear to destabilize the protein following its 
arrival at the plasma membrane133. Both v-fps and v-src have yielded SH2 domain 
mutants which are temperature sensitive for transformation in chick embryo fibroblasts.
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The decrease in the kinase activity at the non-permissive temperature is again more 
marked for v-Fps mutants than for w-Src mutants129*131*133.
In addition to associating with the kinase domain, the SH2 domain also interacts 
in trans with a cellular factor or factors104*130*131*132. Informative in this respect is the 
observation that several mutants of v-Fps and v-Src with lesions in the SH2 domain are 
host-dependent in their transforming activity77*131*134*135*136. This can be explained if the 
mutant proteins fail to bind a critical SH2 ligand in the non-permissive (usually rat) host. 
In elegant experiments^Pawson and colleagues have shown that cellular factors bind to 
the SH2 domain. Using a trpE-SB2 fusion protein, they were able to collect complexes 
containing a cellular protein of 62kDa137. A protein of identical molecular weight is 
found in immunoprecipitates of the Ras GTPase activator protein, GAP138, and in 
immunoprecipitates of v-Fpsm . The binding of the pp60 SH2 domain to a cellular 
protein might positively regulate the activity or stability of the adjacent kinase domain, or 
allow access to important phosphorylation targets. The SH2 domain may have multiple 
functions by virtue of its interactions with the kinase domain and host cell factors.
The Src and Abl proteins share an additional non-catalytic domain (SH3) of 
approximately fifty residues direcdy N-terminal to SH2105*106. Mutant v-Src proteins 
lacking the SH3 motif are able to transform chick embryo fibroblasts130, and indeed it is 
possible to oncogenically activate c-Src proteins by amino acid substitutions and 
deletions in the SH3 region140. These observations imply that the SH3 domain in the c- 
Src protein may have an inhibitory effect on oncogenic potential. SH3 does appear to 
play a positive role in the morphological changes induced by v-Src in transformed chick 
embryo fibroblasts. A number of v-Src mutants that induce a fusiform transformed 
morphology have deletions or amino acid substitutions in the SH3 domain77*130*141*142*143. 
These observations can be incorporated into a model in which SH3, like SH2, forms a 
binding site for cellular ligands that regulate and \  or effect Src function. SH2 and SH3 
apparently have quite different, and perhaps opposing effects.
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In addition to the cytoplasmic protein tyrosine kinases, recent data have 
demonstrated that at least nine cellular polypeptides and a retroviral oncoprotein contain 
sequence elements similar to SH3 and \  or SH273*74*75*144. These are discussed below.
Phospholipase C-y (PLC-y) cleaves phosphatidylinositol 4,5 fosphosphate to yield 
the two second messangers: diacylglycerol, which activates protein kinase C, and inositol 
1,4,5 rnsphosphate, which raises intracellular calcium ion concentration. The turnover of 
inositol phospholipid is a rapid and important result of stimulation of cells with various 
mitogenic agents (reviewed in refs. 145,146,147), and there is some evidence that this 
turnover may be enhanced in v-Src transformed cells148*149*150*151*152. The functional 
relevance of these observations is not clear. The SH2 and SH3 elements in PLC-y are not 
required for catalytic activity, are not found in other PLC isozymes and are therefore 
presumed to be regulatory153*154. Stimulation of phospholipase C activity in response to 
polypeptide mitogens appears to require the intrinsic tyrosine kinase activity of the 
receptors since kinase defective mutants that bind ligand fail to stimulate hydrolysis of 
inositol phospholipids155*156*157. Both platelet-derived growth factor (PDGF) and 
epidermal growth factor (EGF) induce association of PLC-y isozyme 1 with their 
respective receptors and stimulate the phosphorylation of PLC-yl on tyrosine residues by 
the receptor kinase and on serine residues by an unknown protein kinase158*159*160. Nishibe 
et al. have demonstrated an increase in the catalytic activity of PLC-yl following 
stimulation of cells with EGF161. This effect is mediated in part through tyrosine 
phosphorylation of PLC-yl161. However, the stimulation of phospholipase C activity is 
not essential for PDGF-dependent mitogenesis162, and colony stimulating factor 1 (CSF- 
1) does not stimulate association of PLC activity with its cognate tyrosine kinase 
receptor163.
Phosphatidylinositol 3-kinase (PI3-kinase) was the first of this group of proteins 
containing src-homology regions to be found associated with a tyrosine kinase164*165. 
Subsequent purification by conventional means has demonstrated that the enzyme is a
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tightly complexed heterodimer of 85 and llOkDa subunits166. Molecular cloning of the 
p85 subunit revealed the presence of an SH3 and two SH2 domains107’108*109, the latter 
being implicated in binding of this subunit to other cellular proteins. The catalytic 
activity of PI3-kinase appears to reside in the llOkDa subunit, suggesting that the 85kDa 
subunit may direct protein-protein interactions107’109*166. Phosphatidylinositol, 
phosphatidylinositol 4-phosphate and diacylglycerol have been shown to be 
phosphorylated by activities that co-purify with pp60v_5rCl67. Phosphatidylinositol kinase 
activity has also been demonstrated in immunoprecipitates of pp68v_r£>,Sl68. Since these 
activities were not easily separated from and were inhibited in parallel with tyrosine 
kinase activity, they were originally believed to be intrinsic activities of the same 
polypeptide. Phosphatidylinositol kinase activity was also found associated with the 
polyoma middle t-pp60c"5rc complex, and was shown to be separable from the complex 
in high salt and detergent solutions165. Subsequent results indicated that this enzyme was 
distinct from the major phosphatidylinositol 4-kinase activity in fibroblasts165, and that it 
phosphorylated the D-3 position of the inositol ring169. Association of this enzyme with 
the middle t-pp60c_5rc complex appears to correlate strongly with transformation of 3T3 
fibroblasts170, although not absolutely since a point mutant of middle t, 248m, which 
complexes with both tyrosine and lipid kinase activities, is transformation defective171. 
However, there appears to be absolute correlation in this system between elevation of the 
lipid products of PI 3-kinase and cellular transformation in vivo112. Mutants of pp60v“ 
57X173 and of ppl308a8-abln4 that fail to associate with phosphatidylinositol 3-kinase fail 
to transform, whereas transforming mutants of pp60c_,src are able to associate with the 
lipid kinase activity175’176. Furthermore, Hanafusa and colleagues have demonstrated that 
PI3-kinase or an associated protein is phosphorylated on tyrosine by growth factor 
stimulation or in cells transformed with tyrosine kinase oncogenes and that 
phosphorylation is required for the association of PI3-kinase and pp60v~‘yrCl77. Neither 
tyrosine phosphorylation nor kinase activity of pp60 is required for binding177.
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Interestingly, PI3-kinase activity is co-precipitated with mutants of v-Src defective for 
myristylation, suggesting that neither prior membrane localisation nor transformation are 
required for association with pp60173. These data indicate that association of PI3-kinase 
with pp60 is itself insufficient to elicit transformation, although when one considers the 
membrane localization of substrates for this enzyme, this is not surprising. This prompts 
speculation that the absolute requirement for membrane localization of pp60 for 
transformation need not imply the existence of critical membrane targets for the kinase 
activity of Src : an alternative hypothesis would be that membrane association of the v- 
Src product allows recruitment of other molecules to the appropriate membrane 
environment163. The requirement for pp60 tyrosine kinase activity could be incorporated 
into this model : it might favour interaction with these signalling molecules either by 
direct phosphorylation or through conformational change induced upon activation of the 
kinase, or alternatively prevent dissociation once the complex has formed.
All studied receptor-type tyrosine kinases also associate with a 
phosphatidylinositol 3-kinase activity upon ligand binding163. Binding of PI3-kinase is 
best characterised for the PDGF receptor. Association of p85 and PI3-kinase activity can 
be detected within one minute of stimulation of fibroblasts with PDGF164*165. Association 
of PI3-kinase with the receptor requires the kinase insert domain containing one of the 
autophosphorylation sites, tyrosine 751178. Deletion of the kinase insert179 domain or 
mutation of tyrosine 751 to phenylalanine180 dramatically reduces recruitment of PI3- 
kinase following PDGF stimulation. Binding of PI3-kinase to the PDGF receptor is 
dependent on the tyrosine kinase activity of the receptor178*180. Deletion of the kinase 
insert domain abolishes ligand induced DNA synthesis, suggesting that association of 
PI3-kinase with the receptor is required for the mitogenic activity of PDGF178. It is 
proposed that PI3-kinase binds to autophosphorylated receptors through the SH2 domains 
of its p85 subunit, and that tyrosine 751 forms part of the binding site for this enzyme 
(reviewed in ref. 163). Increased tyrosine (and serine) phosphorylation of PI3-kinase
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occurs following association with the activated PDGF receptor164, though at present it 
remains unclear whether the lipid kinase activity is modulated by this modification. It 
may be that recruitment to the plasma membrane, where inositol lipid substrates reside is 
all that is required. However, the stoichiometry of tyrosine phosphorylation of PI3-kinase 
in response to PDGF suggests an important role, perhaps in recruiting other SH2- 
containing proteins to the receptor. The ubiquitous association of PI3-kinase with 
activated tyrosine kinases suggest an evolutionary link, and furthermore implies 
important functions for the novel lipid products of this enzyme163.
Functional p21ray is essential for the transduction of signals from the protein 
tyrosine kinases of growth factor receptors181 and transforming oncogenes182. Biological 
activity of the Ras proteins is regulated by binding of guanine nucleotides and also by the 
intrinsic GTPase activity of the protein (reviewed in refs. 183,184). p21ras-GTP has been 
demonstrated to be the biologically active form of Ras proteins in mammalian cells185*186. 
Activated Ras proteins are transforming, suggesting that they exist mainly in the GTP- 
bound form185. In vivo measurements demonstrate that the rate of GTP hydrolysis is 
greater in cells expressing the normal protein than in those expressing the activated 
mutants, consistent with this hypothesis185. However, in vitro measurement of GTPase 
activity revealed that the intrinsic catalytic activities of normal and activated protein were 
similar, implicating a cellular factor in modulating in vivo activity185. This GTPase 
activator protein (GAP) has been purified and cloned110. The GAP sequence contains 2 
SH2 domains110 and a recently identified SH3 domain187 in the N-terminal region of the 
protein, with the catalytic activity residing in the C-terminal 344 amino acids188. The SH2 
and SH3 domains are believed to play a role in protein-protein interactions137 (see below) 
and are not required for catalytic activity188. Purified preparations of GAP stimulate 
hydrolysis of GTP bound to normal Ras, but not when bound to activated Ras, 
accounting for the observed in vivo difference in GTP hydrolysis185. The catalytic activity 
of GAP suggests a role in negative regulation of Ras activity, and hence modulation of
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this activity could control Ras activity. However, since GAP is found in great excess of 
Rasm , it is possible that GAP has other functions in addition to downregulating p2lras 
activity. Recent evidence suggests that GAP can act as a signal effector in addition to its 
role as a signal terminator. The region of p2lras to which GAP binds in vitro, the 
effector binding region, is important for Ras function. Point mutations within the effector 
binding region of v-Hz-Ras that destroy biological (transforming) activity also prevent 
GAP mediated stimulation of normal Rasl90<m . This suggests that GAP binding is 
essential for p2lras function, i.e. GAP itself may be part of the effector complex. The 
best evidence for an effector function of GAP was obtained in an unexpected fashion. K+ 
channels in isolated atrial membranes are controlled by G^ after activation of muscarinic 
receptors. Addition of recombinant GAP or p2lras blocks the current flow through 
activated K+ channels192. The effect of recombinant GAP is dependent on endogenous 
p2lras, and vice versa. Yatani et al. conclude that p21.GTP-GAP is responsible for 
blocking the channels192. Since this effect could be overcome by binding GTPyS to G ^ it 
is likely that GAP acts directly by inhibiting coupling of G^ to the activated muscarinic 
receptors or indirectly by inhibiting association of G ^  to its py subunits192. Since py 
subunits are often shared amongst G proteins, this observation may have some bearing on 
the downregulation of G protein dependent phosphatidylinositol lipid turnover in growth- 
factor stimulated v-ras-transformed cells193*194.
GAP is phosphorylated on tyrosine in response to EGF138, PDGF195*196, CSF-1197 
and the tyrosine kinase oncogene products of v-src138 and v-fpsm . In addition GAP 
associated proteins of 62 and 190kDa become phosphorylated on tyrosine in cells 
transformed by protein-tyrosine kinase type oncogenes138*196. One of the GAP SH2 
domains is required for binding of p62137. Approximately 10% of GAP becomes 
associated with the PDGF receptor upon stimulation with ligand, though the receptor 
sequence involved is not completely clear196. (Phosphorylation of receptor tyrosine 751, 
the autophosphorylation site implicated in PI3-kinase binding is not primarily responsible
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for this association196). Perhaps association with the PDGF receptor blocks the ability of 
GAP to downregulate p21.GTP, leading to a mitogenic signal. In support of this notion, it 
has been demonstrated that much of the GAP in stimulated cells is complexed to p i90, 
and in this form is relatively inactive in stimulating p21 GTPase activity198. However, 
inhibition of p21.GTP hydrolysis is unlikely to be the whole story given the relative 
abundance of GAP and the evidence for an effector function of the p21.GTP-GAP 
complex. An alternative idea is that p62 \  p i90 \  GAP transduces a mitogenic signal in 
complex with p21.GTP. Excess GAP would terminate signalling by competition, i.e. 
GAP may act as both an effector and inhibitor of p2lraSl". One weakness in this model 
is the failure to detect association of p62 or pl90 with GAP in v-Ras transformed cells163.
At present there is no evidence to suggest that GAP catalytic activity is modulated 
by tyrosine phosphorylation. However, Ha-/?&s GTPase activity is regulated in vitro by 
phospholipids and some fatty acids released upon growth factor stimulation200. This 
observation is intriguing given the co-recruitment of PI3-kinase and PLC-yl to activated 
PDGF receptors. In vivo regulation of GAP activity has been observed in activated T 
cells. Downward et a/.201 have observed a large and very rapid increase in the fraction of 
GTP-bound \>2lras upon stimulation of T cells, apparently through a protein kinase C 
mediated inhibition of GTPase activity. Direct phosphorylation of GAP has not been 
observed, leading the authors to speculate that the activity of a GAP inhibitor might be 
modulated through protein kinase C201. These observations are interesting in view of the 
dissociation of morphological transformation and mitogenesis in ras-transformed 
fibroblasts chronically treated with phorbol ester202*203*204.
Data from a number of groups indicate that GAP is unlikely to be the sole Ras 
target. Intact GAP or the catalytic C-terminus of GAP suppresses c-Ras but not v-Ras 
transformation of NIH 3T3 cells upon co-transfection, and is able to reverse established 
c-Ras transformation, consistent with its proposed function as negtive regulator of p21ras 
activity205. Notably, GAP does not augment c-ras transformation in this system,
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indicating that it is not the sole downstream target of p21rfl^205. However, these 
experiments do not rule out the possibility that GAP functions in conjunction with other 
proteins downstream of \>2\ras. Since the transforming and mitogenic activities of v-Src 
are dependent on functional RaslS2, and GAP co-precipitates with v-Src206, similar 
experiments to address the inhibitory activity of GAP were undertaken in v-Src 
transformed cells. Although inhibition or reversion of transformation was observed, the 
morphology of the revertant clones suggested that these cells were still partially 
transformed207*208.
In addition to negative regulation by GTPase activator proteins such as GAP, 
p21ras is also subject to control at the level of nucleotide exchange. Three groups have 
reported partial purification of a protein or proteins capable of stimulating guanine 
nucleotide exchange on Ras proteins, including transforming and effector mutants that 
are insensitive to the action of GAP209*210*211. These activities may be equivalent to the 
yeast CDC25 product that appears to promote nucleotide exchange on p 2 9 ^ ^ 212*213. 
Elegant work by Rubin and colleagues has demonstrated that a putative activator of Ras 
guanine nucleotide exchange performs a crucial role in signalling by the Drosophila 
Sevenless protein tyrosine kinase214*215. In the absence of functional Sevenless, each 
omnatidium of the Drosophila compound eye lacks a particular photoreceptor cell, the R7 
cell. Using a temperature sensitive variant of Sevenless, the workers were able to use the 
development of the R7 cell as a genetic screen to find downstream effectors of this 
receptor-type tyrosine kinase. Two genes identified by this procedure encode proteins 
with homology to Ras and the yeast activator of Ras guanine nucleotide exchange, 
CDC25214. These data suggest that Sevenless may enhance signalling through Ras by 
stimulating exchange of bound GDP for GTP, though alternative mechanisms (inhibition 
of GAP for example) have not been ruled out214. Subsequent work from this group 
indicates that activated Rasl can substitute for Sevenless function under conditions where 
the Sevenless ligand, Boss, is absent215.
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The v-Crk product of the CT10 virus is a 47KDa Gag-Crk fusion protein105. 
Sequence analysis indicates that this protein has no significant homology with any known 
catalytic domain, and hence v-Crk is believed to transform via a modulation of 
endogenous enzyme activity105. Indeed, cells transformed with v-Crk contain elevated 
levels of protein phosphotyrosine105, much of which is concentrated in three cellular 
proteins that co-precipitate with p47£fl£"cr^105*216*217. Immunoprecipitates of p47 formed 
with anti-Gag antiserum contain both serine \  threonine and tyrosine kinase 
activities105*216. Hanafusa and colleagues have proposed that p47 forms a ternary complex 
with both kinases and substrates, and that this complex favours tyrosine phosphorylation 
of specific proteins either by activating kinase activity or by protecting phosphorylated 
substrates from the action of protein tyrosine phosphatases216.
Association of tyrosine phosphorylated proteins with p47^fl^ “cr^ is dependent on 
a number of structural features. Mutation of either SH2 or SH3 domains reduces or 
destroys transforming ability218*219. Deletion of N-terminal Gag sequences leads to 
relocation and partial loss of transforming activity218. In all cases there is an absolute 
correlation between transformation and elevation of cellular phosphotyrosine218. SH2 
domains appear to bind to conformational determinants that are dependent on tyrosine 
phosphorylation rather than phosphotyrosine itself, since competitor phosphotyrosine 
decreases but does not abolish binding217.
Bacterially expressed SH2 domains have been used by a number of groups to 
demonstrate specific binding of tyrosine phosphorylated proteins. Pawson and colleagues 
have demonstrated in vitro binding of p62 to the N-terminal SH2 domain of GAP, and 
binding of unidentified proteins p i30 and p70 to v-Crk SH2 domains in trpE fusion 
proteins137. This group has also demonstrated binding of GAP and PLC-yl SH2 domains 
to the PDGF and EGF receptor in lysates of stimulated cells137*220*221. Other workers have 
described the association of two tyrosine phosphorylated proteins, pi 10 and pl30 that 
associate with activated pptiO0-5^  proteins in chicken cells222. Binding is dependent on
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an intact pp60 SH2 domain, and also on the presence of activated kinase223. Notably, 
fusiform SH3 domain mutants fail to associate with pi 10, and indeed pi 10 is not 
detectably tyrosine phosphorylated in these cells223. It is apparent that different SH2 
domains show different binding specificities in vitro and presumably in vivo126-137*163. 
Indeed, high-level expression of the GAP src-homolgy region is non-transforming, in 
contrast to the transforming effect of the src-homology region of Crk.
Three recent reports document the isolation of SH2-containing sequences 
encoding a protein tyrosine phosphatase, PTP1C224, and a protein serine \  threonine 
kinase, Akt225 or Rac226. PTP1C contains two N-terminal SH2 domains, which in isolation 
can bind to a variety of phosphotyrosine-containing proteins, including the activated EGF 
receptor224. Although complex formation between PTP1C and activated receptors has 
not been observed in vivo, it is tempting to speculate that this enzyme is representative of 
a class of phosphatases involved in regulating (down-regulating ?) the activity of signal 
complexes formed in response to ligand binding. Alternatively, signal tranduction may 
consist of independent parallel pathways of tyrosine phosphorylation and 
dephosphorylation, regulated by kinases and phosphatases respectively.
The AKT8 virus, the only acute transforming retrovirus isolated from a rodent T 
cell lymphoma, encodes a serine \  threonine kinase, v-Akt, that contains sequences 
resembling an SH2 domain225. pl05v_fl^  is a Gag-Akt fusion protein that demonstrates 
significant catalytic domain homology with protein kinase A and protein kinase C225. 
Both v-Akt and the cellular homologue, c-Akt or c-Rac226, have limited sequence 
homology with previously described SH2 domains, lacking approximately 20 amino 
acids found in the C-terminal region of other SH2 domains and a number of highly 
conserved SH2 residues225. Although suggestive of a link between tyrosine and serine \  
threonine kinases, the functional significance of this SH2-like domain remains to be 
established. At present there is no evidence to indicate that this protein or isolated Akt-
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SH2 domains form specific complexes with tyrosine phosphorylated proteins in vitro or 
in vivo.
In addition to the second messenger and oncoprotein molecules described above, 
there are a number of actin-binding proteins that contain SH2 or SH3 domains. Tensin, 
an actin-binding component of focal contacts and other submembranous cytoskeletal 
structures, contains a single SH2 domain that, in the form of a glutathione S transferase 
fusion proten is capable of binding to tyrosine phosphorylated proteins in vitro211. 
Increased tyrosine phosphorylation of tensin is evident in Src-transformed cells227, 
suggesting that by possessing both actin-binding and phosphotyrosyl-protein binding 
activities and being itself a substrate for tyrosine kinases, tensin may link signal 
transduction pathways with the cytoskeleton. SH3 (but not SH2)-like sequences are 
found in the actin-binding proteins myosin and spectrin, and in a yeast cytoskeletal 
protein228-229. Although the functional significance of SH3 domains is not clear, it is 
possible that these domains are important in localizing proteins to the cytoskeleton. Two 
experimental observations are consistent with this hypothesis. First, deletion of SH3 from 
the c-Abl protein eliminates association with actin filaments and results in 
transformation230’231-232 Second, the SH3 domain appears to determine morphological 
phenotype in ^re-transformed cells77-130-141-142-143.
It is apparent that SH2 domains play a potentially important role in promoting 
complex formation between molecules involved in signal transduction. Extracellular 
ligand binding to its cognate receptor leads to rapid tyrosine phosphorylation and 
recruitment of specific SH2-containing proteins, allowing co-ordinate regulation of 
enzyme activity in response to growth factor stimulation. Thus, a primary role of tyrosine 
phosphorylation may be to promote relocation of cytosolic enzymes to concentrations of 
substrate molecules, rather than (or in addition to) modulating enzyme activity by 
allosteric mechanisms. The spectrum of proteins recruited to specific receptors is perhaps 
dependent on the sequence surrounding the tyrosine autophosphorylation sites, specific
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autophosphorylation sites binding specific SH2-containing proteins. Signalling from this 
complex could be terminated in a number of ways. Firstly, receptor internalisation and 
degradation of signalling molecules could lead to signal termination. Secondly, taking 
GAP as an example, excess unmodified protein might compete for the effector molecules
leading to signal termination. Thirdly, SH2-containing protein tyrosine phosphatases (for
e.
example PTP1C) might be recruited to activated recptors, perhaps leading to 
dephosphorylation of the receptor and \  or secondary signalling molecules, thereby 
disrupting established complexes. Available data prompt speculation that activated non­
receptor tyrosine kinases also promote recruitment of specific tyrosine phosphorylated 
and SH2-containing proteins, the resulting complex resembling a ligand-stimulated 
receptor. Given the tyrosine kinase activity of v-Src is constitutive, it is plausible that the 
signal complexes formed are stable, and hence mitogenic and tranforming signals are 
generated continuously. One weakness with this model is that mutation of the pp60 
autophosphorylation site appears not to prevent transformation in vitro in mouse 
fibroblasts76 (but see ref. 77). However, as noted previously, this tyrosine 416 mutant 
retains detectable phosphotyrosine at other unidentified sites76-78, perhaps allowing 
association with SH2-containing ligands. Other tyrosine phosphorylated signalling 
molecules might associate with pp60 through its SH2 domain. This model is consistent 
with the dependence of Src-transformation on proper membrane localization : mutants 
defective for membrane association might form similar signal complexes but these would 
be unable to act upon appropriate substrates, such as membrane lipids. One prediction of 
this model is that appropriate SH2-domain mutants of pp60 might lead to dissociation of 
transformation parameters, such as cell morphology and growth control.
1.7 Catalytic Domain
The catalytic domains of protein kinases are approximately 30kDa in size. Single 
subunit protein kinases normally contain N-terminal regulatory sequences, although these
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are usually dispensable for catalytic activity and indeed are believed to play regulatory 
roles (see 1.6). The catalytic domains of the protein kinase family contain short amino 
acid stretches that presumably determine the amino acid (serine \  threonine or tyrosine) 
substrate specificity of the enzymes. In a recent study by Hanks et a/.91, the catalytic 
domains of 65 protein kinases were compared, and areas of homology identified. The 
catalytic domains consist of regions of high and low conservation, with 11 subdomains 
being relatively highly conserved. The authors suggest that these highly conserved 
regions are important for catalytic function either through direct involvement in the 
mechanism of catalysis, or indirectly through contributing to the formation of the active 
site. Significant stretches of unique sequence are found in receptor tyrosine kinases, these 
kinase insert domains playing a role in recruitment of specific proteins to activated 
receptor molecules (see 1.6).
Highly conserved residues are believed to participate in catalysis. Nine residues 
are conserved in all 65 sequences examined, these being : glycine 276, lysine 295, 
glutamate 310, aspartate 386, asparagine 391, aspartate 404, glycine 406, glutamate 432 
and arginine 506 (pp60 residues according to Schwartz et a/.114). Another five residues 
are conserved in 64 of the 65 sequences analysed. The Gly-X-Gly-X-X-Gly motif found 
in subdomain I near to the catalytic domain N-terminus is found in many nucleotide 
binding proteins as well as protein kinases, and is believed to form part of the ATP 
binding site. Other residues involved in Mg^+-ATP binding are found in subdomains VI 
and VII (aspartate 386, asparagine 391, aspartate 404, phenylalanine 405 and glycine 
406).
Conserved subdomain II contains an invariant lysine (295) that appears to be 
directly involved in the phosphotransfer reaction, possibly mediating proton transfer. All 
substituents at this position in v-Src result in loss of kinase and transforming activity45*46.
The central core of the catalytic domain consists of subdomains VI to IX. 
Subdomain VIII contains the consensus triplet Ala-Pro-Glu, a conserved feature often
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mentioned as a key protein kinase catalytic domain indicator. Mutagenesis studies have 
demonstrated that each residue of the Ala-Pro-Glu (430-432) sequence is required for 
catalytic activity of v-Src44*233. Studies on other kinases have shown that this sequence 
may be very close to the catalytic site, and indeed sites of autophosphorylation found in 
many protein tyrosine kinases lie within 20 amino acids of this consensus triplet. The role 
of autophosphorylation is discussed in sections 1.3 and 1.6. Subdomains VI and VIH are 
of additional interest in that they contain residues that are specifically conserved in either 
the protein serine \  threonine or the protein tyrosine kinases and as such may play a role 
in recognition of the correct hydroxyamino acid. The most striking indicator of amino 
acid specificity is found in subdomain VI lying between the invariant residues 
corresponding to Src aspartate 386 and asparagine 391; two of the residues implicated in 
ATP binding. The consensus sequence Asp-Leu-Lys-Pro-Glu-Asn in this region is a 
strong indicator of serine \  threonine specificity, whereas the protein tyrosine kinase 
consensus is either Asp-Leu-Arg-Ala-Ala-Asn or Asp-Leu-Ala-Ala-Arg-Asn. Another 
such region is found immediately to the N-terminal side of the Ala-Pro-Glu sequence and 
is highly conserved in the protein tyrosine kinases with a more limited conservation 
among the protein serine \  threonine kinases.
The possible functions of residues in conserved subdomains ID, IV, V, IX, X and 
XI are less well understood.
Mutants temperature sensitive for transformation in vivo have proven valuable in 
many studies of src gene function (reviewed in refs. 55,88,234. Molecular cloning and 
DNA sequence analysis has revealed that the majority of temperature sensitive mutants 
contain lesions in the catalytic domain, and in some cases the specific mutations 
responsible for the conditional phenotype have been defined. Single point mutations 
confer temperature sensitivity on a number of mutant v-Src proteins, including teLA24 
(arginine 480 to histidine)235, ttLA29 (proline 507 to alanine)94 and ttLA31 (glycine 478 
to aspartate)235, whereas two mutations are required for the temperature sensitivity of
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&NY68236. Three general features have emerged concerning the lesions involved in 
temperature sensitivity of the biologically selected kinase domain mutants. One, lesions 
throughout the kinase domain, spanning amino acids 325-503, can influence expression 
of the temperature sensitive phenotype. Two, although many lesions coincide with highly 
conserved sequences among protein kinases and some are predicted to have significant 
effects on protein secondary structure, this is not the case for all lesions in the kinase 
domain that have a profound effect on Src protein function. Three, analysis of these 
mutants has revealed many long range interactions between distant residues. For 
example, revertants of both ttLA24 and &LA31 that transform at high temperatures 
contain second site mutations at either amino acid 377 or 492235, and a wild-type 
revertant of ttLA29 encodes an additional mutation at amino acid 42794. These data 
suggest an interaction between the compensating mutations and the original temperature 
sensitive lesions.
The studies described above of non-conditional and conditional mutants encoding 
lesions in the Src kinase domain provide strong support for the hypothesis that tyrosine 
kinase activity is essential for v-src-induced cell transformation.
1.8 In vivo Src substrates
A longstanding interest in the mechanism of transformation of v-src has resulted 
in numerous attempts to define important substrates for the tyrosine kinase activity of 
pp60. This has proven difficult because protein phosphotyrosine represents less than 1% 
of the total phosphohydroxyamino acid present, even in v-Src transformed cells12, and the 
kinase activity of pp60 is rather promiscuous, resulting in phosphorylation of numerous 
adventitious substrates88. Thus, by conventional labelling techniques, important targets 
have been difficult to pinpoint. Some problems created by the low relative abundance of 
protein phosphotyrosine have been circumvented using anti-phosphotyrosine 
antisera237*238*239*240, since these can enable detection of phosphotyrosine in proteins
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containing a large excess of phosphoserine and \  or phosphothreonine. The major 
shortcoming with this approach is the selective nature of the antiserum : not all 
antiphosphotyrosine antisera react with the same proteins. Another approach using 
monoclonal antibodies to specific tyrosine phosphorylated proteins has been developed 
by Kanner and colleagues241. Using antiphosphotyrosine affinity columns, these workers 
purified tyrosine phosphorylated proteins present in chick embryo fibroblasts expressing 
activated mutants of c-Src. These proteins were used to develop monoclonal antibodies 
specific to known tyrosine phosphoproteins of 110, 120 and 130kDa and several 
previously undescribed proteins. Subsequent work by the same group, discussed below, 
has indicated that two of these proteins form complexes with pp60 in addition to being 
tyrosine phosphorylated in cells expressing ppbO222*223.
The majority of studies designed to define important substrates for the tyrosine 
kinase activity of pp60 have made a comparison between fully transformed and normal 
cells. There are a number of problems with this approach. Firstly, tyrosine 
phosphorylation events involved in initiating transformation can no longer be identified 
as early events, and indeed these proteins may no longer be tyrosine phosphorylated in 
the fully transformed cell. Secondly, although a number of the tyrosine phosphorylated 
proteins present in the fully transformed cells may be required for maintenance of this 
state, the majority of tyrosine phosphoproteins might be either adventitious substrates of 
the promiscuous kinase activity or the result of a cellular response to transformation. This 
renders discrimination of important targets from secondary or adventitious events 
difficult. Superimposed on these problems are growth state effects : Src-transformed cells 
may proliferate more rapidly than their normal counterparts, and the mechanisms 
controlling this partially serum-independent growth might differ from those controlling 
the growth of normal cells. In particular, tyrosine phosphorylation events regulating 
transit from one stage of the cell cycle to another might be very difficult to detect in an 
asynchronous culture. Hence, examination of steady-state transformed cells generally
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precludes identification of kinase substrates important in particular facets of 
transformation.
Some of these problems can be overcome by using temperature sensitve kinase 
mutants. Since the ATP pool can be labelled in the absence of pp60 kinase activity, this 
enables analysis of very early events following temperature shift. Furthermore, cells 
expressing a number of these mutants can be rendered quiescent in a phenotypically 
normal state at restrictive temperature, a shift to permissive temperature stimulating these 
cells to exit GO and proceed through mitosis26-29-242*243. This approach has the potential to 
reduce growth state effects and to facilitate identification of important tyrosine 
phosphorylation-dependent control points within the cycle of Src stimulated cells. 
However, some features of these mutants introduce other problems. These mutants are 
often temperature sensitive for membrane localization as well as for kinase activity234. 
This change in subcellular localization together with rapid reactivation of kinase activity 
against all substrates following temperature shift leads to phosphorylation of many 
adventitious targets. These problems could be resolved using mutant proteins that are 
temperature sensitive for transformation, whilst still retaining kinase activity and 
membrane localization at restrictive temperature. If cells expressing these mutants can be 
rendered quiescent at restrictive temperature, the number of adventitious phosphorylation 
events seen upon temperature shift might be reduced. This may facilitate identification of 
relevant early events. This approach might also be used to identify proteins whose 
synthesis is required for, or is a result of the transforming activity of pp60. The use of a 
putative minimal deviation mutant in searching for proteins whose synthesis or phosphate 
content is modulated in response to activating the transforming and mitogenic activities 
of pp60 forms the basis of part of this Ph.D., and will be discussed below (see 1.13).
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1.9 Cvtosolic Substrates
A number of cytosolic proteins are phosphorylated on tyrosine in v-Src 
transformed cells. Brief descriptions of these proteins are given below, but it should be 
noted that the phosphorylation of none of these correlates invariably with transformation 
in vitro.
1.9.1 p50
The 50kDa member of the previously described tri-molecular complex (see 1.3) 
becomes phosphorylated on tyrosine in v-Src transformed avian cells12. Although 
phosphorylation of this protein appears to be the result of pp60 kinase activity rather than 
a consequence of transformation, tyrosine phosphorylation of this protein is not observed 
in RSV-transformed mammalian cells50. Hence phosphorylation of this protein appears 
not to be essential for transformation.
1.9.2 pp42 \  MAP kinase
The microtubule-associated or mitogen-activated protein kinases (MAP kinases) 
are a family of protein serine \  threonine kinases which respond to growth factor 
stimulation (reviewed in refs. 244,245,246). MAP kinases are believed to play an 
important role in mitotic and meiotic division in eukaryotic cells245-247*248-249»250*251. This 
kinase family is also implicated in the nerve growth factor-induced differentiation of 
PC 12 cells252. The best characterised member of this family is pp42; the following 
discussion will focus on this enzyme, although it seems likely that other family members 
will play similar roles. Activity in vitro is absolutely dependent on both threonine and 
tyrosine phosphorylation of the enzyme, dephosphorylation of either threonine 13 or 
tyrosine 15 resulting in a complete loss of kinase activity253. The rapid activation of this 
enzyme in response to purified mitogens suggests that pp42 might act as a switch kinase, 
receiving signals from tyrosine kinases and converting this information into serine \  
threonine phosphorylation of target proteins. Integration of threonine and tyrosine
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phosphorylation, found in MAP kinases and in p34c^c^254, presumably allows "fail-safe" 
control of activity. The rapid kinetics of activation of MAP kinase following challenge of 
cells with polypeptide mitogens prompts speculation that tyrosine phosphorylation of the 
enzyme is catalysed by activated growth factor receptors, and that pp42 is a target for the 
activity of these peripheral enzymes. A number of observations indicate that this may be 
an oversimplification. It has been noted that treatment of fibroblasts in culture with the 
protein kinase C agonist TPA results in both threonine and unexpectedly, tyrosine 
phosphorylation of PP42255-256. Since phosphorylation of receptor kinases by protein 
kinase C is generally inhibitory257*258, the tyrosine phosphorylation of pp42 is unlikely to 
result from receptor kinase activity under these conditions. Recent work by Cohen and 
colleagues252 and Ahn et al.259 has described activities capable of reactivating 
dephosphorylated MAP kinase in vitro by stimulating both the tyrosine and threonine 
phosphorylation of P42252. Both the threonine kinase and tyrosine kinase activities 
towards dephosphorylated p42 appear to co-purify through a number of chromatography 
steps, suggesting (but not proving) that both activities might be intrinsic to a single 
protein252. There have been reports recently of kinases with dual specificity for protein 
serine \  threonine and tyrosine residues260*261, though the significance of these 
observations remains unproven. The MAP kinase kinase itself appears to be dependent on 
serine \  threonine phosphorylation, suggesting the existence of a kinase kinase kinase252. 
Although providing a possible explanation for the ability of TPA to promote tyrosine 
phosphorylation of MAP kinase, this model argues against pp42 being a direct target for 
activated receptors. Independent control of MAP kinase threonine kinase and MAP 
kinase tyrosine kinase activities would be required in vivo if dual phosphorylation of 
MAP kinase were to provide a fail-safe mechanism for activation of this enzyme. At 
present these apparent kinase activities cannot be distinguished from activities that 
stimulate autophosphorylation by MAP kinase. Indeed, the regulatory phosphorylation 
sites at threonine 13 and tyrosine 15262 lie close to the Ala-Pro-Glu consensus sequence
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mentioned in 1.7, a region containing autophosphorylation sites in a number of protein 
kinases and furthermore, a number of recent reports indicate that MAP kinase purified 
from recombinant E. coli is able to autophosphorylate on tyrosine and threonine, albeit 
extremely slowly, and to the author's knowledge, to an unspecified 
stoichiometry263-264-265. Ahn et al. have proposed that MAP kinase activators might 
stimulate markedly the rate and extent of MAP kinase autophosphorylation in response to 
mitogens, leading to activation of enzyme activity266.
Tyrosine phosphorylation of MAP kinase occurs in response to a number of 
mitogenic agents, including ppbO17*245-255-267. However, reproducible tyrosine 
phosphorylation of this protein in Src-transformed mammalian cells has been difficult to 
achieve, and only one group has suggested that enzyme activity is enhanced in this 
situation268. Dephosphorylated pp42 is a poor substrate for purified pp60 in vitro163, 
suggesting that tyrosine phosphorylation of this protein in Src-transformed cells might be 
indirect.
Given the proposed role of this family of kinases in regulating the response of 
cells to mitogens, growth state effects may have a profound influence on the 
phosphorylation state of this protein. Studies on the tyrosine phosphorylation of this 
putative switch kinase would be facilitated in synchronous populations of cells stimulated 
to transform and re-enter cycle by reactivation of a conditional Src mutant.
Pulverer et al. have recently reported that purified MAP kinases can 
phosphorylate c-Jun protein on some of the N-terminal serine residues that are utilised in 
vivo269. Phosphorylation of these residues is reported to correlate with increased 
transactivation activity as measured by transient assays269-270-271. These data are 
interesting in view of two observations: there is a rapid increase in AP-1 binding activity 
in nuclear extracts following temperature shift of cells expressing conditional Src 
mutants29, and transcription from AP-1 responsive reporter elements is enhanced in Src
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transformed cells28*272. The role of MAP kinases in mediating these effects would be 
amenable to study in the temperature shift system outlined above.
1.9.3 Glvcolvtic Enzvmes
Three soluble, non rate-limiting glycolytic enzymes (enolase, phosphoglycerate 
mutase and lactate dehydrogenase) are phosphorylated on tyrosine in v-Src transformed 
cells16*17. As is the case with p50, the phosphorylation of none of these proteins correlates 
well with cellular transformation.
1-9.4 PI3-Kinase
Tyrosine phosphorylation and association of this enzyme with activated tyrosine 
kinases has been described in detail in section 1.6. Tyrosine phosphorylation of this 
enzyme is required for association with pp60177, though neither tyrosine phosphorylation 
nor association with pp60 correlate absolutely with transformation173. This may be due to 
the location of the substrates for this enzyme : mutants of pp60 defective for 
transformation through cytosolic localisation still associate with PI3-kinase activity173, 
but it is presumed that this complex is non-functional given the absence of inositol 
phospholipids in the cytosol. In view of the ubiquitous association of this enzyme with 
activated tyrosine kinase receptors (see 1.6), PI3-kinase is a potentially important 
substrate for all mitogenic tyrosine kinases, including pp60.
1.10 Cvtoskeletal and Extracellular Matrix Proteins
Since pp60 associates with the cytoskeleton, particularly at sites of cell- 
substratum contact, it is not surprising that several cytoskeletal proteins are 
phosphorylated on tyrosine in v-Src transformed cells (reviewed in refs. 273,274). 
Presumably tyrosine phosphorylation of these proteins is involved in the induction of 
morphological changes observed upon transformation.
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1.10.1 Vinculin
A fraction of this 130kDa protein is localized in adhesion plaques, as is pp60. 
Approximately 1% of the vinculin in Src transformed cells becomes phosphorylated on 
tyrosine275, although whether the adhesion plaque fraction displays a higher 
stoichiometry of phosphorylation is unknown. The relationship of vinculin 
phosphorylation to transformation has been examined in cells infected with a wide 
variety of Src mutants276*277 but no relationship between the degree of vinculin 
phosphorylation and any measured aspect of transformation was discernible.
1.10.2 Integrin
The integrins are a complex of heterodimers with multiple affinities for 
extracellular matrix proteins such as fibronectin, vitronectin and laminin. On the 
cytoplasmic face of the plasma membrane, this glycoprotein complex appears to 
associate with several cytoskeletal components including fibulin and talin. In turn, talin 
interacts with another cytoskeletal protein, vinculin, and possibly the actin bundling 
protein, a-actinin (reviewed in refs. 274,278,279). Since fibronectin loss is a result of Src 
transformation280, and may also play a role in inducing morphological changes273, this 
link between the extracellular matrix and the cytoskeleton is an obvious candidate for a 
functional target. Some data from Kellie and his colleagues suggests that integrin 
phosphorylation may be a relevant event in Src transformation281.
1.10.3 Talin
Talin is a protein that appears to interact with both integrin and other cytoskeletal 
components. This protein, like vinculin, is phosphorylated to low stoichiometry in Src 
transformed cells282. However, this tyrosine phosphorylation does not correlate well with 
transformation273*274*282.
There are also a number of other unidentified cytoskeletal proteins which become 
phosphorylated on tyrosine in \-Src transformed cells. Glenney and co-workers have
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demonstrated that a 22kDa membrane \  cytoskeletal protein becomes phosphorylated on 
tyrosine in chick embryo fibroblasts expressing transforming v-src genes283, although 
phosphotyrosine in this protein is reduced by 95% in cells expressing kinase active but 
transformation defective pp60284. There are no data to suggest that the cytoskeletal SH3- 
containing proteins described in 1.6 are tyrosine phosphorylated. If these proteins were to 
associate with pp60, as proposed in an section 1.6, one might expect them to be targets 
for the kinase activity of the Src protein.
1.11 Calcium Binding Proteins
Two calcium binding proteins, calpactin I285-286 and calmodulin287, are 
phosphorylated on tyrosine in Src transformed cells. Calpactin I is phosphorylated to low 
stoichiometry despite co-localizing with pp60, and this phosphorylation correlates poorly 
with any aspect of transformation288. Calmodulin contains labile phosphotyrosine at sites 
adjacent to the Ca^+ binding site287. The functional relevance of this phosphorylation has 
yet to be evaluated, although the central importance of calmodulin in regulating cellular 
responses to calcium indicates that this would be a worthwhile area for investigation.
1.12 Membrane Proteins
Since membrane association of pp60 is essential for transformation in vitro, it is 
assumed that important substrates reside in this fraction of the cell. A number of tyrosine 
phosphorylated proteins have been identified in membrane preparations, some of these 
correlating well with transformation.
1.12.1 Epidermal Growth Factor Receptor
Rapid tyrosine phosphorylation of the EGF receptor occurs upon Src 
transformation289. The stoichiometry of phosphorylation approaches that achieved with 
saturating levels of EGF289. However, variant cells which lack the EGF receptor can still 
be transformed by v-Src, indicating that the receptor is not a necessary target for Src
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transformation289. Cells overexpressing the c-Src protein are hyper-responsive to EGF290, 
and this enhanced responsiveness is dependent on intact c-Src myristylation, homology 
and kinase domains112. The role of the EGF receptor in v-Src stimulated mitogenesis has 
not been investigated, although phosphorylation of this receptor could be indicative of a 
class of membrane targets whose phosphorylation might induce alterations in growth 
control. One idea is that pp60-mediated phosphorylation of, and \  or association with the 
EGF receptor, or another tyrosine kinase receptor, promotes assembly of the signalling 
complexes described in section 1.6.
1.12.2 Insulin-like Growth Factor 1 Receptor
Identified as a glycoprotein whose tyrosine phosphorylation correlates tightly 
with transformation using a battery of diverse Src mutants291, Weber and colleagues have 
demonstrated that the IGF-1 receptor is constitutively phosphorylated on tyrosine in Src 
transformed cells292. pp60 appears to synergise with ligand, leading to elevated receptor 
autophosphorylation292. This suggests a mechanism whereby Src could override the 
requirement for external growth factors, enhanced signalling resulting from intracellular 
interactions292. The association of signalling molecules with the activated IGF-1 receptor 
is not well characterised, although one report suggests that PI3-kinase activity is 
detectable163.
1.12.3 Ras GTPase activating Protein GAP
In cells expressing a temperature sensitive mutant of pp60, GAP-associated p62 
becomes tyrosine phosphorylated very rapidly following shift to the permissive 
temperature, with phosphorylation of pl90 and GAP occurring more slowly138. In 
addition, the proportion of p2lras in the GTP bound form increases following expression 
of v-Src293, although there is no evidence to suggest that this results from a reduction in 
the GTPase activity of the GAP protein. In Rat2 cells expressing a non-transforming SH2
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domain mutant of v-Fps, tyrosine phosphorylation of p62 and pl24 is missing139. pl24 
might be GAP. GAP and its associated cellular proteins would appear to be candidates 
for functional substrates of pp60.
1.12.4 Unidentified Membrane Proteins
A number of groups have demonstrated that tyrosine phosphorylation of 
membrane proteins in the 110-150kDa range correlates with transformation in vitro. 
Reynolds et al. identified a protein of 120kDa whose tyrosine phosphorylation correlates 
well with transformation using a battery of c-src derived mutants294. This protein is not 
tyrosine phosphorylated in cells expressing non-myristylated pp60294, although it is 
phosphorylated in cells transformed by other tyrosine kinases294. Linder and Burr295 
identified particulate fraction proteins of 115-130kDa whose tyrosine phosphorylation 
mimicked that of the 120kDa protein identified by Reynolds et al29A. Both groups 
confirmed that these proteins were neither integrin nor vinculin.
Wendler and Boschelli296 also identified a group of membrane proteins in the 
120-150kDa size range which became tyrosine phosphorylated in cells expressing wild 
type v-Src. The tyrosine phosphorylation of this group of putative substrates was reduced 
in cells expressing partially transforming SH2 domain mutants of v-Src296. However, it is 
difficult to correlate tyrosine phosphorylation of this group of proteins with 
transformation, since in addition to being partially defective for transformation, the SH2 
domain mutants employed displayed reduced kinase activity296. Furthermore, a number 
of the mutants employed in this study demonstrated transforming properties only after 
extended periods in tissue culture; the correlation between substrate phosphorylation and 
Src lesion is therefore tenuous.
Lau297 has identified a tyrosine-phosphorylated protein of 120kDa in 
immunoprecipitates prepared using antisera to pp60. This protein does not co-migrate
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with the protein identified by Reynolds et al294., and is not vinculin298. Peptide mapping 
and glucosamine labelling experiments suggest that the 120kDa protein is not integrin297.
Tyrosine phosphorylated proteins of 110 and 130kDa are associated with 
activated c-Src variants in chicken embryo fibroblasts222 but neither association with 
pp60 nor tyrosine phosphorylation are sufficient for transformation since tyrosine 
phosphorylated pi 10 and p i30 co-precipitates with non-myristylated, kinase-active 
PP60223. Kanner et al. have generated monoclonal antibodies to pi 10 and p i30 which 
have enabled a more thorough characterisation of these proteins and their interactions 
with pp60241. Several structural and functional prerequisites appear necessary but perhaps 
not sufficient for complex formation. Activation of the c-Src tyrosine kinase activity is 
required : uninfected chick embryo fibroblasts do not contain detectable complexes 
between p i30, pi 10 and endogenous pp60c~src, and mutations which inactivate Src 
kinase activity block both tyrosine phosphorylation and association with pp60223. Stable 
complex formation also requires the structural integrity of part of the SH2 domain of 
Src223. Mutations within the SH3 domain significantly reduce the association of pi 10 
with pp60223. The association of pi 10 with pp60 in transformed cells appears to correlate 
with the redistribution of pi 10 to focal adhesion plaques and the plasma membrane223. 
Cells expressing fusiform SH3 domain mutants of Src contain pi 10 that is neither 
tyrosine phosphorylated nor associated with pp60223. These observations suggest that 
tyrosine phosphorylation and complex formation with membrane associated pp60 are 
required for wild-type transformation.
It is clear that a number of potentially relevant substrates residing in the 
particulate fraction have been identified in Src transformed cells. The identification of 
these proteins, and in particular the generation of specific antisera, will facilitate further 
study.
43
1.13 taLA32 Src. A Minimal Deviation Mutant
Many of the problems encountered in searching for relevant targets of pp60 
tyrosine kinase activity may be circumvented using mutants which differ only minimally 
from the wild type protein in their biochemical properties. The protein encoded by 
tsLA32 src is believed to be one such mutant. Stoker et al.299 have demonstrated that 
chick embryo fibroblasts (CEF) expressing this protein are temperature sensitive for 
transformation by a number of criteria. Firstly, these cells have a normal morphology at 
restrictive temperature and a fusiform transformed morphology at permissive 
temperature. CEF infected with ttLA32 RSV are temperature sensitive for focus 
formation on a monolayer of normal CEF, and are temperature sensitive for anchorage 
independent growth. These in vitro parameters of transformation are believed to correlate 
well with in vivo tumorigenicity15. Hexose uptake, a physiological measure of 
transformation, is increased in ttLA32 RSV infected cells at permissive temperature, 
although this enhanced transport is not as striking as that induced by the wild-type 
protein142. This mutant retains elevated kinase activity at restrictive temperature, both in 
vitro and in vivo299. Association of this mutant protein with the particulate fraction of the 
cell is largely independent of growth temperature93. These data indicate that the 
transformation defect in ttLA32 Src is subtle in nature, and that transformation by this 
mutant is unlikely to result from a gross change in kinase activity or subcellular 
localisation upon shift to permissive temperature. The &LA32 kinase may fail to 
associate with or phosphorylate one or more crucial protein substrates at restrictive 
temperature, thus precluding transformation. However many substrates will be 
phosphorylated at restrictive temperature, and upon shift of these cells to the permissive 
temperature, functionally relevant phosphorylation events should be identifiable. This 
should also enable identification of a group of proteins whose tyrosine phosphorylation at 
restrictive temperature is insufficient to elicit transformation. If cells expressing this 
mutant protein can be rendered quiescent at restrictive temperature, the number of
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adventitious phosphorylation events seen should be reduced further. This system should 
enable a search for novel targets of the tyrosine kinase activity, and an assessment of the 
relevance of previously identified candidate target proteins. Similar arguments apply to 
the identification of proteins whose synthesis or turnover is modulated as quiescent 
fibroblasts are stimulated to transform and re-enter cycle by activating a thermolabile Src 
mutant.
The presence of membrane-associated, kinase active pp60 in cells infected but not 
transformed by tshA32 RSV at restrictive temperature prompts other interpretations. It is 
plausible that a subtle change in subcellular localisation of the kinase and its associated 
proteins occurs following temperature shift, and this brings pre-existing pp60-associated 
signalling molecules into contact with their substrates. This model suggests that new 
tyrosine phosphorylation events would not be observed immediately following 
temperature shift, or if such events were detected, that these might be adventitious 
consequences of a subtle change in localisation. However, one would predict a rapid 
increase in the cellular levels of products generated by the pp60-associated signalling 
enzymes.
The proposed function of SH2 domains in binding tyrosine phosphorylated 
proteins suggests another potential mechanism whereby the association of signalling 
molecules with ttLA32 pp60 might be affected by growth temperature. Subtle changes in 
the stoichiometry of autophosphorylation of the active population of pp60 in response to 
temperature might lead to quantitative changes in the association of specific signalling 
molecules. In this regard it is intriguing that one of the mutations in ttLA32 Src lies three 
residues downstream from the autophosphorylation site. Subtle changes in the 
stoichiometry of autophosphorylation might be difficult to detect since the protein is 
overexpressed.
The three mutations in ttLA32 src have been identified (Stoker, unpublished 
data142), two being located in the kinase domain of the protein at positions 300 (glycine to
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valine) and 419 (arginine to glutamine), the third being located within the SH3 domain at 
position 107 (arginine to proline). The temperature sensitive characteristics of this protein 
in chick embryo fibroblasts are determined by the catalytic domain mutation at position 
300 (V. Fincham, unpublished data). The consequences of the other mutations are 
unclear, though the presence of a mutation in the SH3 domain is interesting in view of 
the fusiform morphology of chick embryo fibroblasts expressing this mutant299. The 
mutation at position 419 is close to the autophosphorylation site at tyrosine 416.
Previous work from this laboratory demonstrated that Rati cells expressing a 
temperature sensitive kinase mutant of v-src could be rendered quiescent by serum 
deprivation at restrictive temperature, and that these cells could re-enter cycle upon shift 
to permissive temperature in the absence of added factors29. (This is also the case in CEF 
expressing ts src mutants242*243). With this in mind and given the practical difficulties of 
working with primary cultures of chick embryo fibroblasts, it was decided to express the 
taLA32 src gene in established Rati fibroblasts. In light of the problems associated with 
Rous sarcoma virus expression in rodent cells300, it was decided to employ a Moloney 
murine leukaemia virus-based vector7 7 *301 to express this mutant The majority of data 
presented in this thesis concern the generation and characterisation of a clonal Rati line 
expressing &LA32 Src, Rati f32. These studies were facilitated by generation of clonal 
lines expressing wild-type Prague A v-Src and a well characterised temperature sensitive 
mutant, ttLA29 Src29*93*94*299. The biological and biochemical properties of the mutant 
proteins are described in chapters III to VI. Preliminary results obtained by two- 
dimensional gel electrophoresis of lysates from quiescent Rati f32 cells shifted to 
permissive temperature are presented in chapter VII.
1.14 v-Src and Mitogenesis
Converging with this interest in substrates of pp60 tyrosine kinase activity is our 
interest in the mitogenic properties of this transforming protein. As stated above, v-Src
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transformation is accompanied by changes in the growth properties of fibroblasts, leading 
to a degree of serum independence. This property of v-Src has been studied in this and 
other laboratories with temperature sensitive mutants26*27*29*242-243. Early work in this 
group employed chick embryo fibroblasts infected with ttLA24 RSV242. Quiescent 
cultures incorporate labelled thymidine after approximately 5-7hrs at permissive 
temperature, with incorporation peaking at approximately 15hrs post temperature shift (J. 
Bell, unpublished data). The brief duration of G1 in chick embryo fibroblasts coupled 
with problems in obtaining stationary cultures (J. Wyke, personal communication) 
precluded a more thorough investigation of the requirements for pp60 in this response. 
These problems have been overcome in a Rati cell system. Welham et al.19 have 
demonstrated that Rati ttLA29 cells can be rendered quiescent at restrictive temperature 
as morphologically normal cells. Quiescent cultures can be stimulated to transit Gl, 
synthesise DNA and divide by addition of serum at restrictive temperature, or by shifting 
to permissive temperature in the absence of added factors29. Temperature shift and serum 
are not synergistic in this assay, indicating that both mitogens might function through the 
same intermediates29. Activation of thermolabile pp60 appears sufficient to initiate all 
events required for mitosis in these cells. Furthermore, since the Gl phase of the cycle 
extends for 16-20hrs in Rati cells, this system is amenable to detailed analysis. In 
experiments where the thermolabile pp60 is activated for periods of time before the cells 
are restored to restrictive temperature, the ability of these cells to enter S phase and 
mitosis appears to be dependent on them having passed a commitment point 4-6hrs prior 
to the onset of S phase (A.W. Wyke, personal communication). Preliminary data indicate 
that cells shifted to permissive temperature for periods shorter than that required to 
commit them to S phase appear to reset when returned to restrictive temperature, such 
that a second shift to permissive temperature does not result in more rapid onset of DNA 
synthesis. This result indicates that hypothetical early Gl events required for entry into S 
phase are not stable, perhaps implying the existence of short-lived molecular species
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rather than stable cellular changes (e.g. cell mass). The simplest interpretation of these 
data is that pp60 activity is required throughout Gl until cells have passed the late 
commitment point, though it is not possible at present to rule out the existence of two or 
more discrete commitment points. Indeed, similar experiments reported by Durkin and 
Whitfield using ts Src-transformed NRK cells indicate that a short incubation at 
permissive temperature is sufficient to propel these cells into S phase, but not into 
mitosis26. Mitosis does however occur if cells are incubated at permissive temperature 
until S phase has started26. These results imply the existence of a second point in Gl or S 
at which pp60 is required to permit further cell cycle progression.
One rapid consequence of activating the mitogenic and transforming properties of 
ttLA29 in quiescent Rati cells is the induction in nuclear extracts of activities capable of 
binding consensus AP-1 oligonucleotides29. The induction of these activities occurs in the 
absence of detectable increases in c-fos and c-jun transcripts29, and is insensitive to 
protein synthesis inhibition (A. W. Wyke, unpublished data). These results indicate that 
induction of AP-1 binding activity is regulated at a post-translational level upon 
activation of the thermolabile Src mutant. This laboratory and others have obtained data 
that suggest AP-1 transactivation activity is also increased in response to Src 
transformation28*272. Efforts are being made to correlate these activity changes with 
specific modifications, in particular phosphorylation, of the proteins involved (A. Catling 
and M. Frame, unpublished data). Interesting in this regard is the published data 
demonstrating that MAP kinase family members can phosphorylate c-Jun on N-terminal 
serine residues that are phosphorylated in vivo269. Pulverer et al.269 and Binetruy et al.210 
demonstrate that enhanced phosphorylation of these c-Jun residues occurs in response to 
TPA and activated Ras, and is said to correlate with an increased transactivation activity 
of the protein. However, it is apparent that c-Jun from TPA stimulated U937 cells 
generates a number of other tryptic phosphopeptides in addition to those identified by 
Pulverer et al,269, and indeed peptides with similar electrophoretic and chromatographic
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properties can be derived from c-Jun phosphorylated in vitro with pp54 MAP kinase (A. 
Catling, E. Black, D. Gillespie and J. Woodgett, unpublished data). Interestingly, pp42, 
later identified as MAP kinase, was found by virtue of its tyrosine phosphorylation in 
Src-transformed cells, and may be a functional target for the tyrosine kinase activity of 
pp60 (see section 1.9.2). We are at present mapping c-Jun phosphorylation sites in 
quiescent cells stimulated to divide by reactivation of a thermolabile Src mutant (A. 
Catling and M. Frame, unpublished). The post-translational modification of Fos in 
response to transformation by Src has not been examined, though it seems likely that this 
will also play a role in regulating AP-1 activity in response to pp60 kinase activity.
Since in these systems transformation accompanies mitogenesis, it is difficult to 
correlate molecular events with a biological endpoint. Studies by Hanafusa and his 
colleagues indicated that non-myristylated, and thereby non-transforming, Src proteins 
were able to prolong the lifespan of chick embryo neuroretinal cells in culture32*33, 
suggesting that the transforming and mitogenic properties of pp60 might be dissociable. 
Similar mutants increased the saturation density of chick embryo fibroblasts37, though the 
mitogenic activity was not assayed more directly in this study. A more comprehensive 
discussion of the properties of myristylation defective Src proteins is given in chapter 
VIII. In an effort to dissociate the mitogenic and transforming activities of pp60,1 have 
constructed a myristylation defective protein based on the temperature sensitive mutant 
tsLA29 Src. One predicts that this mutant protein should retain thermolabile kinase 
properties, whilst being non-conditionally defective for membrane association and 
transformation. The biochemical and mitogenic properties of this mutant have been 
asssayed directly in quiescent Rati and chick embryo fibroblasts and the results of these 
experiments are presented in chapter VIII.
Each results chapter of this thesis consists of a brief introduction, a description of 
the experiments performed and the results obtained. Furthermore, each chapter contains a 
thorough discussion of the data obtained, factors affecting the interpretation of these data
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and suggestions for further work. Chapter IX is a brief general discussion of the results 
obtained in the context of this field, though for discussion of individual experiments one 
should consult the appropriate results chapter.
Chapter II
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II METHODS
II.A. CELL CULTURE AND TRANSFECTION
II.A. 1 Cell Culture
Rati cells302 and derivatives were maintained as stock cultures in Dulbecco 
modified Eagles medium (DMEM) supplemented with 5% newborn calf serum, 2mM 
glutamine, 37.5ug\ml penicillin and 100ug\ml streptomycin (Rati growth medium) in a 
humidified atmosphere containing 5% (v\v) CO2 . Stock cultures of Rati, Rati f, Rati 
f29, Rati f32 and Rati fPrA, and two clones expressing low levels of 29A2 pp60, Rati 
f29A2 G and H, were maintained at the permissive temperature of 35°C. Rati f29A2 3B 
cells were maintained at the restrictive temperature of 40°C. (See chapters in  and VIII 
for a description of these clones). Stock cultures were subcloned at a ratio of 1:10 every 
3 days, as follows. Growth medium was aspirated from the monolayer, and the cells 
covered with 0.25% trypsin in CT buffer (see Materials). The majority of the trypsin 
solution was removed and the monolayers incubated at room temperature or 37 °C until 
the cells could be detached by gentle agitation. Detached cells were resuspended in 
growth medium and replated at appropriate density. Cultures were generally maintained 
at the appropriate temperature for at least two days prior to use. This ensured that the 
cells had acquired the appropriate phenotype.
Quiescent cultures were prepared as follows. Cells were plated at approximately 
7x10^ \  cm^ in growth medium and grown at restrictive temperature for approximately 
two days. Medium was aspirated, and the subconfluent monolayers were washed with an 
equivalent volume of serum-free DMEM. Cells were refed DMEM supplemented with 
0.2% newborn calf serum, 2mM glutamine and antibiotics at 2ml \  35mm dish or 5ml \  
60mm dish (~0.2ml \  cm^), and incubated for a further 40-48hrs at restrictive 
temperature29. This rendered Rati cells and Rati cells expressing ts src mutants 
quiescent.
Chick embryo fibroblasts (CEF) were prepared as described303. Cultures were 
maintained in DMEM supplemented with 10% tryptose phosphate broth, 2mM 
glutamine, 5% newborn calf serum, 1 % heat-inactivated (2hrs at 56°C) chicken serum
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and antibiotics (chick cell medium) in humidified incubators containing 5% (v\v) CO^ 
To minimise plating losses due to transformation, stock cultures of infected CEF were 
maintained at restrictive temperature (41 °C). Cells were subcultured approximately 1:5 
every 2-3 days and were maintained in culture for no more than four weeks. 
Subculturing was performed as described for Rati cell cultures except cells were 
resuspended in chick cell medium. Quiescent cultures of CEF were prepared essentially 
as described for Rati cells, except cultures were maintained at 41 °C.
n.A.2 Cell Storage
Stocks of cells used in this work were maintained in liquid nitrogen. Rati cells 
and derivatives were trypsinised and resuspended in DMEM lacking glutamine and 
antibiotics but supplemented with 20% fetal calf serum and 7.5% dimethylsulphoxide. 
Suspensions were aliquoted in l-2ml Nunc cryotubes and frozen well insulated at -70°C. 
One to two days later, frozen aliquots were stored in liquid nitrogen. Chick embryo 
fibroblasts were stored in a similar fashion except storage medium was fetal calf serum 
supplemented with 7.5% dimethylsulphoxide.
II.A.3 Transfection and G418 selection of Rati cells
Transfection of Rati cells was generally carried out using Lipofectin reagent 
according to manufacturers instructions. Briefly, 5x10^ Rati cells were plated in a 
60mm dish at permissive temperature one to two days prior to transfection. The 
following manipulations were carried out in the wells of a polystyrene 96 well plate, lug 
fpGV-1-based plasmid DNA301 (see chapter HI) was diluted to 50ul in sterile distilled 
water. In a separate well, 30ug of Lipofectin reagent was diluted to 50ul with sterile 
distilled water. The diluted DNA and Lipofectin were combined, mixed gently and 
incubated for fifteen minutes at room temperature. (Mock-transfection mixes lacking 
DNA were prepared in parallel to act as controls during subsequent G418 selection). 
During this incubation period, cells were washed twice with serum-free DMEM 
supplemented with 2mM glutamine and antibiotics, and refed 3mls of the same medium.
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The DNA-Lipofectin mixture was added dropwise to the cells with swirling, and 
transfected cultures incubated for 6 hrs at permissive temperature. An equal volume of 
DMEM supplemented with 10% newborn calf serum, 2mM glutamine and antibiotics 
was added and the dishes incubated at permissive temperature for a further 24-48hrs. 
Cultures were then trypsinised and replated in T175 flasks. G418 was added the 
following day to a final concentration of lmg \  ml, and selection effected for 14 to 21 
days at permissive temperature. G418-containing medium was replaced every 3-4 days. 
This resulted in the death of mock-transfected cultures and the appearance of 100-300 
colonies in transfected flasks. In some experiments, it was found necessary to carry out 
transfection and selection at restrictive temperature. The method used was otherwise 
identical.
Occasional transfections were carried out using the calcium phosphate co­
precipitation method304. Rati cells were plated at 5x10~* \  90mm dish and incubated 
overnight at permissive temperature. The precipitate was formed as follows:
a) 440ul of TE buffer (lOmM tris-HCl, ImM EDTA, pH 8.0) and 50ul of 2.5M 
CaCl2  were added to a sterile plastic bijou.
b) lOug of fpGV-1 based plasmid DNA in lOul TE buffer was added to the bijou 
and mixed gently.
c) the mixture from b) was added to 500ul of 2xHBS (46mM HEPES, 280mM 
NaCl, 1.3mM Na2 HPC>4 .2 H2 0 , pH 7.1) in a sterile plastic bijou and mixed gently. The 
precipitate was allowed to form by incubation at room temperature for 30min.
Fresh medium was added to the cells, and the precipitate added dropwise with 
swirling. Transfections were incubated overnight at permissive temperature in an 
humidified atmosphere with 5% (v\v) CC>2 . The following day, transfected cultures were 
subcultured at a ratio of 1:10 and incubated overnight. G418-selection was carried out as 
described above.
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II. A.4 Cloning Of Rati Derivatives
Well separated colonies were simultaneously scraped and collected using drawn 
Pasteur pipettes. Collected colonies were replated in 6  well plates and grown further to 
allow immunoblot analysis, single-cell cloning and, if necessary, liquid nitrogen storage. 
Typically, 8-12 colonies from 4-5 independent transfections were analyzed and cloned. 
Clonal lines were generated by plating 50-100 cells in 96 well plates. Positive wells were 
trypsinised and cells expanded for immunoblot analysis and storage. Care was taken to 
avoid harvesting colonies resulting from more than one founder cell. Colonies and clonal 
lines were maintained in normal growth medium lacking G418.
II. A.5 Transfection of Chick Embrvo Fibroblasts
Secondary CEF were plated at approximately 5x10^ \  T25 flask and incubated 
overnight at 41°C. Calcium phosphate-DNA co-precipitates304*305 were formed as 
follows:
a) lOug of RCAN based plasmid DNA306 (see chapter HI) was mixed with 240ul 
0.2xSSC (20xSSC stock is 175.3g NaCl, 88.2g trisodium citrate per liter, pH 7.0) in a 
sterile plastic bijou
b) 28ul of 2.5M CaCl2  was added and mixed gently
c) 250ul of 2xHEBS (2xHEBS is 274mM NaCl, lOmM KC1, 1.4mM 
Na2 HPC>4 .7 H2 0 , llmM glucose, 38mM HEPES, pH 7.1) was added and the mixture 
incubated at room temperature for 30min.
The resulting precipitate was added to the cells, and the flasks incubated at 41°C 
for 4hr. Medium was aspirated and cells washed with 3ml chick cell growth medium. 
Cells were then shocked for 4min at room temperature in 1ml of HEBS-glycerol 
(lxHEBS with 15% glycerol). Cultures were then washed briefly in 5ml chick cell 
growth medium before refeeding and further incubation at 41°C. Cultures typically 
reached confluence 4-7 days post-transfection whereupon they were subcultured at a 
ratio of 1:5. Uniform infection, as judged by Western blot and morphology at permissive 
temperature, was achieved after 1-3 passages.
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II.A. 6  Soft Agar Assays
Soft agar assays were used as an indicator of transformation in Rati 
transfectants307. 40ml of 2.5% Difco bacto-agar in a 200ml Duran bottle was melted in a 
microwave and cooled to 44°C. 40ml of 2xDMEM (see below) and 20ml newborn calf 
serum was added to the cooled agar, and the volume made up to 2 0 0 ml with 1 0 0 ml 
lxDMEM. The resulting 0.5% agar solution was maintained at 44°C for pouring (~5ml \  
60mm plate). Base plates were allowed to set at room temperature or 4°C. The required 
number of cells (10^ Rati src cells, 10  ^Rati or Rati f cells) were resuspended in 0.5ml 
Rati growth medium and mixed in a plastic universal with 1ml cooled (~37°C) base 
agar. A base plate was carefully overlayed with this soft agar \  cell mix and allowed to 
set at room temperature. Soft agar assays were typically performed in triplicate, and 
colonies were counted after 14 days incubation at the appropriate temperature.
2xDMEM
lOxDMEM 20ml
200mM glutamine 2ml
lOOmM pyruvate 2ml
7.5% NaHCCh 10ml
1M HEPES 4m 1
Sterile distilled H2 O 58ml
+ antibiotics
ILB. PROTEIN CHEMISTRY AND METABOLIC LABELLING
II.B.1,1 Sodium dodecvl sulphate Polyacrylamide Gel Electrophoresis
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) was 
employed to resolve proteins according to their apparent molecular weight. Gels were 
subject to electrophoresis essentially according to Laemlli308 using a Biorad Protean II 
apparatus. Typical gels were 10% with respect to acrylamide, although the percentage 
cross-linker used varied with the technique being used : for Western blots and 
immunoprecipitations, a stock solution containing 29.2% (w\v) acrylamide, 0.8% (w\v) 
fos-acrylamide was used, whereas for in vitro kinase assay gels, the stock solution used
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was 29.625% (w\v) acrylamide, 0.375% (w\v) Ztis-acrylamide. The latter ratio of 
acrylamide and fo's-acrylamide was found to improve resolution in the 40-60kDa region 
of the gel. Resolving gels were prepared by mixing the following (for two gels): 
stock acrylamide \  fos-acrylamide 35ml
1.5M tris-HCl, pH 8 . 8  39.2ml
distilled H2 O 30.5ml
10% SDS 1.05ml
10% ammonium persulphate 0.35ml
TEMED 0.065ml
The gel mix was pipetted between the gel plates and overlayed with water- 
saturated butan-2-ol. After polymerisation had occurred (0.5-lhr) the overlay was 
removed and the top of the resolving gel washed extensively with distilled water. Excess 
liquid was removed using Whatman 3MM or filter paper, and the comb was inserted 
before the stacking gel was poured. The stacking gel consisted of (for two gels):
30% acrylamide \  to-acrylamide 8.35ml
0.5M tris-HCl, pH 6 . 8 6.25ml
distilled H2 O 30.2ml
10% SDS 0.5ml
1 0 % ammonium persulphate 0.25ml
TEMED 0.05ml
The stacking gel was allowed to polymerise (~30min) before assembly into the
tank. Both reservoirs were filled with running buffer (5x stock, g \ l  tris base, 15, glycine, 
72, SDS, 5 in distilled water, -pH 8.3 ). Wells were flushed extensively with running 
buffer, and bubbles removed from the lower surface of the gel plates before the samples 
were loaded.
Protein samples were denatured in sample buffer (50mM tris-HCl, pH 6 .8 , 30% 
glycerol, 2.5% SDS, 2% p-mercaptoethanol) by heating at 95-100°C for 3-7min. Total 
cellular proteins were extracted by the addition of sample buffer directly to the tissue 
culture plate (approximately 0.5ml \  60mm dish). Lysates were sonicated to shear any
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genomic DNA present. For Western analysis, 50ul of lysate from a confluent 60mm dish 
of Rati or CEF cells was resolved together with an equivalent amount (by Coomassie 
brilliant blue staining) of protein from the other cultures of interest. Proteins purified by 
immunoprecipitation were resuspended and denatured in an equivalent volume of 2 x 
sample buffer.
II.B.1.2 TCA-Precipitation of Labelled Proteins
To ensure consistent spot intensity between individual 2-D gels, equivalent 
amounts of TCA-precipitable radioactivity were loaded on each gel. Typically, lOul of 
labelled lysate was mixed with lOOul of a lmg \  ml solution of BSA in distilled water in 
a precooled 1.5ml eppendorf. 1ml of ice-cold 10% TCA was added, mixed and the tube 
incubated on ice for 30min. The precipitate was collected on a Whatman GF-C filter and 
washed extensively with cold 10% TCA. Filters were washed with 95% ethanol, dried 
thoroughly and counted in 10ml Ecoscint.
II.B.1.3 Protein Estimation
Protein concentration in cell lysates was estimated using the Micro BCA assay 
marketed by Pierce. Protein concentration was normalised prior to pp60 
immunoprecipitation. 60mm dishes were lysed in 1ml NP40 buffer (see section II.B.4.1). 
24ul of lysate was diluted to a total of 1.2ml in distilled water, and 1ml of this diluted 
lysate was mixed with an equal volume of the assay reagent. Lysis buffer blanks were 
included in all assays. Micro BCA assay reagent was prepared according to 
manufacturers' instructions. Reactions were incubated at 60°C for 30min, and cooled to 
room temperature prior to reading at 562nm (1cm path length). Protein concentration 
was estimated by comparison to a standard curve constructed using dilutions of bovine 
serum albumin under the same assay conditions.
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II.B.2 Metabolic Labelling 
II.B.2.1 Tritiated-thvmidine Labelling
Pulse labelling with tritiated thymidine was used to estimate DNA synthesis in 
quiescent cultures stimulated to proliferate in response to serum or temperature shift29. 
Quiescent cultures of Rati derivatives or infected CEF in 35mm dishes were prepared as 
described in II.A.1. Cells were stimulated to proliferate by addition of newborn calf 
serum to 5% (v \  v) at restrictive temperature or by shift to permissive temperature in the 
absence of added factors. At appropriate intervals, 2uCi of methylthymidine (20uCi \  
ml in PBS) was added, and incubation continued for lhr. Dishes were then removed to 
ice and the labelling medium aspirated. Monolayers were washed with 2ml ice-cold PBS, 
then precipitated in situ with 2x2ml ice-cold 5% TCA on ice for 2min. Precipitates were 
washed twice with 2ml ice-cold methanol and air-dried. Precipitated material was 
dissolved by rocking in 0.5ml 0.02M NaOH for 30min at room temperature. 
Incorporation of labelled thymidine into precipitable material was measured by liquid 
scintillation counting of 50ul dissolved material in 5ml Ecoscint.
II.B.2 2 Methionine Labelling
II.B.2.2.1 Immunoprecipitation ofpp60
Growing cultures of Rati, Rati f29, Rati f32 and Rati fPrA at permissive 
temperature were labelled in T25 flasks as follows. Culture medium was aspirated and 
cells washed once with 5ml \  flask of serum-free DMEM supplemented with 2mM 
glutamine and antibiotics but lacking methionine. Cultures were then incubated for lhr 
in 2ml \  flask of the same medium before the addition of 300uCi of -^S-methionine. 
Labelling was for 3hrs. Immunoprecipitates were prepared as described for in vitro 
kinase assays (II.B.4.1) with the exception that lysates were incubated with MAb327309 
for 4hrs. Immune complexes were resolved by SDS-PAGE and labelled proteins were 
detected by fluorography of the dried gel.
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II.B.2.2.2 Methionine Labelling for 2D-gel Electrophoresis
Quiescent cultures of Rati and Rati f32 were prepared in 35mm dishes or in 24 
well plates as described in n.A.l. In some experiments, pulse labelling was used in an 
effort to identify proteins whose synthesis was modulated by activating WLA32 Src. 
Cultures in 35mm dishes were shifted to permissive temperature for 0 (i.e. labelled at 
40°C), 1, 4, 7 or 24hrs before labelling. Cultures were quickly washed with 2ml \dish 
serum-free DMEM supplemented with 2mM glutamine and antibiotics but lacking 
methionine, and incubated for 30min in 1ml \  dish of the same medium at the appropriate 
temperature. 200uCi of - m e t h i o n i n e  was added to each dish and labelling effected for 
30min at the appropriate temperature. Labelled cells were washed briefly in PBS and 
lysed in situ in 450ul 2D-gel sample buffer (9.9M urea, 4% NP40, lOOmM DTT, 2.2% 
ampholytes pH 3-10,2D-gel optimised).
Other experiments were undertaken in parallel with ^^P-orthophosphate 
labelling. These experiments were designed to distinguish between dephosphorylation or 
proteolysis of specific phosphate labelled proteins whose ^2 p content decreased in 
response to temperature shift. For these experiments, Rati and Rati f32 cells were 
grown and rendered quiescent in 24 well plates as described. Cultures were starved of 
methionine for 30min before labelling with 200uCi \  ml -^S-methionine in methionine- 
free, serum-free DMEM supplemented with 2mM glutamine and antibiotics. Labelling 
was for a total of 4hr, during which time cultures were shifted to permissive temperature 
for 0, 15, 30, 60 or 120min. Cultures were placed on ice and washed twice with ice-cold 
PBS before lysis in situ with lOOul \  well 2-D gel sample buffer. In these experiments,
500,000 cpm of TCA-precipitable material was resolved for each sample. 2D-gel 
electrophoresis was expertly performed by Lynn McGarry using a Millipore Investigator 
2D-gel system. Labelled proteins were detected by fluorography at -70°C for 27-32 days 
for the pulse-labelling experiments or for 3-14 days for the 4hr labelling experiments.
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II.B.2.3 Orthophosphate Labelling
II.B.2,3,1 Phosphoamino acid Analysis of Whole Cell Lvsates
Phosphoamino acid analysis was carried out according to the method of Cooper 
et al.310 Briefly, cultures of Rati, Rati f29, Rati f32 and Rati fPrA were maintained in 
exponential growth for at least two days prior to labelling with carrier-free ^2 p_ 
orthophosphate. Cells in T25 flasks were washed twice in phosphate-free DMEM 
supplemented with 2mM glutamine, antibiotics and 5% dialyzed newborn calf serum. 
(Serum was dialyzed overnight at 4°C against sterile distilled water). Cells were then 
incubated for lhr in 2 ml \  flask of the same medium at the appropriate temperature 
before addition of label to lmCi \  ml. Labelling was for 18-20hrs at the appropriate 
temperature. Cultures were removed to ice and washed twice with ice-cold PBS before 
lysis in 1ml of modified RIPA buffer (lOmM tris-HCl, pH 7.0, 150mM NaCl, 1% NP40, 
1% sodium deoxycholate, 0.1% SDS, 2mM EDTA, lOmM sodium pyrophosphate, 
lOmM p-glycerophosphate, lOuM sodium orr/iovanadate, 2mM PMSF and ~lug \  ml 
aprotinin). Cells were incubated on ice for lOmin, then scraped using disposable cell 
scrapers. Flasks were left for an additional lOmin to solubilize adherent structures 
completely before scraping and transfer to screw-cap eppendorf tubes. Lysates were 
centrifuged at 14,000 rpm for 20min at 4°C in a Sorvall SS34 rotor. 300ul of supernatant 
was carefully removed to a fresh tube containing 400ul of NTE (lOmM tris-HCl, pH 7.5, 
lOOmM NaCl, ImM EDTA) and 400ul NTE-saturated phenol at room temperature. 
Tubes were capped tightly and vortexed for 30sec, before centrifugation for lmin in a 
bench top microcentrifuge at room temperature. The aqueous layer was discarded, and 
the phenol phase extracted with a further 800ul NTE. The phenol layer and interface 
material was transferred to a 30ml Corex tube, to which was added 13ml water and 2ml 
100% TCA. After careful thorough mixing, the tubes were placed on ice for lhr. 
Precipitated material was collected by centrifugation at 8000 rpm for lOmin at 4°C in a 
Sorvall SS34 rotor, and the supernatant decanted from the pellet of precipitated protein 
and detergent. The pellet was extracted with 5ml chloroform \  methanol (2:1) at room 
temperature, and the protein precipitate collected with a lOmin centrifugation as before
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but at room temperature. Air-dried pellets were dissolved in 200ul 6 M HC1 and 
transferred to Wheaton vials with 2xl00ul 6 M HC1 washes. Vials were sealed and 
hydrolysis carried out for 2hrs at 110°C. Samples were allowed to cool to room 
temperature before all liquid was collected in the bottom of the vials. The hydrolysate 
was diluted with an equal volume of distilled water and dried under vacuum over solid 
NaOH and P2 O5 . Dried residues were washed twice by redissolving in 200ul distilled 
water and drying under vacuum. Residues were finally redissolved in 30ul pH 1.9 buffer 
(pH 1.9 buffer is 45:156:1799 98-100% formic acid:glacial acetic acid:water) and stored 
at -20°C. Approximately 30-50% was loaded on a single plate together with unlabelled 
standards as outlined in section II.B.2.3.3.
II.B.2.3.2 Phosphoamino acid Analysis of Individual Proteins
Proteins were resolved by SDS-PAGE and located by autoradiography of the 
fixed or unfixed dried gel. Gel slices were excised and proteins eluted essentially as 
described by Beemon and Hunter311. Briefly, the backing paper was scraped from the 
dried gel slices and the bands cut into small pieces. These pieces were allowed to swell 
in a small volume of 50mM NH4 HCO3 , 0.1% SDS before Dounce homogenisation. 
More buffer was added as necessary. The homogenate, together with washes was 
transferred to a plastic tube (Falcon 2051) and made 5% with respect to p- 
mercaptoethanol. The homogenate was boiled for 5min and then shaken overnight at 
37°C. Gel fragments were pelleted by centrifugation at 10,000rpm for lOmin at room 
temperature in a Sorvall HB4 rotor, and the supernatant transferred to a fresh tube. The 
gel fragments were washed with a volume of buffer half that used originally for 2 hr at 
37°C. The gel fragments were pelleted again and the second supernatant pooled with the 
first. RNase A was added to lOug \  ml, mixed thoroughly, and the solution was made 
20% in TCA. Proteins were precipitated for l-4hrs on ice and collected by centrifugation 
for 15min at 10,000 rpm in a Sorvall HB4 rotor at 4°C. The tube was drained thoroughly 
by inversion, and the pellet was washed twice with ethanol at -20°C with the same
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centrifugation conditions. The dried pellet was resuspended in 6 M HC1 and hydrolyzed 
as described above (II.B.2.3.1).
II.B.2.3,3 Thin Layer Separation of Phosphoamino acids
Acid hydrolysates from phosphate-labelled cells or individual proteins were 
separated according to Cooper et a / . 310 Dried hydrolysates were dissolved in pH 1.9 
buffer and spotted in 0.3-0.5ul aliquots onto a 20x20cm cellulose thin layer plate 
(Kodak, lOOum). 0.5ug of each unlabelled phosphoamino acid (phosphoserine, 
phosphotyrosine and phosphothreonine) was loaded on each origin to serve as markers 
following electrophoresis. Hydrolysates were resolved by electrophoresis at pH 1.9 
towards the anode at a constant 700V for 2hr. After thorough drying, the plates were 
rotated and electrophoresis carried out at pH 3.5 towards the anode at a constant 600V 
for lhr 40min. (pH 3.5 buffer is 10:100:1890 pyridine:glacial acetic acid:water). The thin 
layer plate was maintained below 10°C during electrophoresis using a block cooled with 
tap water at approximately 11 \  min. Following electrophoresis the plate was dried 
thoroughly before standards were visualised using ninhydrin (0 .2 % in ethanol, developed 
at 80°C). Dried plates were exposed to X-ray film.
A quantitative estimate of the abundance of individual phosphoamino acids was 
required after separation of total cell hydrolysates. After autoradiography, the areas of 
cellulose containing the ninhydrin stained standards, together with appropriate 
background areas were simultaneously scraped and collected using a glass wool-plugged 
blue tip attached to a vacuum line. The collected material was expelled into a 
scintillation vial containing 10ml of Ecoscint and vortexed vigorously before counting 
for lOmin. Abundance is expressed as a percentage of total radioactivity incorporated 
into the three phosphohydroxyamino acids.
II.B.2.4 Orthophosphate Labelling for 2D-Gel Electrophoresis
Quiescent cultures of Rati and Rati f32 were prepared as described in II.A. 1 in 
35mm dishes or 24 well plates. Cultures were washed in phosphate-free DMEM
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supplemented with 2mM glutamine and antibiotics and starved of phosphate for 30min 
in the same medium. Carrier-free -^P-orthophosphate was added to 0.5-lmCi \  ml and 
labelling effected for a total of 4hr. Cultures were shifted to permissive temperature for 
0, 15, 30, 60 or 120min during this period. After labelling, cells were placed on ice and 
washed twice with ice-cold PBS before lysis in 2-D gel sample buffer (see section 
II.B.2.2.2, lOOul per well or 0.5ml per T25 flask). Approximately 75,000 or 500,000 
cpm of TCA-precipitable material from each well or flask respectively was resolved by 
2-D gel electrophoresis as described above (II.B.2.2.2). Fixed, dried gels were exposed 
to film for 2-7 days at -70°C.
II.B.3 V8  Protease Analysis of Mutant Src Proteins
Growing cultures were labelled exactly as described for the phosphoamino acid 
analysis (section n.B.2.3.1). After lysis as described, 300ul of the clarified RLPA lysate 
was incubated for lhr on ice with 50ul normal rabbit serum. The lysate was then cleared 
by incubation with 250ul heat-killed, formalin fixed Staphylococcus aureus. After brief 
centrifugation, the supernatant was transferred to a fresh tube and mixed with lug 
MAb327309. Immunoprecipitates were formed overnight on ice. Complexes were 
collected by incubation with 50ul S. aureus precoated with rabbit anti-mouse IgG (300ug 
\  ml, 2hrs 4°C) for 2hrs on ice. Immune complexes were washed three times in lysis 
buffer containing phosphatase and protease inhibitors (lOmM sodium pyrophosphate, 
lOmM B-glycerophosphate, lOuM sodium orthovana.da.te, 2mM EDTA, 2mM PMSF, 
-lug  \  ml aprotinin), and then twice in 20mM PIPES-NaOH, pH 6 .8 . Final pellets were 
resuspended in SDS-PAGE sample buffer and separated on a 10% acrylamide gel. pp60 
was located by autoradiography of the unfixed dried gel, and limited V8  proteolysis 
carried out according to Harlow and Lane312. Protease was used at 1, 10 and lOOng per 
well, and digestion products were separated on a 12% acrylamide gel. After drying and 
fixing, digestion products were visualized by autoradiography at -70°C.
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II.B.4 In vitro Protein Kinase Assays
II.B.4.1 Immunoprecipitation of pp60
In vitro kinase activity was measured using a conventional assay41*42. pp60 was 
partially purified by immunoprecipitation from cultures at the appropriate temperature, 
and kinase activity towards self or exogenous substrates measured in the presence of 
Mn^+, Mg^+ and [y^P] ATP. Typically, subconfluent cells in 60mm dishes were 
placed on ice and washed once with ice-cold PBS. Cultures were lysed in 1ml of NP40 
buffer (20mM tris-HCl, pH 6 .8 , 150mM NaCl, 1% NP40, 20mM sodium pyrophosphate, 
lOuM sodium ortho vanadate, 2mM PMSF, ~1 ug\ml aprotinin) for 20min on ice, before 
scraping to cooled 1.5ml eppendorf tubes. Lysates were clarified by centrifugation at
14,000 rpm for lOmin at 4°C in a microcentrifuge, and the protein concentration of the 
supernatant estimated using the Micro BCA assay supplied by Pierce. 200ug of protein 
from each lysate was diluted to 1 ml in cold lysis buffer and mixed with 25ul normal 
rabbit serum on ice for 30min. Normal rabbit serum was removed by the addition of 
250ul heat-killed, formalin fixed S. aureus cells (10% (w\v), washed twice in lysis 
buffer) for 30min on ice. After removal of bound complexes by brief centrifugation at 
4°C, the supernatant was mixed with 0.2ug of MAb327309 and incubated for lhr on ice. 
Specific immune complexes were collected by the addition of 50ul precoated S. aureus 
cells for 30min on ice. Precoating was carried out by incubating a washed 10% (w\v) 
suspension of S. aureus cells with 300ug \  ml rabbit anti-mouse IgG for approximately 
2hrs at 4°C. Precoated cells were washed twice with lysis buffer and resuspended in 
lysis buffer at 10% (w\v) before use. Immune complexes were washed twice in NP40 
buffer and once in kinase buffer (lOOmM PIPES-NaOH, pH 6 .8 , 20mM MnC^, lOuM 
sodium orthovanadate). 25ul of kinase buffer was added to each pellet and 
immunoprecipitates were frozen at -70°C for later assay.
In some experiments, polyclonal rabbit antiserum was used to prepare 
immunoprecipitates. Typically, 5ul of antiserum (G950.4, MW294 or TBR-RLE313) was
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used in place of MAb327, and complexes collected on uncoated S. aureus cells. The 
protocol used was otherwise identical.
II.B.4.2 In vitro Kinase Assay
Most kinase assays utilized acid denatured enolase as a protein substrate. This 
substrate was prepared from an ammonium sulphate precipitate of rabbit muscle enolase 
as follows42. An aliquot of the precipitate was centrifuged at 14,000 rpm for 30min at 
4°C and the supernatant discarded. The pellet was resuspended in buffer A at lOmg \  ml 
(buffer A is 50mM HEPES-NaOH, pH 7.0, ImM DTT, ImM MgC^). The suspension 
was stored on ice for 30min before an equal volume of glycerol was added. Solubilized 
enolase was stored in 25ul aliquots at -70°C. Immediately prior to use, the substrate was 
acid denatured by incubation with an equal volume of 50mM acetic acid at 30°C for 
lOmin. Assays employing enolase as an exogenous substrate contained:
4ul acid denatured enolase 
4ul distilled water
1.5ul kinase buffer
0.5ul [y 2^ P] ATP (5uCi, 3000Ci\mmol) 
and were initiated by the addition of lOul of resuspended immunoprecipitate. Kinase 
buffer replaced enolase in assays of immunoprecipitates formed using TBR-RLE313. 
Assays were incubated at 30°C for 20min before termination with 500ul of wash buffer 
(wash buffer is lOmM tris-HCl, pH 8.0, 400mM NaCl, ImM EDTA, 1% NP40, 0.25% 
sodium deoxycholate). Pelleted S. aureus cells supporting immune complexes were 
washed twice with wash buffer before resuspension in 20ul of 2x SDS-PAGE sample 
buffer. Under these wash conditions pp60 and enolase remain with the pellet. Proteins 
were resolved by SDS-PAGE using 10% acrylamide gels, and fixed, dried gels were 
typically exposed to X-ray film for l-4hrs at room temperature or -70°C.
Other assays employed a commercially available gastrin-related peptide 
substrate, Ray tide. Lyophilized peptide was reconstituted to a concentration of lmg \  ml 
in kinase buffer and stored at 4°C. Each assay contained the following components :
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3ul distilled water
1.5ul kinase buffer
0.5ul [,v32P] ATP (5uCi, 3000Ci\mmol)
5ul Raytide substrate in kinase buffer 
and reactions were initiated by the addition of lOul of resuspended immunoprecipitate. 
Reactions were terminated after 20min at 30°C by the addition of 80ul 10% H3 PO4 . S. 
aureus cells were pelleted by microcentrifugation, and 80ul aliquots of the supernatant 
were spotted on 2x2cm squares of phosphocellulose paper (Whatman P81). Filters were 
washed extensively with 0.5% H3 PO4  and once with acetone. After drying at room 
temperature, filters were counted in 5ml Ecoscint. Radioactivity was normalized to Rati 
controls at the appropriate temperature.
II.B.5 Western Blotting
Extracts of interest were resolved on SDS-PAGE gels together with prestained 
molecular weight markers. Proteins were blotted onto nitrocellulose membranes using a 
Sartorius semi-dry blotting apparatus as follows. Twelve pieces of Whatman 3MM paper 
and one piece of membrane were cut to the size of the gel to be blotted and equilibrated 
in transfer buffer (60mM tris, 50mM glycine, 1.6mM SDS, 20% (v\v) methanol). The gel 
was rinsed in transfer buffer and placed upon 6  pieces of 3MM paper. The membrane 
was placed on the gel and topped with the remaining pieces of 3MM. Air bubbles were 
carefuly removed and transfer effected at full power for 15-40min. The membrane was 
removed after transfer of appropriate prestained markers was complete. At this stage, the 
membrane could be dried and stored at 4°C if not processed immediately. The 
membrane was blocked for 30min at room temperature in blotto (2.5% non-fat milk 
powder, 0.1% NP40 in PBS) before incubation with antiserum (typically anti-src, 
MW294 or anti-gag, 5202, 1:5000 in blotto) overnight at 4°C. The membrane was 
subsequently washed three times in blotto before incubation with anti rabbit IgG 
conjugated to alkaline phosphatase (1:5000 in blotto) for 2hr at room temperature. The 
membrane was washed extensively with blotto and alkaline phosphatase buffer (lOOmM
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tris-HCl, pH 9.5, lOOmM NaCl, 5mM MgC^) before development with chromogenic 
alkaline phosphatase substrate. This substrate was prepared by dissolving 16mg nitro 
blue tetrazolium and 8 mg of 5-bromo-4-chloro-3-indolyl phosphate in 50ml of alkaline 
phosphatase buffer. Substrate solution was added to the membrane and developed as 
necessary before termination in running water.
n.C. RECOMBINANT DNA TECHNIQUES314
II.C.1.1 Host Cells
E. coli strains HB101 and TGI were obtained from V. Fincham. Strain DH1 was 
obtained as competent cells from D. Crouch. Host cells and derivatives were grown at 
37°C with good aeration in L-broth (see materials) supplemented with appropriate 
antibiotics. Ampicillin and kanamycin were used at final concentrations of 100 and 25ug 
\  ml respectively.
II. C. 1.2 Competent Cells
2ml of an overnight culture of HB101 or TGI was diluted to 200ml in sterile L- 
broth and grown at 37°C with good aeration until the absorbance at 550nm reached 0.4- 
0.6 (1cm path length, L-broth blank). The log phase cells were collected by 
centrifugation at 10,000 rpm for 5min at 4°C in a Sorvall GSA rotor. The supernatant 
was decanted and the pellet carefully resuspended in 200ml sterile, ice-cold 80mM 
CaCl2 - The suspension was incubated on ice for 15min before the cells were collected by 
centrifugation according to conditions described above. The pellet was gently 
resuspended in 20ml of sterile, ice-cold 80mM CaCl2  \  15% glycerol and stored on ice 
for 15min. The suspension of competent cells was then divided into 0.5-lml aliquots on 
dry ice before storage at -70°C.
II.C.1.3 Transformation of Bacterial Hosts 
II.C. 1.3.1 HB101 and PHI
E. coli strains HB101 and DH1 were used for routine plasmid transfections. The
appropriate amount of plasmid DNA or ligation mix was pipetted into a precooled
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eppendorf tube. An aliquot of competent cells was thawed on ice, and 200ul mixed 
gently with the DNA of interest. After incubation on ice for 30min, the cells were heat 
shocked by incubation at 25°C for 15min. 0.5ml of prewarmed L-broth was added and 
the suspension was placed at 37°C for 30min to allow expression of the antibiotic 
resistance marker. Cells were then pelleted by brief centrifugation and resuspended in a 
small volume of supernatant before plating on agar plates (2% agar in L-broth) 
supplemented with the appropriate antibiotic. Plates were inverted and incubated 
overnight at 37°C to allow colony formation.
II.C. 1.3.2 TGI
E. coli strain TGI was used for the propagation of bacteriophage M l3. 
Competent cells were thawed on ice and 1 0 0 -2 0 0 ul pipetted to a plastic universal. The 
appropriate amount of phage DNA (single or double stranded) or ligation mix was mixed 
in gently, and the suspension stored on ice for 40min. During this time, an overnight 
culture of TGI was diluted 1:10 in 2YT broth and grown further at 37°C. (2YT broth is 
1% bactotryptone, 1% yeast extract, 1% NaCl (w\v) in sterile distilled water). lOmin 
before the transfection was completed, a lawn mix was prepared. This consisted of (for 
each transfection):
200ul log-phase TGI cells
25ul IPTG (24mg \  ml in distilled water)
30ul X-gal (2% in dimethylformamide)
This mixture was left at room temperature whilst the transfection was completed. 
In addition, top agar was prepared for the plates by melting 0.5% agarose in 1YT broth 
in a microwave. This was allowed to cool in a 42°C water bath whilst the transfection 
was completed. The DNA \  competent cell mix was heat shocked at 42°C for 2min and 
then mixed with 200ul lawn mix at room temperature. 3-5ml of top agarose was added 
and the mixture poured onto a prewarmed YT plate (2% agar in 2YT broth). The top 
agarose was allowed to set at room temperature before the plates were incubated inverted 
overnight at 37 °C. M13mpl8 and M13mpl9 encode an IPTG-inducible (3-galactosidase
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marker which in the presence of the chromogenic substrate X-Gal yields a blue 
colouration. This enables one to distinguish between plaques containing recombinant 
bacteriophage and religated parental bacteriophage.
II.C. 1.4 Glvcerol Stocks
E. coli host strains or hosts bearing useful plasmids were stored as glycerol stocks 
for future retrieval. Stationary cultures in L-broth were mixed with an equal volume of 
glycerol in sterile plastic bijous and frozen at -70°C. Cells were retrieved from these 
frozen stocks using sterile plastic loops.
II.C.2 Restriction Digests and Agarose Gel Electrophoresis 
II.C.2.1 Restriction Digests
Restriction digests were carried out in small volumes buffered using buffer 
concentrates supplied with the enzymes. Small quantities of plasmid DNA (<2ug) were 
digested in a total volume of 20ul using 1-10 units of enzyme per ug of DNA, depending 
on the enzyme used and the number of sites present. Digestion was allowed to proceed 
for l-2hr at 37°C. Larger, preparative digests were carried out in proportionately larger 
volumes. For double digests, manufacturers' information was consulted and the 
appropriate buffer used. Digests of genomic DNA were carried out essentially as 
described except digestion was normally continued overnight. Ocassionally, a second 
aliquot of enzyme was required for complete digestion of genomic DNA. Reactions were 
terminated by the addition of one tenth volume gel loading buffer (see section n.C.2.2).
II.C.2.2 Agarose Gel Electrophoresis
DNA fragments were resolved on non-denaturing agarose gels and visualized by 
ethidium bromide staining. Agarose gel concentration varied according to the fragments 
under study, though 0.8% gels were usually sufficient. Gels mixes were prepared by 
microwaving the agarose in the appropriate volume of lxTAE buffer (50xTAE buffer is 
2M tris base, 50mM EDTA, 57.1ml \  1 glacial acetic acid) until all particles had
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dissolved. The gel mix was cooled to approximately 50°C, made lug \  ml in ethidium 
bromide and cast in the appropriate gel former. Gels were allowed to set at room 
temperature before removal of well formers and installation in the tank. Electrophoresis 
was carried out in lxTAE buffer. Samples for electrophoresis, and molecular weight 
standards (bacteriophage X, Hindin digested, bacteriophage (J)xl74, Haein digested) 
were mixed with one tenth volume of gel loading buffer (0.25% bromophenol blue, 
0.25% xylene cyanol, 25% Ficoll in water), loaded and resolved by electrophoresis 
towards the anode. A permanent record of the gel was made using a polaroid camera 
whilst the gel was illuminated from below using a uv source.
II.C.3 Elution. Extraction and Quantitation Techniques
II.C.3.1 Elution of DNA Fragments from Agarose Gels
Fragments of interest were recovered from agarose gels by centrifugation, 
electroelution or "Genecleaning". Recovery by centrifugation was found to be 
particularly straightforward and reliable. The gel slice containing the fragment of interest 
was removed and trimmed of excess agarose over a uv source. A small (0.5ml) 
eppendorf tube was punctured at the base and plugged with glass wool. The gel slice was 
placed upon the glass wool, and the plugged tube was placed inside a 1 .5 ml eppendorf. 
The tubes were then centrifuged at 5000 rpm for 5-10min at room temperature in a bench 
top minifuge. This resulted in the DNA and gel buffer collecting in the larger eppendorf 
tube, with the agarose remaining with the glass wool. The fragments could be used 
directly for ligation, or could be concentrated by ethanol precipitation if required.
Electroelution was used on few occasions. The trimmed gel slice was placed in a 
dialysis bag with a minimum of TAE buffer and electrophoresis continued for 30min at 
170mA. The current was then reversed for 2min to release the DNA from the face of the 
dialysis membrane. After checking that elution was complete by uv transillumination, the 
TAE buffer containing the fragment of interest was extracted twice with phenol \  
chloroform and once with chloroform before ethanol precipitation overnight at -20°C.
"Geneclean" was used according to manufacturers' instructions.
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II.C.3.2 Extraction with Organic Solvents and Ethanol Precipitation
DNA samples were extracted with chloroform and \  or phenol as necessary to 
remove contaminants that might interfere with subsequent manipulations, e.g. residual 
enzyme activities (restriction, nuclease), detergents. Typically, the sample was first 
extracted with an equal volume of phenol \  chloroform. Phenol \  chloroform was freshly 
prepared by mixing equal volumes of NTE-saturated phenol (see section II.B.2.3.1) and 
chloroform \  isoamyl alcohol (24:1). The aqueous and organic phases were mixed 
thoroughly by vortexing, and then separated by centrifugation in a bench top microfuge 
at 14,000 rpm for 5min. This extraction was repeated if necessary. The aqueous phase 
was carefully removed and extracted with an equal volume of chloroform 
(chloroform:isoamyl alcohol, 24:1) by vortexing and centrifugation as described above. 
The aqueous phase was again collected and transferred to a fresh tube. Chloroform 
extraction of small sample volumes was facilitated by the addition of more aqueous 
phase (TE buffer, lOmM tris-HCl, pH 8.0, ImM EDTA). The final supernatant from 
these extractions was then ethanol precipitated.
Ethanol precipitation was used to collect and concentrate samples of DNA. To 
the aqueous solution of DNA was added one tenth volume of 3M sodium acetate and 2- 
2.5 volumes of ethanol. The sample was mixed by inversion, and stored at -20°C 
overnight, or alternatively placed on dry ice for 15-30min. If the DNA was very dilute 
(<10ug \  ml), yeast tRNA was added to facilitate precipitation. Precipitated DNA was 
recovered by centrifugation in a bench top microfuge for 10-15min at 14,000 rpm at 
room temperature or 4°C. The precipitated material was washed with 70% ethanol, and 
dried briefly under vacuum before resuspension in TE buffer to the appropriate 
concentration.
II.C.3.3 Spectrophotometric Quantitation of DNA
The concentration of DNA in aqueous solutions was measured 
spectrophotometrically. Samples were diluted as appropriate in TE buffer and
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absorbance readings taken at 260 and 280nm in a quartz cuvette with a path length of 
lcm. The spectrophotometer was calibrated using a TE blank. An A2 5 0  value of 1 was 
taken as being equivalent to 40ug \  ml of plasmid or genomic DNA, and 30ug \  ml 
oligonucleotide. The chemical purity of DNA solutions was assessed using the ratio of 
absorbance at 260 and 280nm. An A2 5 0  \  A2 gQ ratio of 1.8-2.0 indicated that the 
preparation was essentially pure. Preparations of DNA with a ratio significantly less than
I . 8  were purified further by extraction and \  or precipitation.
II.C.4 Enzvmatic Modification of DNA
n.C.4.1 Dephosphorvlation of 51 Termini
Linearized plasmid DNA was dephosphorylated using calf intestinal alkaline 
phosphatase essentially according to Maniatis et 0 / . 314 except that reactions were carried 
out in restriction buffer. Dephosphorylated DNA was extracted twice with phenol \  
chloroform and precipitated with ethanol.
II.C.4.2 Phosphorylation of 5' Termini
Oligonucleotides used for in vitro mutagenesis were phosphorylated according to 
manufacturers' instructions. Oligonucleotides for hybridization to dot-blots were labelled 
as follows. 15pmol of oligonucleotide was phosphorylated in a total volume of 30ul 
kinase buffer (lOOmM tris-HCl, pH 8.0, lOmM MgC^, 7mM DTT) using 2 units 
polynucleotide kinase and 30uCi [y^p] ATP (3000Ci \  mmol). The reaction was 
allowed to proceed for 30min at 37°C.
II.C.4.3 Ligation of DNA Fragments
Ligations were effected in a minimum volume, typically 10-20ul. The following 
components were mixed on ice (for a final reaction volume of 2 0 ul):
10-20ng linear, dephosphorylated vector DNA (in TE)
2-10 fold molar excess of purified insert DNA (in TE)
4ul 5x ligation buffer (250mM tris-HCl, pH 7.8, 50mM
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MgCl2, lOOmM DTT, 5mM ATP, 250ug\ml BSA) 
distilled water to 19ul 
lul T4 DNA ligase
For the ligation of cohesive termini, reactions were incubated overnight at 12- 
16°C. Blunt-end ligations were carried out overnight at 4°C. Ligation reactions were 
used to transform bacterial host cells immediately or were stored at -20°C.
II.C.4.4 Generation of Blunt Ends from Cohesive Termini using Klenow Fragment of 
DNA polymerase I
Recessed 3' termini were filled using Klenow enzyme. Reactions were carried out 
in 50mM tris-HCl, pH 7.2, lOmM MgCl2, O.lmM DTT, 50ug \  ml BSA supplemented 
with each dNTP at 2mM. Klenow enzyme was added and reactions incubated at room 
temperature for 30min. The enzyme was then denatured by heating at 70°C for 5min.
II.C.4.5 Bal 31 Nuclease Digestion
Nuclease Bal 31 was used to truncate v-src inserts 5' and 3'. This removed viral 
env and LTR sequences, whilst leaving the v-src coding sequence and splice acceptor 
intact. Preliminary experiments to assess the rate of deletion were carried out using 
Hindin digested bacteriophage X DNA as substrate. Using 20ug of X fragments in a 
lOOul reaction (20mM tris-HCl, pH 8.0, 12mM MgCl2, 12mM CaCl2, 200mM NaCl, 
ImM EDTA), 0.1 unit of nuclease Bal 31 was capable of deleting approximately 50 base 
pairs from each terminus in one minute at 30°C.
Required src inserts were excised from pLA29 (proviral 3.1kbp EcoRI ttLA29 
src fragment cloned in pUC1394*315), RAV 32 and RAV PrA (obtained from V. Fincham) 
using EcoRI. The 3.1kb EcoRI fragment containing src was gel purified and dissolved in 
TE. Approximately lOug of purified fragment was digested with 0.1 unit of Bal 31 in 
lOOul for 6 min at 30°C. 20ul aliquots were withdrawn at 2, 3, 4, 5 and 6 min into 5ul ice- 
cold lOOmM EDTA. Tris-HCl, pH 8.0, MgCl2, spermidine and water were added to each 
tube to create suitable conditions for subsequent digestion with Xhol. The volume of the 
sample was increased three-fold at this stage to reduce the salt concentration to the
74
appropriate level. After Xhol digestion, samples were extracted with phenol \  chloroform 
and ethanol precipitated. Recessed 3' termini were then repaired using Klenow enzyme 
(see H.C.4.4) and the samples analyzed by agarose gel electrophoresis. Lanes containing 
fragments of approximately 1.9-2kb were extracted and the isolated DNA ligated to 
Smai digested, phosphatase treated pMP323 (plasmid Clal2 in ref. 306). This step 
generated plasmids pMP 29, pMP 32 and pMP PrA (see chapter III). Appropriate clones 
were chosen for subcloning to fpGV-1301 by restriction mapping and single-strand 
sequencing in bacteriophage M l3.
II.C.5 Site Directed Mutagenesis
Oligonucleotide-directed mutagenesis was carried out in bacteriophage M13 
using a commercially available kit according to manufacturers' instructions. Mutagenesis 
was carried out using oligonucleotide A2:
5' c 7125 ACC ATG G£A AGC AGC a a 7142 3'
The nucleotides underlined indicate those which differ from the &LA29 src sequence.
This mutation results in a glycine to alanine substitution at position 2- The mutant was
named ttLA29A2 to indicate this change. This mutation prevents myristylation of the
Src protein37*111.
Oligonucleotide A2 was 5' phosphorylated according to manufacturers' 
instructions. The parental template, M l3 ttLA29 src, was generated by ligation of an 
EcoRI-BamHI fragment from pMP29 (see results) to M13mpl9. Single strand template 
DNA was prepared as described (II.C.6.2.1). After mutagenesis, five putative mutant 
plaques were picked and expanded for the production of single-stranded and replicative 
(RF) form DNA. Single-stranded DNA from each putative mutant together with starting 
template M l3 ttLA29 src and non-recombinant M13mpl9 were dot-blotted and screened 
for the presence of the A2 mutation using 5' 3 ^P-labelled oligonucleotide A2 according 
to manufacturers' instructions. Under stringent conditions, 3 of the 5 putative mutant 
clones were found to retain labelled oligonucleotide. The presence of the required
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mutation was confirmed by sequencing. RF form mutant M l3 ttLA29A2 src DNA was 
prepared (II.C.6.2.2) to enable subcloning to pMP323 and fpGV-1.
n.C.6 Preparation of DNA
II. C. 6.1 Preparation of Plasmid DNA
nC.6.1.1 Plasmid Minipreparations
Solutions required:
GTE 50mM glucose
25mM tris-HCl, pH 8.0 
lOmMEDTA
5M acetate 60ml 5M potassium acetate 
11.5ml glacial acetic acid 
to 1 0 0 ml with sterile distilled water
Single bacterial colonies were picked from agar plates and grown overnight in 
5ml L-broth supplemented with the appropriate antibiotic. 1.5ml of the overnight culture 
was pelleted at low speed for lmin in a bench top microfuge. The drained pellet was 
resuspended by vortexing in lOOul of GTE containing 5mg \  ml lysozyme. After 
incubation for 5min at room temperature, alkaline lysis was effected by the addition of 
200ul ice-cold 0.2M NaOH\ 1% SDS. The samples were mixed gently by inversion, and 
stored on ice for 5min. 150ul ice-cold 5M acetate was added and mixed gently by 
inversion before incubation for 5min on ice. The precipitated material was pelleted by 
brief centrifugation. The supernatant was extracted with an equal volume of phenol \  
chloroform (see II.C.3.2), and the aqueous phase precipitated with 0.6 volumes of iso- 
propanol for 15min at room temperature. The precipitate was collected by centrifugation 
in a bench top microfuge for lmin at 14,000 rpm. The pellet was washed once in 70% 
ethanol and dried under vacuum. The final pellet was then redissolved in 50ul TE buffer 
and treated with RNase A (50ug \  ml) for lOmin at room temperature. Minipreparation
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DNA was stored at -20°C. Typically, 5ul of this minipreparation was digested for 
mapping purposes.
II.C.6.1.2 Large Scale Plasmid Preparations
Plasmid DNA for transfection purposes was prepared by a modification of the 
method outlined above in II.C.6.1.1. A large overnight culture (500- 1000ml) was 
harvested in a Sorvall GS3 rotor at 7000 rpm for lOmin at 4°C. The pellet was 
resuspended in a total of 10ml GTE, and solid lysozyme added to 5mg \  ml. The 
suspension was mixed thoroughly and incubated at room temperature for 5min. 20ml of 
ice-cold 0.2M NaOH \  1% SDS was added and mixed gently by inversion before 
incubation on ice for 5min. Protein and detergent was then precipitated by the addition of 
15ml of 5M acetate and incubation on ice for 15min. Precipitated material and cellular 
debris were collected by centrifugation under the conditions outlined above. The 
supernatant was filtered through a double thickness of gauze, and precipitated by the 
addition of 0.6 volumes of iso-propanol for 15min at room temperature. Precipitated 
material was collected by centrifugation in a Sorvall HB4 rotor at 8000 rpm for lOmin at 
4°C. Pellets were drained thoroughly and excess iso-propanol wiped from the walls of 
the tubes before dissolution in 8.5ml TE. Precisely 8 ml of crude plasmid DNA solution 
was added to 8 g of CsCl in a plastic universal. This solution was transferred to screw cap 
polycarbonate ultracentrifuge tube and balanced to within O.lg of the other tubes before 
the addition of 0.5ml of lOmg \  ml ethidium bromide. The balanced tubes were 
centrifuged at 40,000 rpm for 40-48hrs at 16-20°C in a Sorvall T1270 rotor. Plasmid 
DNA was carefully removed from the gradient and extracted with 2-butanol to remove 
ethidium bromide before dialysis overnight against 21 TE buffer. Dialysed plasmid DNA 
was subsequently precipitated with ethanol and resuspended in TE at 0.5-2.0mg \  ml. 
Purified plasmid DNA was stored at 4°C or -20°C.
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II.C.6.2 Preparation of Bacteriophage M13 DNA
n.C.6.2.1 Single Stranded MI3 Preparation
Distinct white plaques were picked from YT plates (see II.C. 1.3.2) using sterile 
toothpicks. Plaques were expanded in 1.5ml of exponential TGI in 2YT broth (1:100 
dilution of an overnight culture in 2YT) for 4.5hr at 37°C. After transfer to eppendorf 
tubes, bacteria were pelleted by centrifugation at high speed for 5min. The supernatant 
was tipped carefully into a clean tube and mixed with 150ul 2.5M NaCl \  20% PEG. 
After incubation for 30min at room temperature (or 4°C overnight) precipitated 
bacteriophage particles were collected by centrifugation for 5 min at room temperature. 
The supernatant was aspirated from the small white pellet and the tube centrifuged 
briefly to facilitate complete removal of the NaCl \  PEG. The pellet was resuspended in 
200ul TE and then mixed thoroughly with lOOul 3:1 phenol:chloroform by vortexing for 
lOsec. The mixture was stored at room temperature for lOmin before a second period of 
vortexing. Aqueous and organic phases were separated by centrifugation for 5min at 
high speed, and the aqueous phase removed to a clean tube. Single stranded DNA was 
collected by ethanol precipitation overnight at -20°C, washed with 70% ethanol, dried 
and resuspended in 20ul TE. This DNA was suitable for transformation of competent 
TGI cells, single-strand sequencing and site directed mutagenesis.
II.C.6.2.2 Replicative Form (RF) M l3 Preparation
Mutants generated by oligonucleotide-directed mutagenesis in Ml 3 were 
subcloned to pMP323. This required the preparation of double stranded insert DNA from 
mutant M l3. Appropriate mutants were selected by dot-blot analysis and sequencing and 
re-transfected into competent TGI cells (see II.C. 1.3.2). Appropriate plaques were 
picked and expanded as described in II.C.6.2.1. Infectious bacteriophage was obtained 
by pelleting the host cells and decanting the supernatant to a fresh tube. 60ul of this 
supernatant was used to infect 10ml of log-phase TGI (A5 5 Q ~0.4, 1cm path length, 2YT 
blank) in 2YT. After growth for 4.5hr at 37°C, double stranded, replicate form (RF) M l3 
was prepared from infected host cells as per plasmid minipreparations (see II.C.6 .1.1).
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The mutant insert could then be recovered by digestion with appropriate restriction 
enzymes (EcoRI and BamHI).
II.C.6.3 Preparation of Genomic DNA
Cells (I0 M 0 8 ) in T175 flasks were washed twice in PBS at room temperature. 
The monolayers were then lysed in 6 -8 ml DNA lysis buffer (lOmM tris-HCl, pH 8.0, 
lOOmM NaCl, 2mM EDTA, 2.5% SDS) containing proteinase K at lOOug \  ml. The 
flasks were incubated at 37°C for 60min before the viscous contents were scraped to 
50ml Falcon tubes. Incubation was continued at 37°C for a further 24-72hr. The viscous 
solution was extracted sequentially with phenol, phenol \  chloroform and chloroform. 
The tubes were mixed gently at each stage to prevent shearing of the high molecular 
weight DNA, and after centrifugation at 3000 rpm for 5min, aqueous material was 
transferred to fresh tubes using wide-bore pipettes. DNA was then precipitated by the 
addition of one tenth volume 0.1M magnesium acetate, one tenth volume of 3M sodium 
acetate and 2.5 volumes of ethanol at room temperature. The precipitate which formed at 
the interface was collected on the tip of a blocked Pasteur pipette and washed in 70% 
ethanol. After air-drying, the DNA was dissolved in sterile TE buffer to a concentration 
of ~0.5mg\ml.
II.C.6.4 Preparation of Oligonucleotides
Oligonucleotides were synthesised on an Applied Biosystems model 381A DNA 
synthesiser. 5' trityl groups were removed on the machine before the oligonucleotide was 
eluted from the column in concentrated ammonia solution (29%) for 1.5hr at room 
temperature. The oligonucleotide in concentrated ammonia solution was sealed in a glass 
vial and incubated overnight at 55°C. Deprotected oligonucleotides were ethanol 
precipitated and washed extensively in 70% ethanol at room temperature to remove salt. 
Dried DNA was dissolved in TE to a concentration suitable for sequencing or 5' end- 
labelling.
ILC.7 Sequencing Methods
II.C.7.1 Single Stranded Sequencing
Single strand sequencing was used to determine the 5' and 3' endpoints of the src 
inserts used, and also to confirm the presence of appropriate mutations in ttLA32 src and 
ttLA29A2 src. Oligonucleotides used for this work are described below (sequence 
numbered according to Schwartz et a/.114) :
M13 universal primer 5’ GTAAAACGACGGCCAGT 3'
Oligonucleotide 107 5’ T7 3 9 6 ACGACTACGAGTCCTG7 4 1 2  3'
Oligonucleotide 300 5' G7 9 5 5 CTGCTTTGGAGAGGTC7 9 7 1  3'
Oligonucleotide 419 5’ C8 3 2 oTGGTGTGCAAGGT8 3 3 3  3'
Oligonucleotide 3' src 5’ Ag6 9 6 GGTCGCTGAATAAGTACGAG8 7 1 6  3’
Oligonucleotides 107, 300 and 419 are sequences found 5' to the mutations in 
ttLA32 src142. These reagents enabled sequencing of the mutations in my molecular 
clones. Oligonucleotide 3' src corresponds to the junction between the end of src coding 
sequences and the 3' untranslated region of RSV114.
Single strand M l3 template DNA was prepared according to section n.C.6.2.1, 
and sequenced using commercially available kits from Pharmacia (Klenow kit) or USB 
(Sequenase kit) according to manufacturers' instructions. Reactions were resolved on 6 % 
denaturing acrylamide gels at a constant 40W. Gels were fixed for 15-30min in 10% 
methanol, 1 0 % acetic acid in water and dried before autoradiography at room 
temperature.
II.C.7.2 Double Stranded Sequencing
Double stranded sequencing was used to confirm the presence of mutations in 
fpGV-32 (see chapter HI) and the A2 mutation in fpGV-29A2 (see chapter VIII). 
Minipreparation plasmid DNA was prepared and sequenced as follows according to an 
unpublished method of D. Crouch. 50ul of RNase treated DNA from a plasmid
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minipreparation (see II.C.6.1.1) was mixed with 30ul of 2.5M NaCl \  20% PEG and 
placed on ice for 60min. The precipitated material was collected by centrifugation and 
washed with 70% ethanol. The dried DNA was dissolved in 16ul TE and denatured by 
adding 4ul of 1M NaOH. 2ul of 3M sodium acetate and 2 volumes of ethanol were added 
and the denatured template precipitated on dry ice for 30min. After collection by 
centrifugation and washing with 70% ethanol, the pellet was dissolved in 20ul TE. 7ul of 
this preparation was mixed with 2ul sequencing reaction buffer (USB Sequenase kit) and 
lul primer (30ng \  ul) and annealed for 30min at 37°C. Sequencing reactions were then 
carried out using the USB Sequenase kit according to manufacturers' instructions. 
Reactions were resolved as described above in section II.C.7.1.
n.C.8 Southern Blotting
10-20ug of genomic DNA was electrophoresed on 0.8% agarose gels together 
with 32p-labelled Hindlll digested X DNA (2000cpm) to serve as markers. The gel was 
depurinated in 0.25M HC1 until the dyes had changed colour, and then left for an 
additional lOmin. After a brief rinse in distilled water, the gel was blotted using 0.4M 
NaOH as the transfer buffer. Transfer to Hybond N+ membrane and hybridization were 
according to manufacturers' instructions. The probe used was a v-src PstI fragment 
(8050-8662, a gift from V. Fincham) oligo-labelled using a commercially available kit 
from Pharmacia. Hybridization was carried out in a minimal volume at 65°C overnight 
in a shaking water bath. After washing to high stringency according to manufacturers' 
instructions, excess liquid was removed and the membrane subject to autoradiography at 
-70°C.
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II.D. MATERIALS
II.D.1 Antiserum
Goat anti-rabbit IgG, 
alkaline phosphatase conjugate
Mouse monoclonal MAb327309
Normal rabbit serum 
Rabbit anti -gag 5202 
Rabbit anti-mouse IgG
Rabbit anti-src G950.4 
Rabbit anti-src MW294  
Rabbit anti-src TBR-RLE313
Promega,
Madison,
Wisconsin, USA. 
Oncogene Scienc Inc., 
Manhasset,
New York, USA. 
Laboratory stocks 
Laboratory stocks 
Sigma Chemicals Co. Ltd., 
Poole,
Dorset, England. 
Laboratory stocks 
Laboratory stocks 
A gift of Dr J. Neil, 
Beatson Institute, Glasgow.
IID.2 Bacterial Hosts
E. coli host strains DH1, HB101 and TGI were obtained from laboratory stocks 
held by Dr D. Crouch (DH1) and V. Fincham (HB101 and TGI). HB101 for RCAN 
work (see chapter III) was obtained from Dr R. Brown, Department of Medical 
Oncology, University of Glasgow.
II.D.3 Cells
Rati cells302 and Rati ttLA2919*94 were obtained from laboratory stocks. CEF 
were prepared as described303, from White cross Brown Leghorn chicken embryos 
supplied by Wickam Laboratories, Hants., England.
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II.D.4 Chemicals
Supplier-Amersham International PLC, Amersham, Bucks., England. 
Amplify
Supplier-Bethesda Research Laboratories (UK), Gibco Ltd., Paisley, Scotland.
All DNA modifying enzymes and appropriate buffer concentrates were obtained 
from BRL unless otherwise stated. The following reagents were also obtained from
Agarose (ultrapure grade)
Bacteriophage X (Hindin digested) 
Bacteriophage (j)xl74 (Hae III digested) 
Prestained protein molecular weight markers 
Urea (ultrapure grade)
Supplier-BDH Chemicals Ltd., Poole, Dorset, England.
All organic solvents (AnalaR grade) were obtained from BDH unless otherwise 
stated. The following compounds were also obtained from BDH (AnalaR, Biochemical 
or Electran grades):
^H-methylthymidine 25Ci\mmol 
[y^PJATP 3000Ci\mmol 
32p-orthophosphate, carrier-free
BRL:
Acylamide Phosphorus pentoxide
Ammonium chloride PEG 6000
Ammonium persulphate Potassium acetate
Aqueous ammonia 
h/s-acrylamide
Potassium chloride
p-mercaptoethanol 
Calcium chloride
Potassium hydroxide 
Sodium acetate
Sodium chloride
D-glucose Sodium citrate
Disodium orthophosphate Sodium deoxycholate
EDTA SDS
Glycerol
Glycine
Hydrochloric acid 
Magnesium acetate 
Magnesium chloride 
Manganese II chloride 
Orthoboric acid
Tris
Xylene cyanol
Sodium orthov anadate
Sodium fluoride
Sodium hydroxide
Orthophosphoric acid
Supplier-Beta Lab., East Mosely, Surrey, England.
Yeast extract
Supplier-BioRad, Richmond, California, USA.
TEMED
Supplier-Boehringer Mannheim UK Ltd., Lewes, East Sussex, England.
Caesium chloride
Calf intestinal alkaline phosphatase 
Klenow fragment E. coli DNA polymerase 
Proteinase K 
RNase A
Supplier-James Burrough Ltd., Witham, Essex, England. 
Ethanol
Supplier-Difco Laboratories, Detroit, Michigan, USA.
BactoAgar Bactotryptone
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Supplier-Gibco Europe, Life technologies Ltd., Paisley, Scotland.
Chicken serum Phosphate-free DMEM 
7.5% sodium bicarbonatelOx DMEM concentrate
Foetal calf serum lOOmM sodium pyruvate 
S. aureus (killed, fixed) 
Trypsin
200mM Glutamine
G418
Lipofectin reagent 
Methionine-free DMEM
Tryptose phosphate broth
Newborn calf serum
Supplier-Koch-Light Ltd., Haverhill, Suffolk, England.
Isoamyl alcohol
Supplier-Merck, Darmstadt, Germany.
Ninhydrin
Supplier-Millipore UK Ltd., Watford, Herts., England.
All reagents required for 2D-gel electrophoresis were obtained from Millipore.
Supplier-National Diagnostics, Manville, New Jersey, USA.
Ecoscint A
Supplier-New England Nuclear, DuPont UK Ltd., Stevenage, Herts., England.
•^S-methionine
Supplier-Oncogene Science Inc., Manhasset, New York, USA.
Raytide (peptide substrate, tyrosine kinase)
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Supplier-Pharmacia Ltd., Milton Keynes, Bucks., England.
Dextran sulphate Sephadex G100
dNTP T4 polynucleotide kinase
Restriction endonuclease Pvul yeast tRNA
Supplier-Rathbum Chemicals Ltd., Walkerbum, Scotland.
Phenol (water-saturated)
Supplier-Safeway supermarket, Glasgow.
Non-fat milk powder ("Marvel")
Supplier-Sigma Chemical Co. Ltd., Poole, Dorset, England.
Ammonium bicarbonate IPTG
Ampicillin Lysozyme
Aprotinin Nitroblue tetrazolium
ATP NP40
(3-glycerophosphate Phosphoserine
5-bromo-4-chloro-3-indolyl phosphate Phosphothreonine
Bromophenol blue Phosphotyrosine
BSA (fraction V) PIPES
Calf thymus DNA PMA
Coomassie brilliant blue R PMSF
DTT Polyvinylpyrrolidone 360
Enolase (rabbit muscle) S. aureus V8  protease
Ethidium bromide Sodium pyrophosphate
Ficoll Spermidine
HEPES X-gal
Supplier-Unipath Ltd., Basingstoke, Hants., England. 
PBS (Dulbecco A, tablet form)
n.D .5 Kits
Supplier-Amersham International PLC, Amersham, Bucks., England.
Oligonucleotide-directed in vitro mutagenesis kit, version 2.
Supplier-Bio 101 Inc., Stratech Scientific, Luton, England.
Geneclean kit
Supplier-Pharmacia Ltd., Milton Keynes, Bucks., England.
Oligo-labelling kit 
^Sequencing kit
Supplier-Pierce, Life Science Laboratories Ltd., Luton, England.
Micro BCA protein assay kit
Supplier-United States Biochemical, Cleveland, Ohio, USA.
Sequenase version 2.0 kit
II.D. 6  Membranes. Paper. TLC plates and X-ray film
Supplier-Amersham International PLC, Amersham, Bucks., England.
Hybond N+
Supplier-Anderman Co. Ltd., Kingston upon Thames, England.
Schleicher and Schuell nitrocellulose membrane BA83 and BA85
Supplier-Bethesda Research Laboratories, Gibco Ltd., Paisley, Scotland.
Dialysis tubing
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Supplier-Eastman Kodak Co., Rochester, New York, USA. 
Duplicating film (DUP-1)
X-ray film (XAR-5)
Supplier-Fuji Photo Film Co. Ltd., Japan.
X-ray film (RX)
Supplier-Phase Separations Ltd., Deeside, Clywd, Wales.
20x20cm cellulose TLC plates (without fluorescent indicator)
Supplier-Sartorius GmbH, Gottingen, Germany.
Dialysis bags
Supplier-Whatman International Ltd., Maidstone, Kent, England.
GF-C filters
3MM chromatography paper 
P81 phosphocellulose paper
II.D.7 Plasmids and Bacteriophages
The following plasmid and bacteriophage DNAs were kind gifts of V. Fincham, 
Beatson Institute, Glasgow:
bacteriophage M13mpl8 
bacteriophage M13mpl9
RAV 32 (Rous-associated virus containing ttLA32 src sequences)
RAV PrA (Rous-associated virus containing vvtPrA src sequences)
The following plasmid DNAs were kind gifts of Dr D. Crouch, Beatson Institute, 
Glasgow:
pMP323 (Clal2 in ref. 306) RCAN, subgroup A306
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The following plasmid DNA was a kind gift of Dr M. J. Welham, Imperial Cancer 
Research Fund, London EC1:
pLA29 (3.1kbp EcoRI ttLA29 src fragment cloned in pUC1394-315)
The following plasmid was a kind gift of Drs E. Liebl and G. S. Martin, University of 
California, Berkeley, California USA: 
fpGV-177 ’301
HD . 8  Research Supplies. Miscellaneous 
Supplier-Beatson Institute Central Services.
Kanamycin
L-broth
Penicillin
Sterile CT buffer Nacl 6 .0 g
trisodium citrate 2.96g
tricine 1.79g
0.005g
700ml
phenol red 
distilled water
PH 7.8
Sterile distilled water
Sterile PBS
Streptomycin
II.D.9 Tissue Culture and Bacteriological Plasticware 
Supplier-A/S Nunc, Roskilde, Denmark.
T25, 75 and 175 tissue culture flasks
Supplier-Becton Dickinson Labware, Plymouth, England.
35, 60 and 90mm tissue culture dishes
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Supplier-Bibby Sterilin Ltd., Stone, Staffs., England.
60 and 90mm bacteriological dishes
II.D.10 Water
Distilled water for gel buffers and buffer stocks was obtained from a Millipore 
MilliRO 15 system. Water for tissue culture, protein /  enzyme work or recombinant 
DNA procedures was further purified on a Millipore MilliQ system to 18MD cm.
Chapter III
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m  GENERATION AND BIOLOGICAL CHARACTERISTICS OF 
CLONAL Rati DERIVATIVES
m.A. Introduction
Initial attempts to obtain stable Rati cell lines expressing teLA32 RSV by direct 
infection were disappointing. Information obtained in this laboratory and others indicates 
that a majority of integrated proviruses are silent in Rati cells, and indeed many of those 
which are expressed are subject to spontaneous silencing300. I therefore decided to 
express &LA32 Src under the control of a murine retroviral promoter. A previously 
characterised temperature sensitive Src mutant, ttLA2929>93-94*299, and wild type Prague A 
(wtPrA) Src were expressed in parallel with ttLA32 Src using the same promoter system. 
The vector chosen, fpGV-1, was a kind gift of E. Liebl and G. S. Martin77*301, and a map 
is shown in figure HI.la. Inserts can be placed under the control of a Moloney murine 
leukaemia virus LTR, and transfected cells selected by virtue of the co-linear neo 
resistance marker77.
As stated in the introduction to this thesis, v-src transformed fibroblasts show a 
number of striking changes in morphology and growth control which distinguish them 
from normal fibroblasts in tissue culture. This chapter will describe the phenotypes of 
clonal Rati cell lines obtained after transfection of the murine expression constructs 
described.
III.B. Results
m.B.l Plasmid Construction
A series of manipulations was required to subclone the inserts of interest into 
fpGV-1. A summary of these steps appears below, with a detailed description appearing 
in Materials and Methods. Nucleotide numbering is after Schwartz et al.114
a) purification of the 3.1kb EcoRI src inserts of interest
b) truncation 3’ by nuclease Bal31 digestion to remove 3' LTR sequences, leaving 
the src coding sequence intact
c) truncation 5' by Xhol digestion at 6983, removing 5' env sequences whilst 
retaining the src splice acceptor site
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Figure IIL1
a) Linear representation of fpGV-1 showing relevant sequences and restriction sites. For 
clarity, the LTR polyadenylation signal is shown to the right-hand side of the diagram. 
fpGV-1 confers kanamycin resistance in E. coli and G418 resistance in appropriate 
eukaryotic cells. Restriction sites : BamHI 3658, EcoRI 3676, Clal 4332. SD, splice 
donor, ColEl ori, ColEl origin of replication, SV40 ori, SV40 origin of replication, 
necfi, neomycin resistance marker, polyA, polyadenylation signal.
b) The proviral 3.1kbp EcoRI fragment containing src was digested with nuclease Bal31 
and Xhol as described in the text, and ligated to Smal digested pMP323. Sequencing in 
M l3 revealed appropriate clones lacking 5' env and 3' LTR sequences. The 3' extent of 
RSY sequence is tabulated in table DLL The orientation of appropriate clones in 
pMP323 is indicated, with relevant restriction sites. SA, splice acceptor.
i) orientation of ttLA29 src insert
ii) orientation of ttLA32 and wtPrA src inserts
Figure III.l
a) fpGV-1 expression vector (5kbp)
neo
LTR SD ColEl ori SV40ori BamHI EcoRI Clal poly A
b) orientation o f src inserts (~1.9kbp) in pMP323 polylinker
i) LA29
6983 RSV sequence
SA 5'
8803
Clal EcoRI BamHI Sail
ii) LA 32 and PrA
8775 (LA32)
6983 RSV sequence 0
SA 5 ’ 3'
src
Clal
Clal Sail BamHI EcoRI Clal
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d) end filling to generate blunt termini
e) ligation to Smal cut pMP323306. This step generated the Clal sites necessary 
for subcloning to fpGV-1.
f) after extensive analysis by restriction digest, appropriate fragments were 
subcloned into bacteriophage M l3. Single strand sequencing was used to confirm the 
presence of mutations and to assess the extent of 31 and 5' truncation. The 3' endpoints of 
the &LA29, ttLA32, and wfPrA src inserts are tabulated in table 111.1. The orientation of 
the inserts with respect to the pMP323 poly linker is shown in figure ID. lb.
g) appropriate clones were subcloned to Clal cut fpGV-1, and expression 
constructs selected after restriction digest analysis (figure III.2a).
Appropriate clones of fpGV-29, fpGV-32, fpGV-PrA, or the fpGV-1 vector itself 
were transfected into Rati cells using standard techniques. For some aspects of the work, 
it was found necessary to express the src inserts in primary chick embryo fibroblasts 
(CEF). The vector employed for this work was the replication-competent avian retroviral 
vector RCAN306. Inserts were subcloned to the Clal site in RCAN (figure in.2b), and 
appropriate clones chosen after restriction mapping. (It was found that RCAN constructs 
were highly susceptible to deletion and rearrangement in some bacterial hosts, even 
those marketed as lacking known restriction systems. One particular batch of E. coli 
HB101 cells was found to be successful and used for all RCAN work). CEF transfections 
were carried out according to Materials and Methods.
TABLE n i  l
INSERT 3' ENDPOINT
ttLA29
ttLA32
wtfPrA
8803
8775
8765
Figure m .2
a) Restriction analysis of fpGV-1 src constructs, src inserts were subcloned to the unique 
Clal site of fpGV-l as outlined in the text Presence of insert was assessed by digestion 
with Clal, and orientation derived by digestion with Bgll or Smal. fpGV-29 is used as an 
example in this figure. Identical results were obtained for fpGV-32 and fpGV-PrA. For 
additional information see figure HI.lb. B, Bgll, C, Clal, S, Smal, M, molecular weight 
markers.
i) predicted restriction map of fpGV-29
ii) restriction analysis of fpGV-29. Digestion 
products resolved by 0 .8 % agarose gel electrophoresis.
b) Restriction analysis of RCAN src constructs, src inserts were subcloned to the unique 
Clal site of the replication competent avian retroviral vector as described in the text. 
Orientation of src inserts was assessed by digestion with Sail. Sail cuts approximately 
900bp upstream of the Clal cloning site in RCAN. See figure EH. lb for position of Sail 
site in src inserts. SD, splice donor, SA, splice acceptor, S, Sail, C, Clal, pPH, E. coli 
replicon, M, molecular weight markers.
i) restriction map of RCAN src constructs
ii) Sail restriction analysis of RCAN src constructs.
Digestion products resolved by 0.8% agarose gel 
electrophoresis. Lane 1, RCAN vector, 2, RCAN 29,
3, RCAN 32,4, RCAN PrA
Figure III.2
a) restriction mapping of fpGV-1 src  constructs
i) B S S S S B  C
LTR src
~6.9kbp
B 2410 (fpGV-1), 8416 (RSV)
C 4332 (fpGV-1)
S 3413, 3665,4950 (fpGV-1), 7631, 7916 (RSV)
ii) kbp M B C S
2 3 .5 -
9 .5 9 -
2.29 
1 .95-
1.35-
1.00 -
0.87-
0 .60-
0 .30-
b) restriction mapping of RCAN src  constructs
i)
SD SA C SA
LTR pol src y  LTRenv
pPH
ii) kbp M 1 2 3 4
23.5 -  
9.59 -
6.64 -  
4.45 _
2.29 
1.95 -
1.35 -  
1.00 -
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m.B.2 Generation of Clonal Rati Derivatives
Transfected Rati cultures were treated with G418 according to Materials and 
Methods, and resistant colonies scored after 10-20 days. Typically Lipofection of lug of 
fpGV-1 based constructs yielded 100-300 G418-resistant Rati colonies. Approximately 
the same yield of colonies could be obtained by transfecting lOug of plasmid using the 
calcium phosphate coprecipitation method.
Colonies obtained by transfection of fpGV-1 were uniformly flat, and 
indistinguishable from parental Rati cells. Colonies obtained by transfection of fpGV- 
29, fpGV-32 or fpGV-PrA expression constructs showed a range of morphologies at 
permissive temperature. In any such transfection approximately 50% of the G418- 
resistant colonies were indistinguishable from parental Rati cells. The remaining 
colonies showed varying degrees of morphological transformation. This yield of 
transformed and non-transformed morphologies has been observed before77 and 
presumably reflects (in part) the configuration of integrated plasmids. Western blot 
analysis indicated that pp60 was undetectable in flat colonies, whereas various levels of 
expression were apparent in lysates of transformed colonies (data not shown). Typical 
flat (fpGV-l) or transformed colonies (fpGV-29, fpGV-32 or fpGV-PrA) were cloned by 
limiting dilution and stocks stored in liquid nitrogen. Clonal lines chosen for study are 
shown in table m .2 .
TABLE m .2
TRANSFECTED PLASMID CELL LINE NAME CLQNE
fpGV-1 Rati f al
fpGV-29 Rati f29 ncs
fpGV-32 Rati f32 aC7
fpGV-PrA Rati fPrA 3C5
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III.B.3 Plasmid Copy Number
Genomic DNA was prepared from Rati and the clonal lines listed in table m.2. 
Genomic DNA from an RSV-transformed Rati clone, VIT316, was obtained from V. 
Fincham for use as a positive control. DNA was digested to completion with EcoRI 
(VIT, Rati, Rati f, Rati f29) or BamHI (Rati f32, Rati fPrA). VIT contains two copies 
of the v-src gene as a result of proviral rearrangement and duplication, and yields src 
containing sequences of 3.1 and 3.5kbp upon digestion with EcoRI (V. Fincham, 
personal communication). EcoRI and BamHI cut the fpGV-l src constructs as indicated 
in figure m.l, generating src containing sequences whose size is dependent upon the 
insertion site within the Rati genome. Southern blotting and subsequent hybridization 
using a src probe should estimate the plasmid copy number in the transformed clones. 
The Southern blot shown in figure m.3a suggests that Rati f29 contains three src inserts, 
with Rati f32 and Rati fPrA containing 3 and approximately 8 copies respectively.
III.B.4 Morphological and Growth Characteristics of Clonal Lines
m.B.4.1 Monolaver Morphology
Clonal lines were maintained in normal growth medium at either permissive 
(35°C) or restrictive temperature (40°C) for at least 48hrs prior to observation under the 
light microscope. The morphology of the various Rati cell lines is shown in figure IH.4. 
The chosen cell lines exhibit the expected characteristics, with both ts mutants being 
fully thermolabile for the transformed morphology. Rati f32 displays a fusiform 
morphology at permissive temperature, in agreement with the behaviour of this mutant in 
CEF. Fusiform morphology has been observed in cells transformed with other SH2 \  
SH3 mutants of v-Src77-130-141-142'143. The wild type PrA transformed cells appear 
somewhat flatter at restrictive temperature, consistent with previous results obtained in 
virally infected CEF299. However, these cells are refractile and fail to arrest at 
confluence. The cloned wild type PrA gene used contains a point mutation at the C- 
terminal end (amino acid 502), this possibly conferring a partial ts phenotype on the 
protein (V. Fincham, personal communication).
Figure m.3
a) Plasmid copy number of Rati src clonal lines. Genomic DNA was prepared from 
clonal lines (Table III.2) and digested to completion with EcoRI (VIT, Rati, Rati f, Rati 
f29) or BamHI (Rati f32, Rati fPrA). Digested DNA was resolved by 0.8% agarose gel 
electrophoresis and blotted as described in Materials and Methods. Probe used was a 
612bp PstI v-src fragment, labelled according to Materials and Methods.
b) pp60v~src expression in Rati src clonal lines. Whole cell lysates were prepared from 
cells at permissive or restrictive temperature. Equivalent amounts of protein from each 
lysate (~30ug, as judged by Coomassie Blue staining) were resolved by SDS-PAGE and 
blotted as described in Materials and Methods. Primary antiserum was anti-5>c MW2 at 
1:5000. The arrow head indicates pp60. A, cells cultured at permissive temperature 
(35°C), B, cells cultured at restrictive temperature (40°C).
Figure III.3
a) Southern Blot analysis of Rati src clones
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Figure III.4
Monolayer morphology of Rati src clones at permissive and restrictive 
temperature. Cultures were maintained in normal growth medium at appropriate 
temperature for at least 48hr prior to photography. Magnification is x500. a, Rati 35°C, 
ft, Rati 40°C, c, Rati f29 35°C, d, Rati f29 40°C, <?, Rati f32 35°C,/, Rati f32 40°C, g, 
Rati fPrA 35°C, ft, Rati fPrA 40°C.
Figure III.4
ifc
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TII.B.4.2 Anchorage Independent Growth
Another characteristic property of v-src transformed fibroblasts is their ability to 
proliferate in an anchorage-independent fashion, this being assayed by growth in soft 
agar307. For these experiments, cells were seeded in soft agar as described in Materials 
and Methods, and colony formation scored after 14 days. Figures in.5 and IH.6 
summarise the results of these experiments.
From these data, one concludes that the capacity for anchorage-independent 
growth correlates well with morphological transformation. Rati and Rati f cells fail to 
form colonies at either temperature, even when seeded at 10^ cells per dish. Rati f29 
exhibits a fully thermolabile ability for proliferation in soft agar, forming many large 
colonies at permissive temperature, but no colonies at restrictive temperature. Essentially 
similar results are obtained with Rati f32, although there is residual colony formation at 
restrictive temperature. Very small colonies appear during the first few days of 
incubation, these remaining static in size over the course of the next two to three weeks. 
This is again consistent with data obtained using virally-infected CEF cultures299. This 
behaviour might result from a slight leakiness in the mutant at restrictive temperature, 
and raises the possibility that given a very high level of expression, the thermolabile 
properties of ttLA32 Src may become less obvious. This should be borne in mind when 
analyzing phosphoprotein patterns since it indicates that important changes may be 
subtle in nature, i.e. of a quantitative rather than qualitative nature.
In agreement with their morphological characteristics, the Rati fPrA cells 
showed a reduction in their capacity for anchorage independent growth at restrictive 
temperature, though this decrease did not approach the striking reduction in colony 
formation seen using the temperature sensitive mutants.
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Figure IIL5
Anchorage independent growth of Rati src clonal lines. Single cell suspensions 
were seeded in triplicate in soft agar as described in Materials and Methods, at a density 
of 105 (Rati, Rati f) or 10^ (Rati f29, Rati f32, Rati fPrA) cells per 60mm dish. 
Cultures were placed at either permissive or restrictive temperature for 14 days before 
colony formation was assessed. Representative areas of agar cultures are shown at a 
magnification of x4. a, Rati 35°C, b, Rati 40°C, c, Rati f 35°C, d, Rati f 40°C, e, Rati 
f29 35°C, /, Rati f29 40°C, g, Rati f32 35°C, h, Rati f32 40°C, i, Rati fPrA 350C J , 
Rati fPrA 40°C.
Figure III.5
Figure IIL6
Anchorage independent growth of Rati src clonal lines. Colony formation is 
presented as the percentage of plated cells forming colonies, and is the mean of triplicate 
determinations. In no case did colony formation deviate more than 6% from the mean 
value. The data shown are representative of two independent experiments. Note that 
<5% plated Rati f32 cells formed "colonies" at restrictive temperature. These "colonies" 
consisted of 2-4 cells. See text. A, cultures at permissive temperature, B, cultures at 
restrictive temperature.
Figure III.6
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III.B.5 pp60 Expression
Since the chosen cell lines appeared to have the expected phenotypes, I examined 
pp60 expression in each of the cell lines at both permissive and restrictive temperatures 
by Western blot analysis. Cells were grown at the required temperature for 48hrs prior to 
harvest, and equivalent amounts of protein from each line were blotted according to 
Materials and Methods. A typical result is shown in figure III.3b, indicating that the cell 
lines containing src plasmids all express detectable levels of pp60. Rati f29 and Rati f32 
contained approximately 5-10 fold more pp60 than Rati fPrA, and in each case these 
levels were not significantly thermolabile. Note that &LA32 pp60 displays a higher 
apparent molecular weight than either teLA29 or vvfPrA Src proteins on SDS-PAGE gels. 
This appears to be a secondary structure effect (see section V.B.2). If one assumes that 
ttLA29, teLA32 and wtPvA Src proteins have equivalent specific activities against 
relevant substrates in the cell at permissive temperature, then the expression levels of the 
( mutant proteins is well above the threshold required for transformation. This implies that 
there is negligible leakiness at restrictive temperature.
m.C Discussion
From this summary of the biological and expression characteristics of the clonal 
lines selected it is apparent that these lines have the expected phenotypes. Both 
temperature sensitive mutants are fully thermolabile for the parameters of transformation 
tested, namely morphology in monolayer culture and anchorage independent growth. 
These results are consistent with data obtained in this laboratory using virally infected 
CEF299. Since the level of Src protein appears to be independent of growth temperature 
one concludes that transformation in this system is not simply the result of exceeding a 
threshold amount of transforming protein. It follows that transformation probably results 
from an increase in the functional activity of constant amounts of pp60.
In conclusion, the data presented above suggest that the Rati f32 line has the 
appropriate biological phenotype. The proposed approach to study early events following 
temperature shift (outlined in chapter I) depends on the cell line and mutant pp60
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satisfying a number of other criteria. The biochemical characterization of the ttLA32 Src 
protein and further analysis of the Rati f32 cell line follow in subsequent chapters.
Chapter IV
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IV IN VITRO KINASE ACTIVITY
IV.A. Introduction
Immunoprecipitation of pp60 from RSV transformed cells yields immune 
complexes which, in the presence of Mg^+ (or Mn^+) and ATP catalyze both the 
phosphorylation of pp60 itself (autophosphorylation)41, and / or exogenous 
substrates10*42. This forms a convenient assay for the kinase activity, and in general this 
in vitro activity reflects the tyrosine kinase activity in vivo. As a first step in 
characterising the kinase activity of the ttLA32 Src protein, in vitro kinase assays were 
performed on immunoprecipitates prepared from the chosen Rati lines. Despite 
numerous attempts using a variety of antisera, substrates and assay conditions, the results 
from these assays were not entirely consistent with data obtained by Stoker et al. 
studying RSV in CEF299. In order to compare directly the behaviour in Rati cells and 
avian cells, I undertook to express the src inserts of interest in CEF using a replication- 
competent avian retroviral vector, RCAN306. The construction of these plasmids is 
described in Chapter III, and infected cultures were obtained as outlined in Materials and 
Methods.
IV.B. Results
The in vitro kinase activity of pp60 was measured using a conventional 
assay10-41’42. Four substrates were used in these experiments : pp6041, enolase42, Raytide 
(a gastrin-like peptide substrate) and immunoglobulin heavy chain10 Briefly, equal 
amounts of total lysate protein were immunoprecipitated with monoclonal or polyclonal 
sera to pp60. A portion of this precipitate was incubated in a buffer containing Mn^+, 
Mg2+ ions and gamma-labelled ATP, either with or without exogenous substrate. Assay 
temperature was standardised to 30°C after preliminary experiments indicated that assay 
temperature had no significant effect on the kinase activity within any given 
immunoprecipitate.
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IV.B.l In vitro Kinase Activity of Rati Cell Lines
Immune complexes were prepared from exponential cultures of Rati, Rati f, 
Rati f29, Rati f32 and Rati fPrA cells growing at permissive or restrictive temperature. 
A typical result obtained using monoclonal antibody MAb327309 is shown in figure
IV.li. Acid-denatured enolase42 was used as an exogenous substrate in this assay. 
Immune complexes prepared from Rati cells or Rati f cells display a very low level of 
kinase activity towards enolase, either as a result of precipitating pp60c_5rc or non­
specific precipitation of another endogenous kinase. Precipitates formed from Rati f29 
cells show the expected temperature sensitivity in pp60 autophosphorylation and kinase 
activity towards enolase29-315. Immune complexes prepared from the Rati fPrA line also 
behave as predicted, displaying activity towards pp60 and enolase when prepared from 
cells grown at either permissive or restrictive temperature. There is slightly less activity 
in precipitates formed from Rati fPrA cells at restrictive temperature, this reduction 
correlating with the biological properties of this protein (see chapter III). Recovery of 
labelled enolase from the Rati fPrA lanes of the gel and subsequent hydrolysis 
demonstrated that all detectable labelled phosphate was incorporated in phosphotyrosine 
(see figure IV.lii). Surprisingly, immunoprecipitates prepared from Rati f32 cells grown 
at either permissive or restrictive temperature failed to show any autophosphorylation, or 
kinase activity towards enolase under these conditions. Increasing the ATP concentration 
from O.luM to 1 or lOuM yielded negative results, and similarly, reducing the assay 
temperature to 0°C or preparing lysates and immuneprecipitates in the presence of ImM 
DTT had no effect (data not shown). In view of this difficulty, I assayed identical 
MAb327 immunoprecipitates using another substrate, the gastrin-related peptide 
Raytide, using a filter binding assay. Figure IV.2a shows the results of this experiment. 
Precipitates prepared from Rati f29 and Rati fPrA cells behave as expected, with 
precipitates from Rati f32 cells showing negligible activity. (This particular result 
underestimates the total activity in the active immune complexes since subsequent 
experiments demonstrated that the peptide substrate was limiting in these assays).
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Figure IV.l
i) MAb327-immune complex kinase assay of Rati src clones. pp60 was 
immunoprecipitated from growing cultures as described in Materials and Methods using 
monoclonal antibody MAb327. Kinase activity in the immune complexes was measured 
at 30°C using acid denatured enolase as exogenous substrate, as described in Materials 
and Methods. Exposure time was 4hr at -70°C. The closed arrow indicates labelled pp60 
and the open arrow enolase (as judged by Coomassie Blue staining). A, cells cultured at 
permissive temperature, B, cells cultured at restrictive temperature.
ii) Two-dimensional phosphoamino acid analysis of enolase phosphorylated in vitro. 
Labelled enolase was extracted from the Rati fPrA lanes of the gel shown in i) and 
hydrolysed as described in Materials and Methods. Hydrolysed enolase was mixed with 
unlabelled standards (phosphoserine, phosphothreonine and phosphotyrosine) and 
resolved by two-dimensional thin layer electrophoresis as described in Materials and 
Methods. Unlabelled standards were visualized with ninhydrin. Exposure time was 18hr 
at -70°C. PS, phosphoserine, FT, phosphothreonine, PY, phosphotyrosine.
iii) MAb327-immunoprecipitation of ^ S - m e t h i o n i n e  labelled pp60. Immunoprecipitates 
were formed precisely as described in i) except cultures were labelled for 3hr prior to 
lysis with 150uCi \  ml ^ S - m e t h i o n i n e .  All cultures were at permissive temperature. 
Immunoprecipitates were resolved by SDS-PAGE and fluorographed for 30hr at -70°C. 
The closed arrow indicates pp60. Lane 1, Rati, 2, Rati f29 ,3, Rati J32,4, RatlfPrA.
Figure IV.l
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Since MAb327 reacts with an epitope residing within residues 100-110 of the 
primary sequence of pp60140 (J. Brugge, personal communication), one possible 
explanation for these negative results is that the mutation at position 107 in ttLA32 Src 
prevents recognition by the antibody. To address this possibility, immune complexes 
were prepared exactly as described for kinase assays with the exception that the cells 
were labelled with ^ S - m e t h i o n i n e  p r io r  to lysis. Precipitated proteins were fractionated 
by SDS-PAGE and detected by fluorography (figure IV.liii). This demonstrates that 
pp60 can be immunoprecipitated from Rati f32 cells under conditions identical to those 
used for kinase assays. Additional species of approximately 50kDa are seen in 
precipitates from src-transformed cells; these probably represent degradation products of 
pp60 and \  or the 50kDa member of the trimeric complex described in chapter I. This 
result does not preclude the possibility that the interaction between the antibody and the 
mutant pp60 abrogates kinase activity as a direct or indirect result of the mutation at 
position 107. To test this possibility, immune complexes were prepared using a number 
of other polyclonal antisera, and kinase activity towards enolase measured as before. The 
result of one such experiment utilizing anti-Src serum G950.4 is shown in figure IV.2b. 
As with MAb327, no kinase activity is detectable in precipitates prepared from Rati f32 
cells. Identical results were obtained using another polyclonal anti-Src serum, MW294 
(data not shown). The preferred substrate in these assays varied with the antiserum used 
to generate the immune complexes. Hence, the preferred substrate in G950.4 
immunoprecipitates was pp60 itself, whereas the majority of incorporated label was 
found in enolase when using MAb327 precipitates. Immunoprecipitates formed using a 
tumour-bearing rabbit serum313, where kinase activity is directed towards pp60 itself and 
the immunoglobulin heavy chain, yielded identical results (data not shown).
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Figure IV.2
a) MAb327-immune complex kinase assay, Raytide substrate. pp60 was 
immunoprecipitated from growing cultures using MAb327 as described in Materials and 
Methods. Kinase activity against the gastrin-like peptide Raytide was measured using a 
filter binding assay as described, and counts were normalised to the Rati precipitate at 
the appropriate temperature. Assay temperature was 30°C. A, cultures at permissive 
temperature, B, cultures at restrictive temperature.
b) G950.4-immune complex kinase assay. pp60 was immunoprecipitated from growing 
cultures using polyclonal antiserum G950.4 as described in Materials and Methods. 
Immune complex kinase activity was measured as described using acid denatured 
enolase as exogenous substrate. Exposure time was 4hr at -70°C. The closed arrow 
indicates pp60, the open arrow enolase (as judged by Coomassie Blue staining). A, 
cultures at permissive temperature, B, cultures at restrictive temperature.
Figure IV.2
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IV.B.2 In vitro Kinase Activity of Infected CEF
From the preceeding it is apparent that kinase activity is consistently undetectable 
in immune complexes prepared from Rati f32. I therefore expressed the ttLA32 src 
insert in chick embryo fibroblasts (CEF), again using ttLA29 and wfPrA src inserts as 
controls. Control CEF cultures or CEF cultures transfected with RCAN, RCAN 29, 
RCAN 32 or RCAN PrA were passaged until uniform infection was achieved. Infection 
was assessed by Western blot analysis using anti-Gag antiserum 5202 (to assess RCAN 
infection) and anti-Src antiserum MW2 (see figure IV.3). Uniformly infected cultures 
were maintained at permissive (35°C) or restrictive (41 °C) temperature for two days 
prior to lysis and immunoprecipitation. Infected cultures were of the expected 
morphology at these temperatures (data not shown). Immunoprecipitates were prepared 
using MAb327, and kinase activity measured using enolase as substrate. Figure IV.4a 
indicates that these in vitro kinase results mimic very closely those seen in the Rati cell 
system, implying that a host-range defect is not responsible for the failure to demonstrate 
kinase activity in Rati f32 immunoprecipitates. To repeat more precisely the method 
used by Stoker et al.2"  immunoprecipitates were prepared from infected CEF cultures 
using a tumour-bearing rabbit serum, TBR-RLE313. Immune complexes were assayed for 
kinase activity in the absence of exogenous substrate, with pp60 and the immunoglobulin 
heavy chain serving as substrates in these assays (figure IV.4b). Immunoprecipitates 
from RCAN 32-infected cells cultured at either permissive or restrictive temperature did 
exhibit a relatively small kinase activity in this assay, although this activity did not 
approach that seen in immunoprecipitates from RCAN 29 or RCAN PrA infected 
cultures. The labelled phosphate incorporated into pp60 and the immunoglobulin heavy 
chain was stable to treatment with 1M KOH at 55°C310, suggesting that phosphotyrosine 
was the predominant phosphoamino acid present (data not shown).
I l l
Figure IV.3
a) pp60 expression in infected CEF. Primary chicken embryo fibroblasts were 
transfected with RCAN expression constructs as described in Materials and Methods. 
Transfected cultures and mock treated controls were passaged 1-3 times at restrictive 
temperature to allow virus spread. Cells were grown at either permissive or restrictive 
temperature for 48hr before lysis. Cultures had aquired the appropriate morphology at 
this point, indicating uniform infection. Equivalent amounts of lysate protein (as 
determined by Coomassie Blue staining) were resolved by SDS-PAGE and blotted as 
described in Materials and Methods. Primary antiserum was anti-Src antiserum MW2 at 
1:5000. The arrow head indicates pp60. A, cells at permissive temperature, B, cells at 
restrictive temperature. Transfected constructs : -, no DNA, R, RCAN, R29, RCAN 29, 
R32, RCAN 32, RPrA, RCAN PrA.
b) Gag expression in infected CEF. Immunoblotting of Gag proteins was used to assess 
infection by RCAN vector, since CEF expressing this virus appear morphologically 
normal. Lysates from a) were resolved and blotted as described in a) except anti-Gag 
antiserum 5202 was used (1:5000). All lysates were from cultures growing at permissive 
temperature. The closed arrow head indicates Pr76 and the open arrow head p27. 
Transfected constructs : see a).
Figure IV.3
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Figure IV.4
a) MAb327-immune complex kinase assay of infected CEF. pp60 was 
immunoprecipitated from uniformly infected cultures using monoclonal antibody 
MAb327 as described in Materials and Methods. Kinase activity in the 
immunoprecipitates was measured using acid denatured enolase as exogenous substrate, 
as described in Materials and Methods. Assay temperature was 30°C, and exposure time 
was 4hr at -70°C. The open arrow indicates pp60, and the closed arrow enolase (as 
determined by Coomassie Blue staining). Transfected constructs are indicated at the top 
of the figure. A, cultures at permissive temperature, B, cultures at restrictive 
temperature.
b) TBR-immune complex kinase assay. pp60 was immunoprecipitated from uniformly 
infected cultures using tumour-bearing rabbit serum TBR-RLE as described in Materials 
and Methods. Immune complex kinase activity against the immunoglobulin heavy chain 
and pp60 was measured as described in Materials and Methods. Assay temperature was 
30°C and exposure time was 2hr at -70°C. The open arrow indicates pp60 and the closed 
arrow immunoglobulin heavy chain (as judged by Coomassie Blue staining). Transfected 
constructs are indicated at the top of the figure. A, cultures at permissive temperature, B, 
cultures at restrictive temperature.
Figure IV.4
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IV.C, Discussion
Under conditions where immunoprecipitates of ttLA29 pp60 and wtPrA pp60 
behaved as expected in an in vitro assay, immune complexes prepared from Rati f32 
cells were consistently inactive. This outcome was largely independent of the 
precipitating antiserum, substrate and host cell background. Identical results were 
obtained after lysis and immunoprecipitation under reducing conditions. This failure to 
detect kinase activity in Rati f32 precipitates was not the result of poor precipitation of 
the mutant pp60, as evidenced by precipitation of -methionine labelled protein. The 
consistent lack of kinase activity appears to result from a defect in the catalytic activity 
of the protein rather than being the result of poor immunoprecipitation. There are several 
possible reasons for this observation :
a) ttLA32 Src transforms cells in vitro via a mechanism independent of intrinsic 
tyrosine kinase activity. This would appear unlikely given the strong correlation between 
kinase activity and transformation. However, one intriguing idea is that the protein 
transforms in much the same way as v-Crk, by way of its SH2 and SH3 domains218. The 
mutation at position 107 in the SH3 domain is interesting in this respect.
b) the post-translational modification of the protein is defective. This would 
appear unlikely given that identical results were obtained from both Rati and CEF 
backgrounds. The post-translational phosphorylation of the protein is covered in chapter
V.
c) ttLA32 pp60 is active against a very limited range of substrates in vitro. This 
possibility could be addressed using biologically relevant substrates.
d) association with a regulatory factor determines kinase activity in ttLA32 pp60 
immunoprecipitates. This would predict the loss of an activator or the co-precipitation of 
an inhibitor during sample preparation. To my knowledge, this has not been observed in 
studies on a large number of \-Src mutants, though inhibitors active against specific 
serine \  threonine kinases are well documented317. I have observed the specific 
precipitation of a 50kDa phosphoprotein in pp60 immunoprecipitates prepared from Rati 
f32 cells growing as transformed cells at permissive temperature. This protein is not seen
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in precipitates prepared from Rati f32 cells growing at restrictive temperature, nor is it 
seen in precipitates prepared from Rati f29 or Rati fPrA. However, upon digestion with 
V8 protease, this protein yields a phosphopeptide pattern consistent with it being a 
degradation product of pp60 (data not shown).
e) the presence of a mutation in the SH3 domain could reduce the kinase activity. 
This could be addressed using appropriate chimaeric molecules.
f) the mutant protein is easily denatured upon lysis and immunoprecipitation. 
Experiments to date have not adequately explained the the in vitro kinase defect
of teLA32 pp60.
Chapter V
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V IN VIVO KINASE ACTIVITY AND POST-TRANSLATIONAL 
PHOSPHORYLATION
V.A. Introduction
Since in vitro kinase assays were largely uninformative, the in vivo consequences 
of expression of teLA32 pp60 were analyzed in two ways. First, the level of protein 
phosphotyrosine in the Rati cell lines was estimated by steady state metabolic labelling 
with 32p-0rthophosphate. Previous work has indicated that the cellular level of protein 
phosphotyrosine is independent of growth temperature in ftLA32 infected CEF299. 
Second, the in vivo phosphorylation state of pp60 was analyzed by limited digestion 
using V8 protease318. This technique provides information on the state of the two major 
phosphorylation sites, serine 1758 and tyrosine 41657. The phosphorylation state of 
tyrosine 416 is also an indicator of pp60 kinase activity since tyrosine 416 is believed to 
be a site of autophosphorylation57.
V.B. Results
V.B.l In vivo Abundance of Phosphotyrosine
Exponential cultures of Rati, Rati f29, Rati f32 and Rati fPrA were maintained 
at permissive or restrictive temperature for at least two days prior to labelling with 32p_ 
orthophosphate (lmCi \  ml) for 18-20hrs as outlined in Materials and Methods. Total 
cellular proteins were prepared as described, and hydrolyzed in 6M hydrochloric acid. 
Hydrolysates were resolved by two-dimensional thin-layer electrophoresis at pH 1.9 and 
pH 3.5 as described by Cooper et aP10. Unlabelled phosphoserine, phosphothreonine and 
phosphotyrosine were added to hydrolysates to serve as markers following ninhydrin 
staining. Typical results are shown in figure V.l. Rati f29, f32 and fPrA all show 
elevated levels of phosphotyrosine at both permissive and restrictive temperature when 
compared to parental Rati fibroblasts, where labelled phosphotyrosine is undetectable. 
Relevant regions of the cellulose plate, together with background areas, were collected 
and radioactivity quantitated by liquid scintillation counting. The abundance of each 
phosphohydroxyamino acid is expressed
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Figure V.l
Phosphoamino acid analysis of total cellular protein in Rati src clonal lines. 
Cultures at permissive or restrictive temperature were labelled to equilibrium with 
carrier-free -^P-orthophosphate and total cellular protein prepared as described in 
Materials and Methods. After acid hydrolysis, hydrolysates were supplemented with 
unlabelled standards (phosphoserine, phosphothreonine, phosphotyrosine) and resolved 
by two-dimensional thin-layer electrophoresis as described. Standards were visualized 
using ninhydrin, and labelled phosphoamino acids revealed by autoradiography. 
Exposure time was ~36hr at -70°C. PS, phosphoserine, PT, phosphothreonine, PY, 
phosphotyrosine. a, Rati 35°C, b, Rati 40°C, c, Rati f29 35°C, d, Rati f29 40°C, e, 
Rati f32 35°C,/, Rati f32 40°C, g, Rati fPrA 35°C, h, Rati fPrA 40°C.
Figure V.l
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Figure V.2
a) Relative abundance of phosphohydroxyamino acids in Rati src clonal lines. 
Phosphoamino acids were scraped from the cellulose plates shown in figure V.l together 
with appropriate background areas. After liquid scintillation counting and subtraction of 
background radioactivity, the percentage abundance of each phosphoamino acid relative 
to the total radioactivity in phosphoserine, phosphothreonine and phosphotyrosine was 
calculated. The abundance of phosphotyrosine with respect to growth temperature is 
shown as a ratio of the percentage in cells at permissive temperature divided by the 
percentage in cells at restrictive temperature. Very similar results were obtained in three 
independent experiments. PY, phosphotyrosine.
b) Relative abundance of phosphotyrosine with respect to growth temperature in Rati src 
clonal lines. Data from a). Abundance of phosphotyrosine is expressed as a percentage of 
total radioactivity in the three phosphohydroxy amino acids. PY, phosphotyrosine, A, 
cells at permissive temperature, B, cells at restrictive temperature.
Figure V.2
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as a percentage of the total radioactivity in all three phosphohydroxyamino acids (figure
V.2). As stated above, phosphotyrosine is undetectable in growing Rati fibroblasts. In 
contrast, all cells expressing pp60, whether at permissive or restrictive temperature, 
exhibit elevated levels of phosphotyrosine. The level of phosphotyrosine in Rati fPrA 
cells is slightly temperature sensitive, correlating well with both the in vitro kinase 
activity and biological behaviour of this "wild type" protein. Somewhat suprisingly, cells 
expressing the thermolabile kinase mutant ttLA29 show only a two-fold reduction in 
phosphotyrosine level at restrictive temperature. This behaviour was consistent over 
three separate experiments, and has been observed by other workers292. These data 
contradict the results obtained using in vitro assays, where the teLA29 kinase activity is 
strikingly temperature sensitive. The abundance of phosphotyrosine in Rati f32 cells is 
largely independent of temperature, there being a slight increase at restrictive 
temperature. These observations suggest that an overall increase in the level of cellular 
phosphotyrosine is not in itself sufficient for transformation, since both Rati f29 and 
Rati f32 cells show elevated levels even when growing non-transformed at restrictive 
temperature. These observations will be discussed later in this chapter.
V.B.2 Post Translational Phosphorylation of pp6 Q
pp60v_5rc is post-translationally phosphorylated on at least two residues. The 
major sites of phosphorylation are serine 1758 and tyrosine 41657. The phosphorylation 
state of tyrosine 416 correlates well with enzyme activity, and published data suggest 
that this residue is autophosphorylated in vitro and in vivo (see chapter I). Serine 17 and 
tyrosine 416 are separated by limited cleavage with Staphylococcus aureus V8  protease, 
yielding a 36kDa fragment derived from the N-terminus of pp60 (VI), and a 24kDa C- 
terminal fragment (V2)319. V8  cleavage allows assessment of both the kinase activity of 
pp60 in vivo, and the extent of post-translational phosphorylation.
Growing cultures were labelled with ^^P-orthophosphate as for the 
phosphoamino acid analysis. pp60 was immunoprecipitated using MAb327 in the 
presence of
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Figure V.3
Post-translational phosphorylation of mutant and wild-type pp60 in clonal Rati 
src lines. Cultures at permissive or restrictive temperature were labelled to equilibrium 
with carrier-free -^P-orthophosphate and pp60 immunoprecipitates prepared as 
described in Materials and Methods. Gel purified pp60 was subject to partial digestion 
with S. aureus V8  protease, and the resulting peptides separated by one-dimensional 
12% SDS-PAGE as described. pp60 was digested with (from left to right in each set of 
three lanes) 1, 10 or lOOng V8  protease. The positions of undigested pp60, and primary 
digestion products VI and V2 (see text) are indicated. Autoradiography was for 7d at - 
70°C. A, cells at permissive temperature, B, cells at restrictive temperature.
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phosphatase and protease inhibitors and immunoprecipitates fractionated by SDS-PAGE. 
pp60 bands were excised and digested with V8  protease as described in Materials and 
Methods. As noted in chapter HI, ttLA32 pp60 migrates at a slightly higher apparent 
molecular weight than either ttLA29 or wtPrA pp60. This apparent size difference is not 
observed in the resulting phosphopeptides, and is presumably a secondary structure 
effect. The data presented in figure V.3 indicate that both temperature sensitive mutants J 
appear to be wild type for tyrosine 416 phosphorylation. Similar results was obtained in 
three experiments. It is somewhat suprising that ttLA29 pp60 is tyrosine phosphorylated 
at restrictive temperature given its striking thermolabile kinase properties in vitro. 
Furthermore, the same mutant appears to be temperature sensitive for in vivo tyrosine 
416 phosphorylation when these experiments are performed in CEF299. This discrepancy 
will be discussed more thoroughly below.
Given the absence of a temperature sensitive control in this analysis, the
interpretation of these results is somewhat tentative. Assuming that tyrosine 416
phosphorylation is the result of autophosphorylation, the data are consistent with teLA32 
pp60 being kinase active at both permissive and restrictive temperatures. This result also 
excludes the possibility that the lack of in vitro kinase activity in Rati f32 pp60
immunoprecipitates (chapter IV) is the result of defective post-translational
phosphorylation, since the protein is wild type in this respect.
V.C. Discussion
The data presented in this chapter suggest that Rati f29, Rati f32 and Rati fPrA 
cells contain elevated tyrosine kinase activity at both permissive and restrictive 
temperatures. Comparing the abundance of phosphotyrosine with the abundance of pp60 
in these cells (see figures III.3b and V.2) it is apparent that the wild-type PrA kinase has 
a greater specific activity than the two temperature sensitive mutants at either permissive 
or restrictive temperatures. The elevation of cellular phosphotyrosine in Rati f29 cells at 
restrictive temperature was unexpected in view of both the published data generated 
using ttLA29 RSV-infected CEF299 and the in vitro kinase data presented in chapter IV.
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However, it is perhaps pertinent to stress that these mutants were initially selected as 
being temperature sensitive for transformation in CEF320. Restrictive temperature in this 
system is 41°C rather than 39-40°C in mammalian cell systems. It is formally possible 
that this slight lowering in restrictive temperature, necessary to allow cell survival, is 
sufficient to allow the ttLA29 kinase to function. This could explain the V8  digestion 
results and the elevation in cellular phosphotyrosine seen in Rati f29 growing at 40°C.
A corollary of this argument would be that the major transformation defect in &LA29 
pp60 in mammalian cells is its inability to locate to the particulate fraction at restrictive 
temperature. This would prevent access to important substrates, explaining the 
conditional biological properties of this mutant. These data also suggest that membrane 
association and kinase activity are dissociable.
Alternatively, the elevation of cellular phosphotyrosine resulting from kinase 
activity of ttLA29 pp60 at restrictive temperature may be insufficient to elicit 
transformation, i.e. cellular phosphotyrosine must exceed a threshold value before 
transformation is possible. These alternatives are not necessarily exclusive. One 
presumes that the lack of in vitro kinase activity in pp60 immunoprecipitates from Rati 
f29 cells at restrictive temperature results from instability of the mutant protein.
ttLA32 pp60 appears to be somewhat different in that previous work from this , 
laboratory93 (and my preliminary results, not shown) indicate that this protein retains 
substantial membrane association at restrictive temperature, likening it to the wild type 
protein. The results of the total cell protein phosphoamino acid analysis suggest that the 
transformation defect in ttLA32 is rather subtle in nature. One possibility is that this 
kinase fails to associate with and \  or phosphorylate one or a number of important 
proteins at restrictive temperature. This model predicts that only a small number of 
primary tyrosine phosphorylation events would be seen rapidly following shift of Rati 
f32 cells to permissive temperature. This idea has been discussed at length in chapter I.
The tentative conclusion from these studies is that the Rati f32 cell line behaves 
in a manner compatible with the proposed approach to studying early events of v-src 
transformation.
Chapter VI
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VI M ITO G EN IC  A C T IV IT Y  O F TH E ts M U T A N TS
VI.A. Introduction
As outlined in the introduction to this thesis, the described approach to studying 
early events of v-src transformation depends on the cell line chosen having a number of 
characteristics. These are as follows:
a) the cells should be temperature sensitive for transformation
b) the cells should express a mutant pp60 whose membrane localization and 
kinase activity is not grossly affected by incubation at restrictive temperature
c) one should be able to render these cells quiescent by serum deprivation at 
restrictive temperature and these cells should re-enter cycle upon shift to permissive 
temperature in the absence of added factors.
These properties should reduce the number of adventitious phosphorylation 
events seen following temperature shift, facilitating identification of physiologically 
relevant changes. The temporal sequence of events can also be followed using this 
approach, since growth state effects are minimised. Rati f29 and Rati f32, and parental 
Rati cells were tested for their ability to re-enter cycle upon temperature shift.
VI.B. Results
Quiescent cultures were prepared as described in Materials and Methods, and 
cells stimulated either by the addition of serum at restrictive temperature, or by 
temperature shift to 35°C. Rati ttLA2919-94, a clonal line demonstrated to re-enter cycle 
following temperature shift29 was included as a control for these experiments. Cells were 
labelled at appropriate time points with tritiated thymidine, and harvested one hour later. 
Label incorporated into TCA-precipitable material was counted and the data plotted. 
Figure VI. 1 demonstrates that both Rati f29 and Rati f32 could re-enter cycle following 
shift to permissive temperature, unlike parental Rati fibroblasts which failed to 
incorporate tritiated thymidine in response to temperature shift. Note that the precise 
timing of entry
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Figure V I .l
Mitogenic activity of the temperature sensitive mutants in Rati. Rati, Rati 
teLA29, Rati f29 and Rati f32 were rendered quiescent at restrictive temperature by 
serum deprivation as described in Materials and Methods. Cultures were left untreated at 
40°C (■), stimulated by addition of newborn calf serum to a final concentration of 5% (v 
\  v) at 40°C (A) or shifted to permissive temperature in the absence of added factors (©). 
Cultures were pulse-labelled (lhr) with tritiated thymidine at four-hourly intervals, and 
radioactivity incorporated into TCA-precipitable material was measured by liquid 
scintillation counting. Incorporation is expressed as cpm x 10"^ per 35mm culture 
dish at each time point, a, Rati, b, Rati ttLA29, c, Rati f29, d, Rati f32.
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Figure VL2
Expression of pp60 in Rati f32 following serum stimulation or temperature shift 
of quiescent cultures.
a) Time course of ^H-thymidine incorporation in Rati f32 cells stimulated to enter cycle 
by addition of serum at restrictve temperature or temperature shift. See figure VI. 1 for 
details.
b) Immunoblot analysis of pp60 over time course shown in a). Parallel cultures were 
treated identically to those in a) except lysates were prepared for immunoblot analysis at 
0, 4, 8 , 12, 16, 24, 28 and 32hrs. Equivalent volumes of lysate were resolved by SDS- 
PAGE and blotted according to Materials and Methods. Primary antiserum was MW2 at 
1:5000 dilution. Only the relevant areas of the blots are shown, with time increasing 
from left to right. Culture conditions are shown to the right of each blot.
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into S phase, and the magnitude of the S phase peak varied somewhat between 
experiments. However, the onset of S phase was consistently slower and often less 
synchronous in temperature shifted cultures than in serum stimulated cultures, with DNA 
synthesis starting at approximately 20-24hrs post temperature shift. Cultures of Rati f29 
and Rati f32 cells were noticably transformed after approximately 16hrs at permissive 
temperature. Both entry into cycle and transformation appeared not to require gross 
changes in the level of pp60, since immunoblot analysis throughout this timecourse 
revealed only modest changes consistent with a doubling in cell number (figure VI.2).
VI.C. Discussion
The mitogenic activity of pp60 has been characterised quite extensively by a 
number of groups26*27-29'242*243. Rati cells expressing the thermolabile mutant ttLA29 
have been characterized extensively in this laboratory, and found to re-enter cycle 
following shift to permissive temperature29. This stimulation of proliferation occurs in 
the absence of added factors29.1 have therefore asked whether ftLA32 Src behaves in a 
similar fashion, using parental cells and cells expressing ttLA29 Src as controls. The 
data shown suggest that Rati f32 cells can be rendered quiescent by serum deprivation,
H'
in spite of retaining substantial tyrosine kinase activity and, presumably, pp60 membrane ! 
localization at restrictive temperature. These cells can then be stimulated to transform : 
and re-enter cycle by shifting to permissive temperature in the absence of added factors.
In addition, there is a rapid increase in the ability of nuclear extracts to bind AP-1 
consensus oligonucleotides following temperature shift of quiescent Rati f32 cells (A. 
W. Wyke, personal communication). This is in good agreement with the results of 
Welham et al., using the Rati ttLA29 system29. As with cells expressing ttLA29 Src29 or 
ttLA23 Src26, the onset of DNA synthesis is somewhat delayed when compared to the 
serum response, and in some cases entry into S phase appears to be somewhat less 
synchronous than for serum stimulated cells at restrictive temperature. This delay does 
not reflect a requirement for a net increase in pp60 expression as evidenced by the
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immunoblot in figure VI.2. The reasons for this delay are not yet clear, though there are 
several possibilities :
a) the delay is merely a temperature effect.
b) cells stimulated by temperature shift as opposed to serum are limited for 
factors that allow entry into S phase, e.g. nutrients required for an increase in cell mass, 
nucleotide precursors.
c) cells shifted to permissive temperature secrete a mitogenic factor upon 
transformation, this functioning in an auto- or paracrine fashion.
d) the mitogenic activity of the ts mutants requires turnover of existing pp60.
e) transformation relieves contact inhibition, allowing the mitogenic activity of 
pp60 to be expressed.
f) events leading to DNA synthesis and mitosis in cells stimulated with pp60 are 
fundamentally different to those in serum stimulated cells.
At present there is little data to support any of these hypotheses. Note that 
morphological transformation and mitogenic activity are both temperature sensitive in 
Rati f32. This is interesting in view of the wild type-like in vivo behaviour of this mutant 
protein. It seems likely that these two endpoints are not dissociable, either because they 
use a common target molecule or because transformation indirectly leads to mitogenesis, 
perhaps through relief of contact inhibition or via secretion of transformation specific 
growth factors. Whether morphological transformation and mitogenic activity are 
separable forms another part of this project and will be described elsewhere in this thesis.
Results detailed in previous chapters demonstrate that Rati f32 is conditional for 
morphological transformation and anchorage independent growth, despite retaining 
elevated protein phosphotyrosine at restrictive temperature. Previous work from this 
laboratory using teLA32-infected CEF, and my own preliminary data (not shown) using 
Rati f32 cells indicate that substantial amounts of pp60 are retained in the particulate 
fraction at restrictive temperature93. The results presented in this chapter confirm that 
these cells can be rendered quiescent at restrictive temperature, despite expressing kinase 
active, membrane associated pp60. These cells are then stimulated to re-enter cycle
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simply by shifting to the permissive temperature. In conclusion, the Rati £32 cell line 
satisfies the criteria outlined at start of this chapter, and would therefore merit use in 
studying early events of v-src stimulated mitogenesis and transformation.
Chapter VII
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VII EARLY CHANGES IN PROTEIN SYNTHESIS AND 
PHOSPHORYLATION FOLLOWING TEMPERATURE SHIFT OF 
QUIESCENT Rati <32
VII.A. Introduction
Many attempts to define substrates important in v-Src function have been 
compromised by the choice of cell line and exact experimental approach. Much 
emphasis has been placed on the comparison between transformed cells and their normal 
uninfected counterparts. Results from this type of experiment are difficult to interpret 
given that observed changes in protein synthesis and modification could be a 
consequence of, rather than a prerequisite for transformation. Growth state effects are 
also a potential problem in this type of approach, rendering cell cycle stage-specific 
events difficult to detect. Indeed, growth-state can be influenced by the techniques 
employed in detecting changes. For instance, radiolabelling with -^P-orthophosphate or 
even -^S - m e t h i o n i n e  can lead to S and G2 arrest66*321, precluding observation of events 
in the G1 phase of the cycle. Refined approaches have utilized temperature sensitive 
mutants of Src to study early events following activation of pp60 kinase activity, and 
combined with appropriate treatment of the cells under study, this has lead to some 
understanding of the temporal sequence of events following induction of the mitogenic 
and transforming activities of pp60. However, these approaches have employed pp60 
mutants which are typically conditional for kinase activity. Following shift to permissive 
temperature kinase activity is reactivated against all substrates, leading to 
phosphorylation of many adventitious substrates, hindering identification of relevant 
events. I have used a mutant whose biochemical properties are essentially wild type, but 
whose biological activity is temperature sensitive. The prediction is that cells expressing 
this mutant should exhibit fewer adventitious events following temperature shift 
facilitating identification of important changes. Note that this approach should also 
enable us to identify a group of proteins whose combined tyrosine phosphorylation at 
restrictive temperature is not sufficient for transformation in vitro.
Preceeding characters have dealt with the generation and characterization of the 
Rati f32 cell line, the results obtained suggesting that this line could be of use in the
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study of early events of v-Src transformation and mitogenesis. Therefore, experiments 
were performed to address the following questions :
a) can one detect changes in protein synthesis following temperature shift of 
quiescent Rati f32 cultures.
b) can one detect changes in phosphorylation of cellular proteins following 
temperature shift of quiescent Rati f32 cultures.
Preliminary results of these experiments are detailed below.
VII.B. Results
VII.B.l Protein Synthesis Following Temperature Shift of Rati f32
To investigate changes in protein synthesis involved in the GO \  G1 and G1 \  S 
transitions, quiescent cultures of Rati f32 and Rati were shifted to permissive 
temperature for 0 (i.e. maintained at 40°C), 1, 4, 7 or 24hrs. At one hour before this time 
period had elapsed, the cultures were incubated in methionine- and serum-free medium 
for 30 minutes prior to labelling for the remaining 30 minutes with 200uCi \  ml of ^ S - 
methionine in methionine- and serum-free medium. Monolayers w'ere washed in PBS 
before lysis in 2D-gel sample buffer. 2D-gel electrophoresis was expertly performed by 
Lynn McGarry, as outlined in Materials and Methods.
Although the 2D-gel system used is able to resolve approximately 2000 
methionine-labelled proteins, preliminary results indicate that very few proteins 
demonstrate detectable changes in rate of synthesis or degradation following temperature 
shift of quiescent Rati f32 cells. The majority of these differences only became apparent 
following a 24hr shift to permissive temperature, and were not observed at 1, 4 or 7hr 
timepoints. This correlates with the entry of these cells into S phase (see chapter VI), and 
also with the onset of morphological transformation. The seven changes observed, 
designated a-g, are indicated by arrows in figure VII. 1. These changes (four increases 
and three decreases in labelling intensity) were not observed in cultures of Rati cells 
treated in parallel, and so probably do not reflect non-specific
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Figure VII. 1
Changes in protein synthesis \  degradation following temperature shift of 
quiescent Rati f32. Quiescent cultures of Rati f32 were shifted to permissive 
temperature for 0 or 24hrs prior to pulse-labelling with -methionine as described in 
Materials and Methods. Whole cell lysates were prepared and resolved by 2D- 
electrophoresis as described in Materials and Methods. Indicated (arrows) are proteins 
whose labelling intensity is modulated by activating the transforming and mitogenic 
activities of teLA32 pp60 (see text). These changes were not observed in parallel cultures 
of Rati. Autoradiography was for 27d at -70°C. IEF, isoelectric focusing, SDS-PAGE, 
sodium dodecyl sulphate polyacrylamide gel electrophoresis.
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b) Rati f32, permissive temperature 24hrs
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effects of the temperature change. In comparison to quiescent cultures, proteins a, c and 
e were poorly labelled in shifted cultures whereas proteins b, d,f, and g became labelled 
to higher intensity following a 24hr shift to permissive temperature. Apparent molecular 
weights for these proteins are listed below in table VII. 1.
TABLE VTT.l
Protein Apparent Mol. Weight \kDa Labelling ?a
a 60 f
b 45 t
c 43 |
d 25 f
e 20 |
/  14 f
S 13 I
a Change in labelling intensity following 24hrs at permissive temperature, j  increased 
labelling, j decreased labelling.
VII.B.2 Protein Phosphorylation Following Temperature Shift of Rati f32
One of the main aims of this project is to look at changes in protein 
phosphorylation early after temperature shift of quiescent Rati f32 cultures. There are a 
number of specific questions that can be addressed using this system:
a) which proteins display changes in phosphate content following temperature
shift ?
b) more specifically, which species display increased tyrosine phosphorylation 
upon temperature shift and hence might constitute primary targets of pp60 kinase 
activity ?
c) can we identify a group of proteins whose combined tyrosine phosphorylation 
is insufficient for transformation ?
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These questions form a long-term project, and as such results of a very 
preliminary nature are discussed below.
Quiescent cultures of Rati and Rati f32 were deprived of phosphate for 30 
minutes then labelled with carrier-free -^P-orthophosphate (lmCi \  ml) for a total of 
4hrs. Cells were shifted to 35°C for 0, 15, 30, 60 or 120 minutes within this 4hr period 
before lysis in 2D gel sample buffer. Equivalent TCA-precipitable counts per minute 
(-500,000 per gel) were resolved by two-dimensional electrophoresis.
Preliminary results of these experiments have been disappointing. Three 
independent experiments of the type outlined above have failed to yield consistent 
results. In each experiment rapid changes (maximal by 15 min.) in the intensity of ^2p. 
labelled Rati f32 species have been observed, but these appear not to be reproducible 
between experiments. Indeed, whereas in one experiment label was seen to disappear 
rapidly from a group of proteins, in the following experiment, these proteins became 
phosphorylated following temperature shift of quiescent Rati f32 cells. These 
experiments will require careful attention to detail, and some suggestions are offered in 
the discussion below.
VII.C Discussion
A previous study of protein synthesis in quiescent ttLA23-NRK cells stimulated 
to transform and re-enter cycle has demonstrated that very few proteins are induced upon 
activation of pp6027. Durkin and Whitfield observed seven changes in the incorporation 
of -^S-methionine into individual proteins of 18.5-44kDa following activation of 
ttLA23 pp6027. Three of these pp60-induced proteins also appeared or accumulated 
during the G1 transit of serum-stimulated cells27. My preliminary results support these 
observations, though the different resolving systems employed preclude a direct 
comparison with the data of Durkin and Whitfield, and those changes observed in 
response to PDGF and serum by other workers322-323. However, it seems reasonable to 
assume that the cellular machinery required for the mitogenic response to serum or
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serum factors is also required for the mitogenic response to pp60, and hence further 
studies in this system should yield information on the essential components.
It is somewhat surprising that most of the observed changes were apparent only 
after an extended period at permissive temperature. This is in contrast to the effect of 
serum or serum factors upon quiescent cultures of fibroblasts where striking changes are 
apparent within 40min of stimulation323. There are several possible reasons for this 
difference. First, the magnitude of the mitogenic stimulus might be significantly 
different. Second, it is plausible that many of the effects elicited by whole serum are not 
directly related to the mitogenic mechanism. Indeed it is apparent that the overall rate of 
protein synthesis is increased markedly following serum stimulation of quiescent 
fibroblasts27-324, whereas activating pp60 does not result in a significant increase in 
incorporation of -methionine27. pp60, unlike other mitogens might selectively 
promote the appearance \  disappearance of only a small number of proteins which are 
essential for transit of Gl, DNA replication and cell division. Third, it is formally 
possible that events leading to DNA synthesis and mitosis in serum stimulated cells are 
fundamentally different to those in v-src transformed cells. The slower, sometimes less 
synchronous entry of temperature shifted Rati f32 or Rati f29 cells into S phase 
suggests that this might be the case (see discussion in chapter VI).
The SVc-induced changes detected in these studies might represent only a small 
subset of the total changes in protein synthesis in response to pp60 activation. New 
proteins synthesized in response to Src might be low abundance species or might be 
expressed only transiently during Gl transit. Proteins which are relatively stable until a 
particular point in the cycle and are then degraded, for instance some cyclins, might not 
be detected since the labelling protocol is biased towards detection of newly synthesized 
proteins. In summary, a range of culture and labelling conditions will be required to 
define many src-induced changes in protein synthesis \  turnover. As a first step it might 
be useful to label cultures continuously for a number of hours following temperature 
shift, comparing these cells to parallel cultures maintained at restrictive temperature. 
Any changes observed could then be analyzed more thoroughly.
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Preliminary attempts to investigate changes in phosphoprotein profile following 
temperature shift of quiescent Rati f32 cells have been disappointing. As indicated in
VII.B.2, results from three short time-course experiments have not been reproducible for 
technical problems. Potential sources of error are outlined below, together with measures 
that might improve reproducibility :
a) growth and labelling media. Variation in the composition and physical 
properties (pH, osmolarity etc.) of medium used might influence the results of these 
experiments, particularly over short time courses. In particular, any change of pH 
following shift between incubators might result in spurious results. One could perhaps 
minimise these problems by labelling and shifting in chemically defined medium, such 
as a Ringer solution. It might be wise to use a non-bicarbonate buffering system to 
prevent large pH changes following temperature shift. Stocks of growth and labelling 
media should perhaps be frozen to reduce variation between experiments.
b) cell density and passage history. There are circumstantial data to suggest that 
cell density plays a large role in determining the magnitude of a number of Src- 
responsive effects (M. Frame, personal communication). It is important therefore that 
cells for these experiments are set up at identical densities and are cultured for a defined 
period before the experiment begins. Control cultures not expressing the Src protein 
should always be included in parallel.
c) labelling protocol. Labelling should be carried out according to a standard 
protocol. It is important that cells are maintained at the appropriate temperature prior to 
and during the experiment, and that required temperature changes should be effected as 
rapidly as possible. This might be achieved by floating culture vessels on water baths. If 
possible, it would be wise to examine parallel cultures for transformation and re-entry 
into cycle following temperature shift.
d) detection of protein phosphotyrosine. Since ~99% of protein phosphate in 
these cells is phosphoserine and phosphothreonine (see chapter V), detection of 
phosphotyrosine is not straightforward. Two methods are currently available : alkaline 
hydrolysis of - ^ P - l a b e l l e d  proteins310 and Western blotting using antisera specific for
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phosphotyrosine237*238*239-240. Protein phosphotyrosine is relatively stable to treatment 
with 1M KOH at 55°C, whereas phosphoserine and, to a lesser extent, phosphothreonine 
are hydrolyzed310. Alkaline enrichment of phosphotyrosine can be carried out in the 
gel310, or on Immobilon P membranes325 (Millipore). The latter method avoids the 
marked expansion and contraction of the gel seen upon hydrolysis in situ. However, 
there are problems in ensuring reproducible blotting between gels, and indeed consistent 
blotting within any given gel. These problems are compounded by the large number of 
gels that are often required in these experiments. Obviously, Western blotting using anti- 
phosphotyrosine specific antisera suffers from the same blotting problems, though prior 
labelling of cells is not required. Other problems with this approach include the 
specificity of the antisera (which can be checked by radiolabelling and phosphoamino 
acid analysis) and the range of tyrosine phosphorylated proteins recognized by the 
antisera used. Since different antisera yield significantly different profiles of 
phosphotyrosine-containing proteins, it is perhaps wise to use mixtures of antisera for 
this application. In summary, one reasonable approach to detect protein phosphotyrosine 
might be to blot labelled proteins to Immobilon P membranes for autoradiography before 
subsequent alkaline hydrolysis. Labelled species resistant to hydrolysis could then be 
checked by immunostaining with anti-phosphotyrosine antisera.
From the above it is clear that these questions constitute a long-term project, 
although I believe most of the techniques and materials required are now in place.
Chapter Yin
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VIII ARE THE TRANSFORMING AND MITOGENIC ACTIVITIES 
OF pp60 DISSOCIABLE ?
Vin.A. Introduction
The proceeding chapters of this thesis have outlined an approach to the study of 
early consequences of activating a thermolabile v-src mutant. The &LA32 mutant was 
chosen for this approach on the basis that its behaviour deviates only minimally from the 
wild type protein. The prediction is that this type of approach should facilitate 
identification of relevant events. Parallel studies in this laboratory have concentrated on 
describing the behaviour of the AP-1 transcription factor following temperature shift of 
ttLA29 infected Rati fibroblasts. Welham et al. have demonstrated that the ability of 
nuclear extracts to retard oligonucleotides containing consensus AP-1 binding elements 
increases rapidly upon temperature shift of quiescent cultures of Rati &LA2929. Since 
these experiments result in two biological endpoints, namely transformation and re-entry 
into cell-cycle, equating early events with the correct endpoint is not straightforward. 
Mutants capable of dissociating these two endpoints would therefore be useful both in 
characterising early events following temperature shift in the Rati f32 system, and in 
dissecting further the relevance of the AP-1 band-shift assays. Evidence that the various 
transformation phenotypes can be dissociated is provided by the studies of Becker et 
al.326, Weber and Friis327, and also by Hanafusa and Calothy and colleagues32-33-328*329-330. 
In particular, the latter workers have demonstrated that morphological transformation \  
anchorage independence and stimulation of proliferation induced by v-Src are separable 
in primary neuroretinal cells of the chick embryo33, using pp60 defective for membrane 
localization32. Cells infected with these mutants are morphologically normal but exhibit 
a prolonged proliferative lifespan in culture. Of the mutants studied, those demonstrating 
the clearest dissociation of mitogenic and transforming activities are proteins defective 
for myristylation32. Although not addressing the mitogenic activity directly, these studies 
suggest that similar mutants might be useful for dissociating the transforming and 
mitogenic activities of pp60 in fibroblasts.
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This chapter will describe the construction of a mutant non-conditionally 
defective for myristylation but temperature sensitive for in vitro kinase activity, and its 
properties in Rati and CEF.
VIII.B. Results
VIII.B.l Mutagenesis of taLA29 src
Mutagenesis of /sLA29 src was carried out in bacteriophage M l3 using a 
commercially available kit according to manufacturers' instructions. The oligonucleotide 
used, oligo. A2, had the following sequence : 5' C ACC ATG GCA AGC AGC AA 3'. 
Nucleotides which differ from the ttLA29 sequence are underlined. This mutation results 
in a glycine to alanine substitution at position 2 of pp60, a change reported to prevent 
myristylation37*111. The mutant is named "29A2" to indicate this change.
Five plaques generated by the mutagenesis reactions were analyzed by dot- 
blotting. DNA from these putative mutants and from the starting M13-ttLA29 src DNA 
was spotted on Hybond N and hybridized with 5' -^P-labelled oligo. A2 according to 
instructions supplied with the mutagenesis kit. The membrane was washed three times in 
6xSSC at room temperature and exposed to X-ray film overnight. All species retained 
labelled oligonucleotide A2 after these low stringency washes. To detect phage 
containing mutant insert, the membrane was washed for five minutes in 6xSSC 
prewarmed to 51°C. This is five degrees below the calculated Tm of mutant oligo \  non­
mutant template hybrids. The membrane was again exposed to X-ray film overnight. 
This high stringency wash removed all label from the starting template DNA and from 
two of the five putative mutant DNAs. The remaining putative mutants were sequenced 
to confirm the presence of the codon 2 mutation, and one of these positive clones, M l3 
29A2-1 (see figure Vni.la) was used to prepare double stranded replicative form (RF) 
DNA. RF DNA from M l3 29A2-1 was digested to completion with EcoRI and H indin  
and fractionated by agarose gel electrophoresis. A 1.9kb band was recovered from the 
gel and ligated to EcoRI \  HindUI cut pMP323 to generate the Clal sites necessary for 
subsequent subcloning
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Figure VIIL1
a) Mutagenesis of &LA29. Starting template (M13 29) and putative mutant (M13 29A2- 
1) were sequenced according to Materials and Methods. Products were resolved by 
denaturing polyacrylamide gel electrophoresis and revealed by autoradiography (18hrs, 
room temperature). The starting template and mutant sequences of interest are indicated 
in the figure. A, C, G, T-dideoxynucleoside triphosphate in termination reaction.
b)i) Restriction analysis of fpGV-29A2. 29A2 src was subcloned to the unique Clal site 
in fpGV-1 as outlined in the text. Presence of insert was assessed by digestion with Clal 
and orientation derived by digestion with BgU or Smal, followed by 0.8% agarose gel 
electrophoresis. For additional information see figures III. lb and IH.2a. B, BgU, C, Clal, 
S, Smal, M, molecular weight markers
ii) Restriction analysis of RCAN 29A2. 29A2 src was subcloned to the unique Clal site 
in RCAN as outlined in the text. Presence and orientation of src inserts were assessed by 
digestion with Sail followed by 0.8% agarose gel electrophoresis. For additional 
information see figures III. lb and m.2b. M, molecular weight markers, 1, RCAN, 2, 
RCAN 29,3, RCAN 29A2.
Figure V III.l
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to the expression vector fjpGV-1. Appropriate clones of fpGV-29A2 were identified by 
restriction mapping (figures VIII.lb and m.2a) and transfected into Rati cells according 
to Materials and Methods. Some aspects of this work required expression of the 29A2 
mutant in CEF. The previously described RCAN vector was used for this purpose. 
Appropriate clones were identified by restriction mapping (see figures VIII.lb and 
III.2a) and transfected according to Materials and Methods.
VIII.B.2 Derivation of Rati f29A2 Clones
Rati cultures were transfected with fpGV-29A2 and selected with G418 at 
permissive temperature according to Materials and Methods. Transfection efficiency was 
similar to that obtained using the previously described expression constructs (see chapter 
ID). As expected, all G418-resistant colonies obtained from these transfections were 
morphologically normal. More than thirty independent single cell clones from three 
independent transfections at permissive temperature were screened for pp60 expression 
by immunoblot analysis. Results for 23 G418-resistant clones derived from two 
independent transfections are shown in figure VIIL2. None of these clones express pp60 
to a level approaching that seen in the Rati f29 clone, although a number do express 
detectable pp60. The properties of two of these clones (G and H) are described later in 
this chapter.
Since transfection and selection at permissive temperature yielded only clones 
expressing low levels of 29A2 pp60, one possibility was that an active cytoplasmic 
kinase was toxic in these cells. To address this possibility, transfection and selection 
were carried out at restrictive temperature. Any pp60 expressed at this temperature 
should have basically the same properties as ttLA29 Src protein, i.e. it should have a 
reduced kinase activity and be cytoplasmic in nature. Given that #LA29 Src protein 
appears not to be toxic at restrictive temperature, one would predict that cytotoxicity of 
the 29A2 protein should be minimized under these conditions. G418-resistant colonies 
obtained by transfection and selection at restrictive temperature were screened for pp60
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Figure VIIL2
Transfection of fpGV-29A2 into Rati cells at permissive temperature. Rati cells 
were transfected with fpGV-29A2 and selected for G418-resistance at permissive 
temperature as described in Materials and Methods. Colonies or single cell clones 
derived from these transfections were analysed by Western blotting, using appropriate 
positive and negative controls. Equivalent amounts of lysate protein (as judged by 
Coomassie blue staining) were resolved by SDS-PAGE and blotted as described in 
Materials and Methods. Primary antiserum was MW2 at 1:5000. The arrowhead 
indicates pp60.
a) single cell clones from transfection #1 at permissive temperature plus positive (Rati 
f29) and negetive (Rati) controls.
b) colonies obtained from transfection #2 at permissive temperature plus positive (Rati 
f29) and negative (Rati) controls.
Figure VIII.2
a) fpGV-29A2 transfection #1, permissive temperature
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Figure VIIL3
Transfection of fpGV-29A2 into Rati cells at restrictve temperature. Four 
independent Rati cultures were transfected at and selected for G418-resistance at 
restrictive temperature as described in Materials and Methods. Colonies were analysed 
by Western blotting using appropriate positive and negative controls. Equivalent 
amounts of lysate protein (as judged by Coomassie blue staining) were resolved by SDS- 
PAGE and blotted as described in Materials and Methods. Primary antiserum was MW2 
at 1:5000. The arrowhead indicated pp60. II-V represent independent transfections and 
A-E represent individual colonies from these transfections.
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expression by Western blot analysis (figure Vffl.3). Although generally similar to the 
results obtained from transfections at permissive temperature, two colonies did exhibit 
reasonable expression of pp60. These colonies, 3B and 3D were picked from the same 
transfection and hence may not result from independent transfection events. Colony 3B 
was selected for single cell cloning and further study. Although uniformly flat and non- 
reffactile at restrictive temperature, 3B became more refractile at permissive 
temperature. Upon reaching confluence at 35°C, cells appeared to be lost from the 
surface of the monolayer. Additionally, colonies formed after plating at low density at 
permissive temperature demonstrated a range of morphologies, suggesting that 3B was 
not clonal (not shown). Furthermore, Southern analysis suggested the presence of more 
than one cell clone in 3B (not shown). Interestingly, the refractile colonies that resulted 
from plating at low density at permissive temperature grew very poorly. These 
observations are consistent with the 29A2 mutant protein being somewhat toxic at 
permissive temperature. Unfortunately, attempts to clone Rati f29A2 3B (even at 
restrictive temperature) yielded uniformly flat lines which failed to express detectable 
pp60. Hence, with reservations regarding the viability and clonality of Rati f29A2 3B in 
mind, this line was characterised together with the two low expressing clones (G and H) 
from transfections at permissive temperature. These experiments and the tentative 
conclusions drawn from them are outlined below.
VIII.B.3 In vitro Kinase Activity of Rati f29A2
Cultures of Rati f29A2 G and H (low expressing clones derived from 
transfections at permissive temperature, figure VIII.2) and Rati f29A2 3B (colony 
derived from transfection at restrictive temperature, figure VIII.3), together with 
appropriate control cultures of Rati and Rati f29, were grown for at least two days at 
permissive or restrictive temperature. MAb327 immunoprecipitates were prepared 
according to Materials and Methods, and in vitro kinase assays performed. Figure VIII.4 
indicates that the
147
Figure VHL4
MAb327-immune complex kinase assay of Rati f29A2 lines. pp60 was 
immunoprecipitated from growing cultures of Rati, Rati f29 or the Rati f29A2 lines 
indicated as described in Materials and Methods using monoclonal antibody MAb327. 
Kinase activity in the immunoprecipitates was measured at 30°C using acid-denatured 
enolase as exogenous substrate, as described in Materials and Methods. The open arrow 
indicates pp60 and the closed arrow enolase (as judged by Coomassie blue staining). A, 
cells at permissive temperature, B, cells at restrictive temperature.
i) Rati f29A2 clones G and H. Autoradiography was for 3hrs at -70°C.
ii) Rati f29A2 colony 3B. Autoradiography was for lhr at -70°C.
Figure VIII.4
i) MAb327-immune complex kinase assay of Rati f29A2 clones H and G
Rati Rati f29 f29A2-H f29A2-G
A B A B A B A B
92 —
6 8 __
2 9 __
ii) MAb327-immune complex kinase assay of Rati f29A2-3B
Rati Rati f29 f29A2-3B
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myristylation defective mutant 29A2 derived from tsLA29 src retains the thermolabile 
kinase properties of the &LA29 protein in in vitro assays, and that the absolute level of 
kinase activity at permissive temperature mirrors the level of expression of pp60 as 
assessed by Western blot (see figures VIII.2 and Vin.3).
VIII.B.4 Mitogenic Activity of 29A2 In Rati Cells
Quiescent cultures of Rati f29 and cells expressing the 29A2 protein were 
prepared according to Materials and Methods. Cultures were stimulated either by 
addition of serum to a final concentration of 5% at restrictive temperature, or by shifting 
the cultures to permissive temperature in the absence of added factors. At appropriate 
intervals cultures were labelled with tritiated thymidine and incorporation into TCA- 
precipitable material was estimated by liquid scintillation counting. The results of these 
experiments are shown in figure VTII.5. Under conditions where Rati f29 cells entered S 
phase in response to temperature shift, cells expressing the myristylation defective 
mutant 29A2 failed to incorporate labelled thymidine. This was true of clones expressing 
low levels of the mutant protein (clones G and H) and of the line expressing levels of 
pp60 approaching that seen in the Rati f29 line (Rati f29A2 3B). These cells respond 
normally to serum at restrictive temperature, demonstrating that they are capable of re­
entering cycle from a quiescent state. The data suggest that the 29A2 mutant is not itself 
a complete mitogen in Rati fibroblasts when assayed directly. Possible technical reasons 
for this result will be discussed in more detail later in this chapter.
Since the available Rati lines expressing the 29A2 protein did not re-enter cycle 
following shift to permissive temperature, I examined the properties of this mutant in 
infected CEF cultures. The 29A2 src Clal fragment was subcloned to the avian retroviral 
vector RCAN to yield RCAN 29A2 and uniformly infected cultures obtained as 
described in Materials and Methods. RCAN and RCAN 29 infected cultures were 
prepared in parallel to serve as controls. The monolayer morphology of these infected 
cultures is shown in figure VIII.6 , demonstrating clearly the normal morphology of 
RCAN 29A2 infected cultures.
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Figure VIIL5
Mitogenic activity of ttLA29A2 pp60 in Rati cells. Rati f29, Rati f29A2 G, 
Rati f29A2 H and Rati f29A2 3B were rendered quiescent at restrictive temperature by 
serum deprivation as described in Materials and Methods. Cultures were left untreated at 
40°C (B), stimulated by addition of newborn calf serum to a final concentration of 5% (v 
\  v) at 40°C (A) or shifted to permissive temperature in the absence of added factors (#). 
Cultures were pulse-labelled (lhr) with tritiated thymidine at four-hourly intervals, and 
radioactivity incorporated into TCA-precipitable material was measured by liquid 
scintillation counting. Incorporation is expressed as cpm x 10"^ per 35mm culture 
dish at each time point, i, Rati f29, ii, Rati f29A2 H, iii, Rati f29A2 3B.
Figure VIII.5
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Figure Vin.6
Monolayer morphology of RCAN 29 and RCAN 29A2-infected CEF. Cultures 
were maintained in normal growth medium at appropriate temperature for at least 24hrs 
prior to photography. Magnification is ~x750. a, RCAN 29 35°C, b, RCAN 29 41°C, c, 
RCAN 29A2 35°C, d, RCAN 29A2 41°C.
Figure VIII.6
151
VIII.B.5 In vitro Kinase Activity of RCAN 29A2 Infected CEF
Extent of CEF infection was gauged by Western blot analysis using anti-Gag 
serum 5202 (not shown) and anti-Src serum MW2 (figure Vin.7a). The 29A2 protein 
was expressed to the same level as the prototype fsLA29 protein in chick embryo 
fibroblasts, with no obvious toxic effects. The reason for this differential behaviour in 
Rati and chick embryo fibroblasts is not clear. Immunoprecipitates were prepared from 
infected cultures as described using MAb327, and in vitro kinase assays performed using 
acid-denatured enolase as substrate. Figure Vin.7b demonstrates that the in vitro kinase 
activity of 29A2 pp60 mimics closely the behaviour of the prototype ttLA29 protein. 
When prepared from CEF, both the absolute levels and the temperature sensitivity of 
these kinases are closely matched when assayed in vitro.
The data presented above suggest that growing cultures infected with RCAN 29 
and RCAN 29A2 were well matched in terms of pp60 expression and in vitro kinase 
activity, although clearly different morphologically. It was therefore important to 
determine if both kinases reactivated with the same kinetics following temperature shift. 
Quiescent cultures of CEF infected with RCAN, RCAN 29 and RCAN 29A2 were 
prepared as described in Materials and Methods. Appropriate dishes were shifted to 
permissive temperature for 0, 0.5, 1 or 4hrs before lysis and immunoprecipitation with 
TBR-RLE. Kinase assays were carried out according to Materials and Methods, and 
labelled immunoglobulin and pp60 detected by autoradiography. Figure VIII. 8  
demonstrates that both ttLA29 and WLA29A2 kinases reactivate over this timecourse, 
whereas no activity is detected in immunoprecipitates from RCAN infected cultures. 
Coupled with the apparent lack of toxicity, these results enabled a more direct 
comparison of the mitogenic activity of the ttLA29 and 29A2 Src proteins than had been 
possible in the Rati cell system.
152
Figure VIIL7
a) pp60 expression in infected CEF. Uniformly infected cultures were maintained in 
normal growth medium at the appropriate temperature for at least two days prior to lysis. 
Equivalent amounts of lysate protein (as judged by Coomassie blue staining) were 
resolved by SDS-PAGE and blotted according to Materials and Methods. Primary 
antiserum was MW2 at 1:5000. The arrowhead indicates pp60. A, cells at permissive 
temperature, B, cells at restrictive temperature, -, mock-transfected CEF, R, RCAN 
transfected CEF, R29, RCAN 29 transfected CEF, R29A2, RCAN 29A2 transfected CEF.
b) MAb327-immune complex kinase assay of infected CEF. Uniformly infected cultures 
were maintained in normal growth medium at the appropriate temperature for two days 
prior to lysis. pp60 was immunoprecipitated from equivalent amounts of lysate protein 
using monoclonal antibody MAb327. Kinase activity in the immunoprecipitates was 
measured at 30°C as described in Materials and Methods using acid-denatured enolase 
as exogenous substrate. The open arrow indicates pp60 and the closed arrow enolase (as 
judged by Coomassie blue staining). Autoradiography was for 4hrs at -70°C. A, cells at 
permissive temperature, B, cells at restrictive temperature, -, mock-transfected CEF, R, 
RCAN transfected CEF, R29, RCAN 29 transfected CEF, R29A2, RCAN 29A2 
transfected CEF.
Figure VIII.7
a) pp60 expression in infected CEF
R R29 R29A2
b) MAb327-immune complex kinase assay of infected CEF
R R29 R29A2
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Figure Vm.8
Kinase reactivation in quiescent CEF expressing RCAN 29 and RCAN 29A2. 
Uniformly infected cultures of CEF were rendered quiescent at restrictive temperature as 
described in Materials and Methods. Cultures were shifted to permissive temperature for 
the indicated times and pp60 immunoprecipitates prepared as described using antiserum 
TBR-RLE. Kinase activity against immunoglobulin heavy chain and pp60 was measured 
as described. The open arrow indicates pp60, and the closed arrow immunoglobulin 
heavy chain (as judged by Coomassie blue staining). Transfected constructs are indicated 
at the top of the figure. Autoradiography was for 1.5hrs at -70°C.
Figure VIII.8
Kinase reac t iva t ion  in CEF expressing RCA N  29 and RCA N  29A2
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VIII.B. 6  Mitogenic Activity of 29A2 In CEF
Primary CEF were transfected with RCAN 29 or RCAN 29A2 and passaged until 
uniform infection was achieved. Infected cultures were rendered quiescent by serum 
deprivation at restrictive temperature (41°C) as oudined in Materials and Methods. 
Cultures were then stimulated by addition of serum at restrictive temperature or by shift 
to permissive temperature in the absence of added factors. DNA synthesis was assessed 
by pulse-labelling at appropriate intervals with tritiated thymidine. The results from two 
of these experiments are presented in figure VIII.9. Cultures infected with RCAN 29A2 
remained morphologically normal and incorporated little tritiated thymidine above 
control levels in response to temperature shift, whereas shift of RCAN 29 infected 
cultures to permissive temperature resulted in entry into S phase and morphological 
transformation. RCAN 29 and RCAN 29A2 infected cultures responded similarly to 
stimulation with serum at restrictive temperature, demonstrating that differential viability 
was probably not responsible for the failure of RCAN 29A2 infected cells to re-enter 
cycle. In summary, results obtained in chick embryo fibroblasts closely resemble those 
obtained in the Rati cells. These data suggest that a myristylation defective, temperature 
sensitive kinase is non-mitogenic in fibroblasts when assayed directly.
One well characterised response to activation of the transforming and mitogenic 
activities of ttLA29 Src is the early increase in AP-1 oligonucleotide binding activity 
present in nuclear extracts29. The induction of binding activity correlates with re-entry 
into cycle and transformation, indicating that modulation of the activity of this 
transcription factor family might be required for either one or both of these biological 
endpoints. Preliminary data indicate that AP-1 binding activity is not elevated similarly 
in response to reactivating ttLA29A2 pp60 in CEF (M. Frame, A. Lang and A. Catling, 
figure Vlll.lOa), correlating with the failure of these cells to re-enter cycle and 
transform. I was therefore interested to investigate the effects of artificially elevating 
AP-1 binding activity in CEF infected with the non-transforming, non-mitogenic mutant 
29A2. The protein kinase C agonist
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Figure VIIL9
Mitogenic activity of &LA29A2 Src in CEF. Cultures uniformly infected with 
RCAN 29 (B ,4 , ©) or RCAN 29A2 (O, • , +) were rendered quiescent at restrictive 
temperature as described in Materials and Methods. Cultures were left untreated at 
restric^e temperature (■,<€}, stimulated with 5% (v \  v) newborn calf serum at restrictive 
temperature (4,®) or shifted to permissive temperature in the absence of added factors (@,-f 
). Cultures were pulse labelled (lhr) with tritiated thymidine at four-hourly intervals, and 
radioactivity incorporated into TCA-precipitable material measured by liquid 
scintillation counting. Incorporation is expressed as cpm x 10"^ per 35mm culture 
dish at each time-point. The results from two independent experiments are shown.
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Figure VIIL10
a) AP-1 binding activity after temperature shift of infected CEF. Cultures uniformly 
infected with RCAN 29 or RCAN 29A2 were rendered quiescent at restrictive 
temperature as described in Materials and Methods. Cultures were shifted to permissive 
temperature for the indicated times, and nuclear extracts were kindly prepared by M. 
Frame and A. Lang. Equivalent amounts of extract protein were incubated with excess 
^P-labelled adenovirus E3 AP-1 oligonucleotide, and complexes resolved by non­
denaturing polyacrylamide gel electrophoresis. Transfected constructs are indicated 
above appropriate lanes. Autoradiography was for 18hrs at-70°C.
b) PMA is insufficient to stimulate mitogenesis in RCAN 29A2-infected CEF. RCAN 
29A2-infected CEF were rendered quiescent at restrictive temperature by serum 
deprivation as described in Materials and Methods. Cultures were left untreated at 
restrictive temperature (H), stimulated with 5% (v \  v) newborn calf serum at restrictive 
temperature (O), shifted to permissive temperature in the absence of added factors (A) or 
shifted to permissive temperature in the presence of lOOng \  ml PMA (^  ). This 
concentration of PMA elevates AP-1 DNA binding activity under these conditions (M. 
Frame and A. Catling, not shown). Cultures were pulse labelled (lhr) with tritiated 
thymidine at four-hourly intervals, and radioactivity incorporated into TCA-precipitable 
material measured by liquid scintillation counting. Incorporation is expressed as cpm 
x 10"4  per 35mm culture dish at each time point.
Figure VIII.10
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phorbol 12-myristate 13-acetate (PMA) is reported to elevate AP-1 activity in quiescent 
fibroblasts331. PMA was used to stimulate the activity of AP-1 in RCAN 29A2 infected 
CEF. Quiescent cultures of CEF infected with RCAN 29A2 were prepared as described 
in Materials and Methods. Cultures were treated with lOOng \  ml PMA at restrictive 
temperature or were shifted to permissive temperature in the presence of lOOng \  ml 
PMA. Control cultures were shifted to permissive temperature in the absence of PMA or 
were stimulated at restrictive temperature by the addition of serum to a final 
concentration of 5%. This concentration of PMA is demonstrated to elevate AP-1 DNA 
binding activity under these conditions (M. Frame and A. Catling, not shown). Figure 
Vin.lOb suggests that quiescent RCAN 29A2 infected CEF do not incorporate tritiated 
thymidine in response to this concentration of PMA either at restrictive or permissive 
temperature. In addition, cell transformation also fails to occur in temperature-shifted 
cells stimulated with this concentration of PMA. The implication is that transformation 
and mitogenesis require cell membrane events, in addition to an elevation of nuclear AP- 
1 DNA binding activity.
VIHC. Discussion
The data presented above suggest that the myristylation mutant 29A2 is not 
capable of acting as a complete mitogen in Rati and CEF using a direct assay. However, 
there are a number of potential technical problems associated with the Rati cell system 
that render this conclusion tentative. First, the protein is poorly expressed in Rati cells. 
The failure to detect a mitogenic activity in the low expressing Rati clones could 
therefore result from sub-threshold expression of the mutant protein. Although one 
colony expressing reasonable amounts of 29A2 pp60 was assayed for mitogenic 
activity, this too yielded negative results. The interpretation of this result is however not 
straightforward since the Rati f29A2 3B cells appear not to be clonal; non-expressing 
cells in this population could exert a suppressive effect on those cells expressing 29A2 
pp60. Attempts to generate single cell clones from the Rati f29A2 3B population yielded 
only lines in which pp60 was undetectable by Western blot. The reason(s) for the poor
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expression of this protein in Rati cells is unclear. The glycine to alanine mutation used 
in this study has been used by numerous groups, none of whom have reported problems 
in expressing non-myristylated proteins in a number of cell types. The mutation used 
preserves a consensus sequence for translational initiation, and is more than lOObp 
downstream of the src splice acceptor. This would suggest that the expression problems 
are unlikely to result from RNA splicing defects or poor translational initiation. 
However, it is possible that the mutant protein is turned-over rapidly in Rati cells, 
leading to low steady state expression. This possibility has not been addressed.
The second problem encountered in expressing 29A2 in Rati cells is the apparent 
toxicity of the protein. This might in part explain the low levels of expression of this 
protein in the majority of clones and colonies screened following transfection of fpGV- 
29A2, and also the failure to generate clonal lines from Rati f29A2 3B. It is possible that 
those cells in the Rati f29A2 3B population expressing reasonable amounts of the 
mutant protein do respond to temperature shift by transiting Gl, but fail to incorporate 
labelled thymidine as the non-specific toxic effects of a cytoplasmic kinase manifest 
themselves at permissive temperature. Given that other myristylation mutants are not 
reported to be toxic in mammalian cells, this non-specific toxicity would presumably 
result from the combination of mutations in the 29A2 protein. Alternatively, the toxicity 
observed might be rather more specific. One possibility is that the cytoplasmic kinase is 
capable of initiating some but not all events leading to mitosis, leading to mitotic 
catastrophe. If this is the case, it might be possible to rescue such cells by adding specific 
agonists to compensate for these deficiences.
Many of the problems associated with expression of the 29A2 protein in Rati 
cells were overcome in CEF. CEF cultures uniformly infected with RCAN 29 or RCAN 
29A2 express similar amounts of pp60 and exhibit equivalent in vitro kinase activities. 
Coupled with the apparent lack of toxicity in the CEF background, this enables a more 
direct comparison of the mitogenic and transforming activities of the two proteins than 
has been possible in Rati cells. Examination of the mitogenic activity of the 
myristylation mutant in this CEF background also yielded negative results, as had been
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the case in a Rati cell background. This is not due to a defect in the reactivation of the 
myristylation mutant kinase, since under these conditions the in vitro kinase activity of 
teLA29A2 reactivates with kinetics similar to the prototype ttLA29 protein. RCAN 29 
and RCAN 29A2 infected cultures respond similarly to serum at restrictive temperature, 
indicating that both cultures are able to re-enter cycle.
In summary, it appears that a temperature sensitive kinase defective for 
myristylation is not mitogenic in the fibroblast cells studied. This contradicts the results 
reported by Calothy et a l. using infected cultures of primary chick neuroretinal cells32. 
These workers found that mutants defective for membrane association, by virtue of 
mutations in the myristylation domain32 or through increased pp50 \  pp90 complex 
formation328*329, prolonged the lifespan of neuroretinal cells in the absence of 
transformation. This discrepancy might result from the use of different cell types, or 
from differences in experimental approach. The stringent assay for mitogenic activity 
used in this study will reveal complete mitogens whose function is largely independent 
of exogenous factors. The studies of Hanafusa Calothy and colleagues utilise 
neuroretinal cells which do not normally proliferate in vitro, even when maintained in 
serum-containing medium. Under these conditions, introduction of a mutant pp60 
defective for myristylation is sufficient to stimulate these cells into cycle. It is possible 
that this mitogenic activity results from synergy between the mutant pp60 and serum 
factors. This idea could be tested by shifting quiescent cultures infected with RCAN 
29A2 to the permissive temperature in the presence of specific agonists which are 
themselves not complete mitogens. Such studies might include an examination of the 
properties of conditioned medium from src-transformed cells. Preliminary data from an 
experiment employing the protein kinase C agonist PMA as a potential co-mitogen are 
described above. Other potentially interesting agonists include insulin and in particular 
insulin-like growth factor I, since tyrosine phosphorylation of the receptor for this ligand 
correlates well with transformation in vitro292 Alternatively, it might be possible to 
express a myristylation defective wtfPrA protein in cells already expressing teLA29 Src: 
temperature shift experiments would then enable a thorough examination of the
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mitogenic properties of the non-myristylated protein. It is possible that non-myristylated 
proteins are capable of stimulating early events required for G1 transit, but are 
insufficient to stimulate entry into S phase. Reactivating a thermolabile transforming 
mutant in this situation might result in more rapid entry of cultures into S phase, early 
events having already been completed. One could also design experiments to address any 
later requirement for Src using cells co-expressing suitable non-myristylated and 
myristylated Src proteins.
The studies of Hanafusa and colleagues have indicated that the mitogenic and 
transforming activities of pp60 show poor correlation with in vitro or in vivo kinase 
activity, although both biological properties did correlate with the presence of a v-Src 
kinase domain328-329. Furthermore, the thermolability of different parameters of 
transformation becomes apparent at different temperatures: thus anchorage independent 
growth of PA104-infected chick embryo fibroblasts is essentially abolished at 37°C, 
whereas the protein still retains a mitogenic activity in chick neuroretinal cells at this 
temperature328. This differential temperature sensitivity is not reflected in thermolabile 
complex formation with pp50 and pp90, since the mutant is predominantly complexed at 
34, 37 and 41°C329. One possible explanation for the observed dissociation of anchorage 
independent growth and mitogenic activity is that substrate recognition becomes more 
stringent as temperature is increased, such that substrates required for anchorage 
independent growth are not phosphorylated at 37°C329. Alternatively, it is possible that 
the absolute level of phosphorylation of a particular substrate involved in eliciting a 
number of transformation parameters varies with temperature. Since the transformation 
parameters were measured in different cell types, albeit from the same host, a trivial 
explanation for these observations would be that the restrictive temperature for this 
mutant varies with cell type. A more direct test of mitogenic activity of PA 104 in CEF 
would be useful to exclude this possibility.
The experiments reported in this chapter indicate that factors sited in or in 
proximity to the plasma membranes of fibroblasts are important for both the 
transforming and mitogenic activities of pp60. Preliminary data indicate that membrane
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association of pp60 is required for induction of AP-1 binding activity, since temperature 
shift of quiescent RCAN 29A2-infected CEF does not result in stimulation of AP-1 
binding activity. Furthermore, it is apparent that other events required for mitogenesis 
and transformation are dependent upon membrane association of pp60, since elevating 
AP-1 activity (with PMA) in concert with reactivating ttLA29A2 pp60 does not result in 
transformation or re-entry into cycle. If one assumes that both endpoints are mediated 
through the tyrosine kinase activity of pp60 (but see refs. 328,329), this implies that 
phosphorylation of common target(s) results in both biological endpoints, or that 
multiple signal transduction pathways, initiating at the cell membrane, are activated in 
response to Src. The former possibility allows little scope for dissecting the transforming 
and mitogenic activities. The latter situation might allow dissociation of these two 
activities in one of two ways :
a) use of mutants defective for substrate recognition and \  or association with 
other signalling proteins. These might be mutated around the autophosphorylation site at 
tyrosine 416 or in the N-terminal homology domains of pp60, or mutants such as PA104 
described above.
b) use of pp60 derivatives that are membrane associated through interactions 
other than the pp60-32kDa complex. This might favour interaction with initial targets 
specific to one or other of the pathways leading to transformation or mitogenesis.
Alternatively, one could select appropriate cell types on the basis of their 
behaviour. For instance neuroretinal cells might be useful in examining a mitogenic or 
co-mitogenic activity of Src protein using the 2D-gel approach. However, these cells do 
not normally proliferate in culture, and hence there are practical difficulties associated 
with this approach. It might also be possible to select appropriate cell lines defective for 
certain signal transduction pathways. This approach could yield information on the 
pathway(s) leading to Src transformation and mitogenesis.
Chapter IX
163
IX GENERAL DISCUSSION
One aim of this project was to investigate early consequences of activating the 
transforming and mitogenic activities of the v-Src protein pp60. In particular, I was 
interested in defining changes in phosphoprotein profile and protein synthesis that 
resulted from the induction of these activities. This conceptual approach demanded a 
system where phenotypically normal cells could be stimulated to transform rapidly and 
reversibly under experimental conditions. In addition, I needed a system where 
phenotypically normal cells could be rendered quiescent and yet retain the ability to 
enter cycle upon activating the mitogenic activity of pp60. Both requirements could be 
fulfilled by employing a temperature sensitive mutant of pp60. Temperature sensitive- 
transformation mutants are, by definition, temperature sensitive for transformation and 
have also been used successfully to investigate the mitogenic activity of 
pp6026>27*29*242'243. Many of these mutants induce wild-type characteristics of 
transformation at permissive temperature, whilst being essentially biologically inactive 
at restrictive temperature. The biochemical lesions in a number of these mutants have 
been described55-88-234 (see 1.7), the most frequent being defects in membrane localization 
and \  or kinase activity. As outlined in section 1.13, this conceptual approach to defining 
early consequences of the transforming and mitogenic activities of pp60 depends on 
minimizing the impact of adventitious activities of pp60. For this reason I decided to use 
a temperature sensitive mutant whose biochemical behaviour deviates only minimally 
from the wild-type protein. One would predict that such a mutant would express most if 
not all adventitious activities at restrictive temperature whilst the host cells are still 
phenotypically normal. These non-transforming activities might manifest themselves in 
altered protein and phosphoprotein profiles in comparison with parental cells under the 
same conditions, and therefore one might be able to identify a group of src-responsve 
proteins \  phosphoproteins whose perturbation is not sufficient to elicit transformation. 
By inducing phenotypic transformation and mitogenesis in this system, one predicts that 
important early changes would be visible against a preset background of adventitious 
events.
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One mutant generated in this laboratory, ttLA32, appeared from previous work to 
have properties compatible with some aspects of this approach. In chick embryo 
fibroblasts (CEF) the protein retains both membrane association93 and kinase activity at 
restrictive temperature299, whilst being temperature sensitive for a number of 
characteristics of transformation. Information on the mitogenic properties of this mutant 
was not available. This mutant was chosen for further study together with a well 
characterised temperature sensitive mutant, ttLA29 and the wild-type parent wfPrague A. 
In view of the practical difficulties associated with generating equivalent infected CEF 
cultures for analysis by 2D-gel electrophoresis, I decided to generate clonal immortal 
fibroblast lines expressing these Src proteins. Much of this thesis is dedicated to 
describing the generation and characterisation of these clonal lines.
Previous attempts to introduce ttLA32 RSV into established Rati fibroblasts had 
been largely unsatisfactory (my own data, not shown, M. Welham and J. Wyke, personal 
communication), so expression of the mutant Src was achieved under the control of a 
murine retroviral promoter. Additional experiments were undertaken in CEF, using 
replication-competent retroviral constructs. Chapter HI documents the construction and 
transfection of the expression constructs used in these studies, and the biological 
properties of the clonal lines generated. The results indicate that it was possible to 
express the ttLA32 protein in Rati cells, and that this mutant was temperature sensitive 
for transformation in Rati cells.
Subsequent chapters have described the biochemical properties of ttLA32 pp60 
in Rati cells, and in general these match the published data closely. Rati cells 
expressing this mutant exhibit elevated levels of protein phosphotyrosine at both 
permissive and restrictive temperatures. In addition I have demonstrated that the mutant 
protein is non-conditionally phosphorylated on tyrosine in vivo, presumably as a result of 
autophosphorylation (see chapter V). Both results indicate that the kinase is functional in 
vivo at both permissive and restrictive temperatures. The significance of these results is 
however unclear, since the well characterised temperature sensitive mutant teLA29 Src 
also demonstrated significant levels of protein phosphotyrosine at restrictive
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temperature, and displayed wild-type in vivo autophosphorylation characteristics. Hence, 
the characteristics of teLA29 Src in this clonal Rati line differ from those reported for 
infected CEF299. It is noteworthy that Weber and colleagues have reported similar results 
in other cell types208-292. The lower restrictive temperature used might result in 
significant leakiness in the kinase activity of the teLA29 in rodent cells. This implies that 
the major transformation defect of &LA29 Src in Rati cells is its failure to associate with 
the particulate fraction of the cell at restrictive temperature. Assuming that this is the 
case, one can make two predictions. Firstly, it should be possible to dissociate membrane 
association and kinase activity in ttLA29 Src, and secondly one should be able to use 
ttLA29 Src to look for membrane substrates in Rati cells. This latter property of teLA29 
Src might be useful in further defining changes observed using the &LA32 system. 
Dissociation of the membrane binding and kinase activities of pp60 will be discussed 
later in this chapter.
In summary, these data suggest that ttLA29 Src is itself a minimal deviation 
mutant in Rati cells, and that its properties complement those of rsLA32 Src with regard 
to the proposed 2D-gel approach to identifying early events in Src-induced 
transformation and mitogenesis.
In vitro kinase activity has been routinely used as an indicator of the in vivo 
activity of numerous mutants of pp60, and in general, the apparent in vitro and in vivo 
activities correlate well. Published data indicate that CEF infected with &LA32 RSV 
contain in vitro kinase activity when cultured at either permissive or restrictive 
temperature, in contrast to &LA29 infected cells where the in vitro kinase activity is 
thermolabile299. I have attempted to repeat these results in the clonal Rati lines. As 
documented in chapter IV, I have been unable to detect significant kinase activity in 
immunoprecipitates prepared from clonal Rati f32 or in immunopnecipitates prepared 
from CEF infected with RCAN 32, under a variety of conditions. In contrast, kinase 
assay of immunoprecipitates prepared from cells expressing teLA29 Src demonstrated 
clear temperature sensitivity, as had been observed in infected cultures of Rati and 
CEF94-299. This raises some interesting questions. Firstly, why is it not possible to detect
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in vitro activity of the ttLA32 protein when cells expressing this mutant exhibit elevated 
levels of protein phosphotyrosine ? Secondly, why does the in vitro activity of the 
tsLA29 protein not mimic its in vivo activity ? Possible reasons for the lack of in vitro 
kinase activity in immunoprecipitates prepared from cells expressing ttLA32 Src are 
given in chapter IV. It seems likely that this mutant protein might be particularly 
susceptible to conformational change upon lysis or interaction with precipitating 
antibodies. Similar problems were encountered by Sefton et al. studying ttLA90, toNY68 
and teBK5332. In addition, this protein might be somewhat susceptible to proteolysis, 
since a degradation product of pp60 was found in immunoprecipitates prepared from 
phosphate labelled Rati f32 cells grown at permissive temperature (see chapter IV). I am 
not aware of other transforming mutants that exhibit undetectable in vitro activity under 
the mild conditions of lysis employed.
The behaviour of fsLA29 pp60 in in vitro assays is also somewhat puzzling. In 
view of the elevated level of protein phosphotyrosine in Rati f29 cells at restrictive 
temperature, the lack of activity in immunoprecipitates prepared from cells under these 
conditions suggests one of three things : the mutant protein is labile when prepared from 
cells at restrictive temperature332, or the precipitating antibody selectively complexes 
inactive kinase at restrictive temperature, or an inactive kinase is capable of elevating 
cellular phosphotyrosine by a mechanism independent of its own enzymatic activity. The 
latter suggestion would liken teLA29 pp60 at restrictive temperature to the product of the 
v-crk oncogene105. However, Snyder et al. were unable to detect elevated levels of 
cellular phosphotyrosine in Rati cells expressing SF2, a point mutant (lysine 295 to 
methionine) of v-src non-conditionally defective for in vitro kinase activity, suggesting 
that this mutant is incapable of stimulating endogenous tyrosine kinases46. Although this 
result does not support the hypothesis that ttLA29 pp60 elevates cellular 
phosphotyrosine at restrictive temperature independently of its intrinsic kinase activity, it 
is noteworthy that SF2 is not detectably phosphorylated either on tyrosine or serine in 
vivo, and indeed, is not a substrate for protein kinase A in vitro46. Similar results were 
obtained by Parsons and colleagues using defective kinases generated by point mutations
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at amino acids 430-43344*233. Cells expressing these CHpm mutants display lowered 
levels of tyrosine phosphorylated p36 protein44, and both the serine and tyrosine 
phosphate content of the mutant Src proteins is reduced44*233. The lack of N-terminal 
serine phosphorylation might suggest that the native conformation of pp60 is dirupted by 
the SF2 and CHpm mutations, leading to a loss of both kinase and perhaps, other 
activities. It is formally possible that other kinase inactive mutants whose overall 
structure is conserved might behave differently. However, studies have demonstrated 
that there are functional interactions between the catalytic and N-terminal domains of the 
src-family proteins (see chapter I), and hence the mutants required might be difficult to 
obtain.
One alternative explanation for the lack of kinase activity in immunoprecipitates 
prepared from Rati f29 cells at restrictive temperature might be that the protein is 
complexed to pp50 and PP9050, a form which has been shown to exhibit much reduced 
protein kinase activty in vitro56. However, Welham and Wyke have demonstrated that 
most of the Src protein at restrictive temperature in Rati teLA29 cells is monomeric94. It 
should also be stressed that the lack of in vitro catalysis may be due only to the 
conditions used to measure catalysis and not a true absence of kinase activity332.
Previous work from this laboratory has demonstrated that ttLA29 pp60 is located 
predominantly in the cytoplasm in Rati cells grown at restrictive temperature93*94. 
Assuming that some of this protein retains tyrosine kinase activity, the in vitro kinase 
assay data suggest that the majority of this active protein is not accessible to the 
precipitating antibody, as a result of its environment or conformation. Cytoplasmic 
localization per se appears not to preclude immunoprecipitation of in vitro active kinase, 
as evidenced by my results obtained using the myristylation mutant &LA29A2 Src (see 
chapter VIE, discussed later in this chapter). Again, it may be that teLA29 pp60 is 
susceptible to conformational change when precipitated from cells grown at restrictive 
temperature, such that its inherent kinase activity is reduced. Alternatively, it is 
conceivable that the catalytic activity of this protein is reduced at restrictive temperature
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and that elevation of cellular phosphotyrosine in Rati cells results from the thermolabile 
nature of endogenous protein phosphotyrosine phosphatases.
From the preceeeding it is apparent that the biological and biochemical 
characteristics of &LA32, and indeed ttLA29 Src were consistent with these mutants 
being employed in the aforementioned approach to describing early events of v-src- 
induced transformation and mitogenesis. It remained important to establish whether the 
Rati f32 line could be rendered quiescent by serum deprivation at restrictive 
temperature, as had been demonstrated for Rati cells expressing ttLA29 RSV29. The 
results presented in chapter VI indicate that this mutant is temperature sensitive for both 
the transforming and mitogenic activities of pp60. This is perhaps somewhat surprising 
in view of the characteristics of this protein. As discussed in chapter VI, it is plausible 
that the transforming and growth-regulatory properties of pp60 are effected through 
common mediators, and as such are not dissociable in fibroblasts. Experiments 
undertaken in an attempt to dissociate the mitogenic and tranforming activities of pp60 
are described in chapter VIII, and will be discussed later in this chapter.
Preliminary experiments to define changes in protein profile in temperature- 
shifted quiescent cultures of Rati f32 cells have demonstrated a small number of 
proteins whose synthesis \  degradation is modulated by activating the transforming and 
mitogenic activities of ttLA32 Src. The small number of changes I have observed is in 
good agreement with data published by Durkin and Whitfield27, who have defined six 
proteins which appear or disappear as quiescent ttLA23-infected NRK cells transform 
and re-enter cycle following shift to permissive temperature. However, due to the 
differences in separation techniques employed in these studies, I am unable to comment 
on whether the changes I have observed correspond to those observed in other systems. 
Indeed, it is important that these changes are investigated in cells expressing other 
temperature sensitive mutants, for instance ttLA29 and ttLA29A2 to ascertain 
correlation with transformation and mitogenesis.
Preliminary attempts to define early changes in the phosphoprotein profile of 
quiescent Rati f32 cells following temperature shift have been disappointing. Possible
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technical reasons for the failure of these experiments are given in the discussion to 
chapter VIII. In addition to these technical problems, parallel analysis of candidate 
substrates might facilitate interpretation of data from these experiments. These 
candidates might include the Ras GTPase activator protein, GAP138, members of the 
MAP kinase family255, c-Raf-1333 and the insulin-like growth factor I receptor292. With a 
knowledge of the labelling and electrophoretic behaviour of these candidate substrates \  
effectors, it would be possible to use them as internal reference points in the 2D-gel 
analysis.
Data obtained from the 2D-gel approach outlined above will correlate changes in 
protein synthesis and phosphorylation with both exit from the quiescent state and 
transformation. To further define the role (if any) of these biochemical events it would 
be useful to test mutants that are thermolabile for one biological endpoint whilst non- 
conditionally defective for the other. Since all temperature sensitive transformation 
mutants tested to date appear to be thermolabile for both the morphological and growth 
regulatory aspects of transformation in fibroblasts, I have attempted to generate a mutant 
defective for morphological transformation which nonetheless should retain a 
thermolabile kinase activity. Studies by Hanafusa and Calothy and colleagues indicate 
that pp60 proteins defective for membrane localization by virtue of mutations in the 
myristylation domain are still capable of stimulating proliferation of primary chick 
neuroretinal cells in the absence of morphological transformation32.1 therefore mutated 
the myristylated glycine of teLA29 pp60 to alanine, a residue that does not serve as a 
substrate for the myristyl-transferase37-111. The generation and properties of this mutant 
have been described in detail in chapter VIII. From the data presented, it would appear 
that this mutant is defective in activities leading to both morphological tranformation and 
mitogenesis, despite a retention of in vitro kinase activity. Together with the previously 
discussed properties of teLA29 pp60 in Rati cells, these data suggest that a cytoplasmic 
Src protein with associated tyrosine kinase activity is not sufficient to stimulate 
mitogenesis in quiescent fibroblasts. A number of technical explanations are offered for 
the failure of this protein to stimulate mitogenesis in Rati cells, although many of these
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problems were overcome in a CEF background. As discussed in chapter VIII, this result 
implies interaction with or phosphorylation of common targets results in both biological 
endpoints, or that multiple signal transduction pathways, initiating at the cell membrane 
are activated in response to Src. Alternatively, it is plausible that changes in cell 
structure or cell-cell communication resulting from morphological transformation are 
required to enable expression of the mitogenic activity of pp60. This is not to say that 
morphological transformation of fibroblasts invariably leads to deregulated growth 
control, since the growth of rat fibroblasts transformed with v-fos is at least partially 
serum dependent (R. Hennigan, personal communication). It would be interesting to 
express teLA29A2 Src in quiescent v-/as-transformed fibroblasts such that reactivation 
of pp60 could be effected in a transformed cell background. The apparent toxicity of the 
protein in Rati cells might be a problem, though it should be possible to co-express both 
v-fos and teLA29A2 src in CEF. If this approach allowed the temporal dissociation of 
mitogenesis and transformation, changes in protein synthesis and phosphorylation could 
be investigated using the 2D-gel approach.
An alternative approach to the problem of dissociating mitogenesis and 
morphological transformation in Src-transformed fibroblasts employs cells defective for 
aspects of certain signal transduction pathways involved in mitogenesis. Cells for these 
studies can be obtained in one of two ways. Firstly, a number of cell lines have been 
selected on the basis of their non-responsiveness to specific agonists, and in at least two 
cases, the molecular basis of the defect is partially understood247*289. Secondly, it is 
possible to obtain cells defective for signalling pathways using specific agonists or 
antagonists. For instance, protein kinase C can be downregulated in Swiss 3T3 
fibroblasts in response to chronic TPA treatment334, this enabling an examination of the 
requirement for this enzyme in a given situation. At this point it is worth noting that 
downregulation of protein kinase C abolishes the mitogenic activity of activated Ras, 
without affecting morphological transformation202-204. Indeed, microinjection studies 
have suggested that Ras functions downstream of tyrosine kinase oncogene products in 
the induction of transformation and stimulation of cell proliferation182. Additional studies
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have indicated a requirement for two parallel /tas-dependent pathways, one dependent on 
protein kinase C, in mitogenesis335, and it is tempting to speculate that GAP and 
associated proteins play a role in one or both of these pathways. However, the role of 
protein kinase C in Src-induced mitogenesis and transformation is at present unclear. A 
number of studies in NRK cells336, NIH 3T3337 and CEF338 have indicated that protein 
kinase C activity is increased in response to activating thermolabile pp60 or Src-induced 
transformation. However, other studies suggest that prior downregulation of the enzyme 
does not prevent Src-induced mitogenesis or transformation, and therefore may be 
irrelevant to these endpoints150. Preliminary data from this laboratory indicate that 
chronic treatment of Rati tsLA29 cells with phorbol dibutyrate has no effect on either 
the mitogenic or transforming activity of pp60 upon temperature shift of quiescent 
cultures (A. W. Wyke, personal communication). Experiments to test this result in Swiss 
3T3 cells, where the response to chronic phorbol ester treatment is well characterised, 
are underway (M. Unlu, personal communication). These data are relevant in 
consideration of the published Src-induced changes in AP-1 activity28*29, since phorbol 
ester agonists of protein kinase C are potent stimulators of AP-1 activity331. It is 
conceivable that the observed transient increases in AP-1 activity following temperature 
shift of Rati ttLA29 are merely a consequence of the increase in protein kinase C 
activity following activation of pp60. Although there is some evidence to suggest that 
transcripts from an AP-1 responsive gene, stromelysin, accumulate following 
temperature shift of quiescent Rati ttLA29 cells (A. W. Wyke, personal 
communication), the mechanism (i.e. transcriptional or post-transcriptional) and factors 
required are not defined. Indeed it has been reported that transcriptional activity of the 
stromelysin gene is mediated through sequences in addition to AP-1 elements339, perhaps 
by the c-ets family proteins340. Further experiments are required to confirm or otherwise 
the functional involvement of AP-1 in mediating early events following activation of 
thermolabile pp60. In particular, a study of Src mutants defective for transformation and 
\  or mitogenic activity might allow correlation of increased AP-1 activity with one or 
other of these biological endpoints, or with a particular property of pp60, such as
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membrane localization or kinase activity. Complementary approaches designed to 
abrogate AP-1 activity, by expression of either dominant inhibitors of functional 
complex formation or expression of anti-sense RNA might also yield information on the 
requirement for AP-1 following temperature shift. However, one should appreciate that 
the number of structurally distinct AP-1 complexes in vivo is potentially large, and that 
each member of this family is likely to respond differently to inhibition.
CONCLUSIONS
Protein serine \  threonine phosphorylation and dephosphorylation is a well 
documented mechanism whereby cells regulate the activity of critical enzymes. Protein 
tyrosine phosphorylation is presumed to offer the cell another means of covalently 
regulating specific enzymes. Many studies have been undertaken on the assumption that 
pp60v_,src transforms fibroblasts in vitro by modulating the activity of critical membrane 
proteins in an allosteric fashion. This model predicts that key regulators of Src 
transformation might be identified by virtue of their tyrosine phosphorylation in 
transformed cells. Despite a great deal of effort, non-candidate approaches to identifying 
targets for the tyrosine kinase activity of pp60 have been largely unsuccessful. A number 
of tyrosine phosphorylated proteins have been identified, although in no case is there 
inviolate correlation between transformation and phosphorylation of these substrates (see 
1.9-12). In view of these results and the technical problems involved in this approach, 
many groups have taken to examining candidate substrates for differential 
phosphorylation and activity following Src transformation. This approach has identified 
a number of potential substrates for the tyrosine kinase activity of the Src protein, and 
tyrosine phosphorylation of a number of these candidates has been demonstrated to 
correlate with transformation using a battery of partially, conditionally and non- 
conditionally defective mutants (see 1.9-12). In addition, tyrosine phosphorylation of a 
number of these proteins has been demonstrated to occur in mitogenic stimulation of 
normal cells, indicating that these proteins may play a role in normal growth control (see
1.6). These studies have not however examined the temporal sequence of events
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following activation of Src, and indeed many of the described changes may in 
themselves be consequences of transformation.
Recent data from diverse systems have indicated that the primary role of protein 
tyrosine phosphorylation may not be in the allosteric control of enzyme activity. Much 
data (see 1.6) indicates that an important function of tyrosine phosphorylation is to 
promote the formation of very specific, stable protein-protein interactions. Tyrosine 
phosphorylation and specific complex formation occur in response to both growth factor 
stimulation and oncogenic agents such as retroviral tyrosine kinases. Available data 
strongly suggest that formation of these specific complexes is dependent both on tyrosine 
phosphorylation of certain components and structural features, SH2 domains, of other 
components. One model accounting for these features has been described in chapter I of 
this thesis. Briefly, this model suggests that tyrosine phosphorylation in response to 
mitogenic or transforming agents functions to recruit specific signalling molecules to 
appropriate sites in the cell, often at the plasma membrane. These signalling proteins 
(e.g. GAP, PI 3-kinase, PLCy-1) are then able to utilize localised concentrations of 
substrates to generate specific intracellular signals. This allows a highly co-ordinated and 
rapid response to stimulation, and suggests that allosteric modulation might not be 
essential to this mechanism of control; relocation of enzymes to their substrates may be 
the overriding regulatory mechanism. It follows that important early effectors for growth 
factor receptors and oncogenic kinases might not be substrates for tyrosine 
phosphorylation, and hence might not be identifiable by conventional labelling 
approaches; recruitment to appropriate membrane locations might be dependent only on 
pp60 autophosphorylation. I speculate that the v-Src product pp60 may transform 
fibroblasts in vitro by recruiting specific proteins to appropriate plasma membrane and 
cytoskeletal environments through formation of specific phosphotyrosine-dependent 
complexes. This could account for two main transformation requirements of pp60: 
tyrosine kinase \  autophosphorylation activity and membrane localization. Furthermore, 
one can envisage a number of similar but distinct routes to transformation based on
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subtle variations of this model. These models and their implications with respect to the 
search for crucial Src effectors are outlined below.
Chapter I presented evidence supporting the contention that autophosphorylated 
growth factor receptors and oncogenic tyrosine kinases, which are themselves tyrosine 
autophosphorylated, form specific complexes with SH2 domain containing proteins (see
1.6). Two identified complex proteins, PI 3-kinase and PLC-yl act upon lipid substrates 
and hence are dependent on relocation to membrane environments for functional 
activity. A third SH2-containing complex member, GAP, associates with and stimulates 
the GTPase activity of membrane bound Ras proteins. Signals generated by these 
complexes would be dependent on the integrity of the membrane complex, and hence on 
the tyrosine phosphorylation of specific components. Signal termination could occur by 
internalisation and proteolysis of the the complexes, or by dephosphorylation of specific 
autophosphorylation sites. Interesting in this respect is the identification of an SH2- 
containing protein tyrosine phosphatase which might plausibly promote signal 
termination224. pp60v' 5rc might transform cells by promoting constitutive complex 
formation and signalling in a number of ways. Since pp60v"lSTC autophosphorylation is 
apparently ligand-independent, signalling complexes could form around the Src protein; 
the constitutive tyrosine kinase activity of pp60v_,STC would preclude dephosphorylation 
and signal termination. Furthermore, this could account for the behaviour of SH2- 
domain mutants of pp60 that are host-range restricted for transformation; the prediction 
is that these proteins fail to associate with appropriate signalling molecules in the non- 
permissive host. As outlined in chapter I, a number of biochemical activities have been 
identified in association with pp60v'5rc.
Alternatively, pp60v-,yrc kinase activity might promote signal complex formation 
upon other membrane targets. The most likely candidates for such a model would be 
tyrosine kinase-type receptor molecules. I speculate that the reported phosphorylation of 
growth factor receptors in Src transformed cells might result in inappropriate formation 
of otherwise ligand-dependent signalling complexes. The constitutive tyrosine kinase 
activity of pp60v_,src might preclude dephosphorylation and inactivation of these
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complexes. This model could account for the host-range specific transforming activity of 
some pp60v_5rc mutants defective for autophosphorylation77 : signal complex formation 
is not dependent on the structural integrity of the pp60v"5rc autophosphorylation site, 
and full transformation would require the presence of appropriate host receptors. Note 
that this model suggests that parameters of transformation might be dissociable using 
appropriate autophosphorylation mutants in the correct cellular background. However, 
this model has practical implications for attempts to define important targets for Src. To 
illustrate this point I will draw parallels with polypeptide growth factor function. 
Complete polypeptide mitogens elicit a discrete number of early biochemical events that 
appear necessary for ligand-induced DNA synthesis. One current hypothesis is that DNA 
synthesis will result in these cells if this spectrum of early events can be achieved by 
treatment with a combination of factors that individually are non-mitogenic (see 1.6 and 
ref. 163). At the molecular level, this implies that DNA synthesis will result from a 
complete mitogen recruiting all required activities to its cognate receptor or alternatively 
DNA synthesis will result from activities recruited to two or more distinct receptor types 
in response to stimulation with co-mitogens. Assuming that transformation occurs in a 
similar fashion, it follows that the initial (receptor) targets for Src activity might vary 
with the particular mutant or cell type under study i.e transformation can result from 
functional redundancy at the level of the initial target. Correlating early events with the 
biological endpoint is therefore difficult unless one has a knowledge of the intermediate 
steps linking the intitial target with the end result. As noted above, these intermediate 
steps need not involve tyrosine phosphorylation nor changes in the intrinsic activity of 
particular enzymes, and are therefore potentially very difficult to identify by classical 
methods of Src research. Candidate approaches designed with the action of polypeptide 
mitogens in mind might be the best way of addressing these problems, and I believe that 
these studies should not be biased towards identification of tyrosine phosphorylated 
intermediates for the reasons alluded to above.
A third model based on the functional properties of isolated SH2-domains and the 
behaviour of p47^fl^ "cr^ might also be invoked in explaining the transforming activity of
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pp60v_,src. A recent report has indicated that recombinant SH2 domains from PLC-y can 
inhibit dephosphorylation of the EGF receptor in vitro, leading Rotin et al.341 to 
speculate that the resulting increase in tyrosine phosphorylation and signal molecule 
recruitment might result in tranformation341. The behaviour of p47#fl£ 'cr^ is particularly 
interesting since this oncoprotein elevates cellular phosphotyrosine in the absence of an 
identifiable kinase domain105. As discussed in chapter I, v-Crk is believed to transform 
via a modulation of endogenous enzyme activity, and SH2 domains have been 
demonstrated to be important determinants in v-Crk oncogenesis218. v-Src might 
transform in a similar fashion by locking receptor molecules or other tyrosine 
phosphorylated proteins in an active form through interaction with the kinase SH2 
domain. The apparent requirement for v-Src kinase activity is more difficult to 
accommodate in this model. Tyrosine kinase activity might be required for initiating the 
transformed state by phosphorylating appropriate targets which are then protected by the 
adjacent SH2 domain. This would predict that maintenance of the transformed state 
might not require continuing Src kinase activity. To my knowledge, this has not been 
tested, and indeed mutants of pp60v_,src conditional for kinase activity but wild-type for 
transformation would not be identified by conventional biological screening. An 
alternative idea is that exposure of the pp60 SH2 domain is important in conferring 
oncogenicity, and that activated kinase activity is merely a consequence of the structural 
requirements for exposure of SH2. Some published data support the idea217 that tyrosine 
527 phosphorylation promotes interaction between the catalytic and SH2 domains of 
pp60c_,srCl76-342, and indicate that the protein has little kinase activity in this form83. 
Overexpression of this protein is non-transforming in fibroblasts54. If tyrosine 527 
phosphorylation is prevented by point mutation82-83 or C-terminal truncation84, the 
biochemical and transforming activities of the protein increase dramatically. It is 
plausible that these mutations prevent cis interaction between the kinase and SH2 
domains, exposure of SH2 allowing binding of tyrosine phosphorylated ligands. Binding 
of v-Src SH2 domains to these ligands might protect them from dephosphorylation and 
inactivation. Polypeptide growth factors (promoting autophosphorylation of their
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cognate receptors) or pp60 kinase activity might be required for initiating 
transformation.
In summary, the described models make five general points :
a) transformation may occur through one or more of a number of related but 
distinct pathways based upon formation of signalling complexes
b) there may be redundancy at the level of the primary tyrosine phosphorylation 
event(s)
c) relocalization of specific proteins to their substrates may be more important 
than overt changes in their intrinsic catalytic activity
d) tyrosine kinase activity might be dispensable for the maintenance of 
transformation, or might be a consequence of structural changes activating another 
transforming activity of pp60, e.g. exposure of SH2. The latter suggestion does not rule 
out the involvement of kinase activity in transformation; it merely indicates that tyrosine 
kinase activity alone is insufficient
e) most and maybe all protein tyrosine phosphorylation events seen upon v-Src 
transformation are adventitious, resulting from association with pp60 or indiscriminate 
activity against other proximal proteins.
The conceptual approach to identifying pp60 substrates outlined in this thesis 
might therefore be inadequate to detect physiological effectors of Src function. The 
models presented indicate that primary events in v-Src function need not be tyrosine 
phosphorylation events, or that if these initiating events are marked by tyrosine 
phosphorylation, there is likely to be functional redundancy at this level. This suggests 
that even discriminatory mutants such as ttLA32 and ttLA29 Src are perhaps unlikely to 
be useful in the optimised 2D gel approach I have outlined in this thesis, since observed 
changes in tyrosine phosphorylation might simply reflect subtle changes in pp60 
localization. However, many of the speculative suggestions noted above are at present 
untestable, since it appears likely that appropriate kinase activity is important in the 
context of SH2 domain interactions. Abrogation of kinase activity, even by conservative
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point mutation tends to have long-range effects on pp60 conformation45-46 and hence, it is 
difficult to analyse the effect of pp60 kinase activity and pp60 SH2 domains in isolation.
The properties of fsLA29 and ttLA32 pp60 are consistent with some features of 
the models presented above. First, both proteins increase protein phosphotyrosine in 
vivo, and both are tyrosine phosphorylated in vivo at restrictive temperature, suggesting 
that tyrosine phosphorylation alone is insufficient for transformation. The models 
presented above would predict that ttLA29 pp60 might participate in the formation of 
appropriate signalling complexes at restrictive temperature, though these would be 
functionally inactive through cytosolic localization until shift to permissive temperature. 
The observed in vivo kinase and autophosphorylation activity of teLA29 pp60 are 
consistent with this possibility. Second, the reported membrane localization of teLA32 
pp60 at restrictive temperature indicates that correct localization together with kinase 
activity is also insufficient to elicit transformation. One possibility therefore is that other 
pp60 sequences determine the transforming potential in this background, either by 
directing subtle changes in localisation or complex formation. The ttLA32 SH3 domain 
mutation is interesting in this regard. This particular mutant would be useful in defining 
changes in complex formation following temperature shift given its wild-type 
biochemical properties. Experiments to assess the effect of the SH3 domain mutation 
upon binding of tyrosine phosphorylated ligands to the adjacent SH2 domain might be 
particularly informative. Furthermore, one might suggest that the composition of the 
proposed signalling complex formed around ttLA29 pp60 at restrictive temperature is 
unlikely to change following temperature shift; relocation of associated enzymes to 
substrates would elicit transformation. This again predicts that any observed tyrosine 
phosphorylation events might be adventitious. Although the speculative models outlined 
above suggest that the described optimised approach to identifying early tyrosine kinase 
targets for Src is perhaps naive, it is clear that the same mutants and cell lines might be 
useful in investigating the role of signal complex formation in Src transformation. 
Studies on the complex forming activity of Src mutants would also be complemented by
179
parallel studies on growth factor receptor complex formation in these same cells in view 
of the proposed involvement of these molecules in Src transformation.
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